Download:
pdf |
pdfAttachment 6
National HIV Surveillance System (NHSS)
OMB # 0920-0573
HIV/AIDS Surveillance Report 2010
1
Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010
Vol. 22
Diagnoses of HIV infection among adults and adolescents, by sex and
transmission category, 2010—46 states and 5 U.S. dependent areas
Males
Females
N = 37,910
N = 10,168
Male-to-male sexual contact
Heterosexual contact a
Injection drug use (IDU)
Other b
Male-to-male sexual contact and IDU
Note. All displayed data have been statistically adjusted to account for reporting delays and missing risk-factor information, but not for
incomplete reporting.
a
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
b Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
CS-228642
The HIV Surveillance Report is published annually by the Division of HIV/AIDS Prevention, National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC),
U.S. Department of Health and Human Services, Atlanta, Georgia.
Data are presented for diagnoses of HIV infection and AIDS reported to CDC through June 2011.
The HIV Surveillance Report is not copyrighted and may be used and reproduced without permission. Citation
of the source is, however, appreciated.
Suggested citation
Centers for Disease Control and Prevention. HIV Surveillance Report, 2010; vol. 22.
http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Published March 2012. Accessed [date].
On the Web: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
Confidential information, referrals, and educational material on HIV infection and AIDS
CDC-INFO (formerly, the CDC National AIDS Hotline)
1-800-232-4636 (in English, en Español)
1-888-232-6348 (TTY)
E-mail: cdcinfo@cdc.gov
Acknowledgments
Publication of this report would not have been possible without the contributions of the state and territorial
health departments and the HIV surveillance programs that provided surveillance data to CDC.
This report was prepared by the following CDC staff and contractors: Stacy Cohen, Xiaohong Hu, Daxa Shah,
Sabitha Dasari, Irene Hall, Timothy Green, Marie Morgan (editing), Michael Friend (desktop publishing),
Janet Brzuskiewicz (graphics), Ruiguang Song, John Gerstle, Sridevi Wilmore, Jianmin Li, Xiuchan Guo, the
HIV Incidence and Case Surveillance Branch, the Quantitative Sciences and Data Management Branch, and
the Prevention Communication Branch.
Contents
Contents
Commentary
Technical Notes
5
12
Tables
Section 1 Diagnoses of HIV Infection and AIDS
1a
Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2007–2010—46 states with
confidential name-based HIV infection reporting
17
1b
Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2007–2010—46 states and 5
U.S. dependent areas with confidential name-based HIV infection reporting
19
2a
AIDS diagnoses, by year of diagnosis and selected characteristics, 2007–2010 and cumulative—United
States
21
2b
AIDS diagnoses, by year of diagnosis and selected characteristics, 2007–2010 and cumulative—United
States and 6 U.S. dependent areas
23
3a
Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2010—46 states with
confidential name-based HIV infection reporting
25
3b
Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2010—46 states and 5 U.S.
dependent areas with confidential name-based HIV infection reporting
26
4a
AIDS diagnoses, by race/ethnicity and selected characteristics, 2010—United States
27
4b
AIDS diagnoses, by race/ethnicity and selected characteristics, 2010—United States and 6 U.S. dependent
areas
29
5a
Diagnoses of HIV infection among children <13 years of age, by race/ethnicity, 2007–2010—46 states
with confidential name-based HIV infection reporting
31
5b
Diagnoses of HIV infection among children <13 years of age, by race/ethnicity, 2007–2010—46 states and
5 U.S. dependent areas with confidential name-based HIV infection reporting
31
6a
AIDS diagnoses among children <13 years of age, by race/ethnicity, 2007–2010 and cumulative—United
States
32
6b
AIDS diagnoses among children <13 years of age, by race/ethnicity, 2007–2010 and cumulative—United
States and 6 U.S. dependent areas
32
7
AIDS diagnoses among children <13 years of age, by year of diagnosis, 1992–2010—United States and
6 U.S. dependent areas
33
8
Diagnoses of HIV infection among adult and adolescent Hispanics/Latinos, by transmission category and
place of birth, 2010—46 states and 5 U.S. dependent areas with confidential name-based HIV infection
reporting
34
9
AIDS diagnoses among adult and adolescent Hispanics/Latinos, by transmission category and place of
birth, 2010—United States and 6 U.S. dependent areas
35
10a
Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2009—46 states
with confidential name-based HIV infection reporting
36
10b
Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2009—46 states
and 5 U.S. dependent areas with confidential name-based HIV infection reporting
37
Section 2 Deaths and Survival after a Diagnosis of HIV Infection or AIDS
11a
Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2007–
2009—46 states with confidential name-based HIV infection reporting
38
11b
Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2007–
2009—46 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting
40
3
12a
Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2007–2009 and
cumulative—United States
42
12b
Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2007–2009 and
cumulative—United States and 6 U.S. dependent areas
44
13a
Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2002–2006, by
selected characteristics—46 states with confidential name-based HIV infection reporting
46
13b
Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2002–2006, by
selected characteristics—46 states and 5 U.S. dependent areas with confidential name-based HIV infection
reporting
47
14a
Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2002–2006, by selected
characteristics—United States
48
14b
Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2002–2006, by selected
characteristics—United States and 6 U.S. dependent areas
49
Section 3 Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
15a
Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2007–2009—
46 states with confidential name-based HIV infection reporting
50
15b
Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2007–2009—
46 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting
52
16a
Persons living with an AIDS diagnosis, by year and selected characteristics, 2007–2009—United States
54
16b
Persons living with an AIDS diagnosis, by year and selected characteristics, 2007–2009—United States
and 6 U.S. dependent areas
56
17a
Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end
2009—46 states with confidential name-based HIV infection reporting
58
17b
Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end
2009—46 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting
59
18a
Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2009—
United States
60
18b
Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2009—
United States and 6 U.S. dependent areas
62
Section 4 HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
19
Diagnoses of HIV infection, by area of residence, 2010—United States and 6 U.S. dependent areas
64
20
AIDS diagnoses, by area of residence, 2010 and cumulative—United States and 6 U.S. dependent areas
65
21
Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence,
year-end 2009—United States and 6 U.S. dependent areas
66
22
Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end
2009—United States and 6 U.S. dependent areas
68
23
Diagnoses of HIV infection, 2010, and persons living with a diagnosis of HIV infection, year-end 2009, by
metropolitan statistical area of residence—United States and Puerto Rico
70
24
AIDS diagnoses, 2010 and cumulative, and persons living with an AIDS diagnosis, year-end 2009, by
metropolitan statistical area of residence—United States and Puerto Rico
74
Web Addresses for Reports of State and Local HIV Surveillance
4
Contents
79
Commentary
The Centers for Disease Control and Prevention
(CDC) collects, analyzes, and disseminates surveillance data on HIV infection and AIDS; these data are
one of the nation’s primary sources of information on
the HIV epidemic in the United States. The annual
surveillance report, published by the Division of HIV/
AIDS Prevention (DHAP), summarizes information
about diagnosed HIV infection and AIDS in the
United States and dependent areas. HIV surveillance
data are used by CDC’s public health partners in other
federal agencies, health departments, nonprofit
organizations, academic institutions, and the general
public to help focus prevention efforts, plan services,
allocate resources, develop policy, and monitor trends
in HIV infection.
The presentation of 2010 data is based on the date
of diagnosis of HIV infection or AIDS (diagnosis as
of December 31, 2010; reported to CDC as of June
30, 2011), not the date of report to CDC. The term
diagnosis of HIV infection refers to a diagnosis of
HIV infection regardless of the person’s AIDS status
at the time of diagnosis. HIV diagnoses do not necessarily represent new infections (incidence): some persons were infected recently, and others were infected
at some time in the past. Because of reporting delays,
the actual numbers of cases diagnosed in a given year
may be higher than the numbers of diagnoses of
HIV infection (unadjusted) presented for recent years;
however, the numbers of diagnoses for a calendar
year typically stabilize after 2 to 3 years of reporting.
Where indicated, counts of diagnoses and deaths
have been statistically adjusted (estimated) to correct
for delays in reporting. Because states implemented
confidential name-based reporting at different times,
the areas included in estimates of numbers and rates
of diagnoses of HIV infection are based on the date of
implementation of confidential name-based HIV
infection reporting. Although all states had successfully implemented confidential name-based HIV
infection reporting by April 2008, a national comparison of HIV diagnosis rates will not be possible until
all states have mature HIV reporting systems.
This report includes estimated numbers and rates of
diagnoses of HIV infection based on data from 51
areas (46 states and 5 U.S. dependent areas) that have
had confidential name-based HIV infection reporting
for a sufficient length of time (i.e., implemented in
area since at least January 2007 and reported to CDC
since at least June 2007) to allow for stabilization of
data collection and for adjustment of the data in order
to monitor trends. This report marks the first time that
HIV diagnosis data from California, Delaware,
Montana, Oregon, Rhode Island, and Washington
(state) have been included in the estimates of diagnoses of HIV infection. According to the cumulative estimated number of AIDS diagnoses through 2010, these
46 states represent approximately 92% of AIDS diagnoses in the 50 states and the District of Columbia.
From 2007 through 2010, the annual estimated
number and rate of diagnoses of HIV infection
remained stable in the 46 states. Estimated numbers
and rates of diagnoses of HIV infection increased in
some subgroups and decreased in others. Variations in
trends between groups are expected and may be due to
differences in testing behaviors, targeted HIV testing
initiatives, more streamlined surveillance practices in
some jurisdictions, and possibly changes in the numbers of new HIV infections in some subgroups. HIV
incidence surveillance data provide the best indication
of changes in the numbers of new HIV infections.
Recent incidence estimates from 2006 through 2009
suggested overall stability in new HIV infections, but
a 21% increase in HIV incidence for persons aged 13–
29 years. The overall stability in HIV incidence estimates is consistent with the stability of overall diagnoses of HIV infection during 2007–2010; during this
time, the numbers of diagnoses of HIV infection
increased 10% among persons aged 15–19 years and
33% among persons aged 20–24 years.
The pie charts on the cover depict the estimated percentages of diagnoses of HIV infection among adults
and adolescents in 2010, by sex and transmission category, for persons residing in the 46 states and 5 U.S.
dependent areas with confidential name-based HIV
infection reporting. As shown in the figure, in 2010, an
estimated 77% of diagnosed HIV infections among
males were attributed to male-to-male sexual contact,
and 86% of diagnosed infections among females were
attributed to heterosexual contact.
5
The analyses of AIDS diagnoses were based on
data from the 50 states, the District of Columbia, and
6 U.S. dependent areas. This report marks the first
time the Republic of Palau has been included in numbers and rates of AIDS diagnoses, deaths, and persons
living with AIDS. For trends in AIDS diagnoses,
tables of data for the most recent 4-year period include
the cumulative totals through 2010 for all 50 states,
the District of Columbia, and 6 U.S. dependent areas.
The 2010 HIV Surveillance Report is organized
into 4 sections:
1. Diagnoses of HIV infection and AIDS
2. Deaths and survival of persons with a diagnosis
of HIV infection or AIDS
3. Persons living with a diagnosis of HIV infection
or AIDS
4. HIV infection and AIDS data, by state and metropolitan statistical area (MSA)
Sections 1–3 (Tables 1a/b–18a/b) present trends in
numbers (statistically adjusted and unadjusted) and
rates (adjusted) of diagnoses of HIV infection and
AIDS, deaths of persons with a diagnosis of HIV
infection or AIDS, and persons living with a diagnosis
of HIV infection or AIDS. Section 4 (Tables 19–24)
presents numbers (adjusted and unadjusted) and rates
(adjusted) of diagnoses of HIV infection and AIDS
and persons living with a diagnosis of HIV infection
or AIDS, by state and MSA. Numerical rankings,
based on rates of AIDS diagnoses, are provided by
MSA in Table 24. All 50 states, the District of
Columbia, and 6 U.S. dependent areas had implemented confidential name-based HIV infection
reporting by April 2008. These 57 areas are represented in the columns of unadjusted numbers in
Tables 19 and 21, presenting diagnoses of HIV
infection and persons living with a diagnosis of HIV
infection (respectively). Because these numbers have
not been adjusted for reporting delays, they should be
viewed as minimums.
The tables in the 2010 report present data in 2 formats. Tables in the first format—labeled “a”—exclude
data from the dependent areas (American Samoa,
Guam, the Northern Mariana Islands, Puerto Rico, the
Republic of Palau (where indicated), and the U.S.
Virgin Islands). Tables in the second format—labeled
“b”—include data from the dependent areas.
Readers are encouraged to read all titles and footnotes carefully to ensure a complete understanding of
the displayed data.
6
HIGHLIGHTS OF ANALYSES
The statements in this section, unless otherwise indicated, are based on estimated data. All rates are per
100,000 population. Our standard for determining
trends in numbers and rates is based on an increase or
a decrease of 5% or more. Exceptions to this standard
were made where numbers were small or rates were
based on small numbers.
Diagnoses of HIV Infection and AIDS
Diagnoses of HIV infection
From 2007 through 2010, the estimated number and
the estimated rate of annual diagnoses of HIV infection in the 46 states with confidential name-based
HIV infection reporting remained stable (Table 1a). In
2010, the estimated rate of diagnoses of HIV infection
in the 46 states was 16.1 per 100,000 population.
• Age group: From 2007 through 2010, the rates
among persons aged 15–19 and 20–24 increased.
The rates among persons aged 35–39, 40–44, and
45–49 decreased. The rates remained stable
among children (aged less than 13 years) and
persons aged 13–14, 25–29, 30–34, 50–54, 55–
59, 60–64, and 65 years and older. In 2010, the
largest percentage of all diagnoses (16%) and the
highest rate per 100,000 population (36.9) were
those for persons aged 20–24 years.
• Race/ethnicity: From 2007 through 2010, the
rate among American Indians/Alaska Natives
increased. The rates among Hispanics/Latinos,
Native Hawaiians/other Pacific Islanders, whites,
and persons reporting multiple races decreased.
The rates among Asians and blacks/African
Americans remained stable. In 2010, blacks/
African Americans accounted for 46% of all
diagnoses of HIV infection. In 2010, the rates
were 62.0 in the black/African American
population, 20.4 in the Hispanic/Latino
population, 19.3 in the Native Hawaiian/other
Pacific Islander population, 15.4 in the
population of persons reporting multiple races,
9.7 in the American Indian/Alaska Native
population, 7.3 in the white population, and 6.5 in
the Asian population.
• Sex: From 2007 through 2010, the rate among
males remained stable, but the rate among
females decreased. In 2010, males accounted for
Commentary
79% of all diagnoses of HIV infection among
adults and adolescents. The rate among adult and
adolescent males was 31.4 and the rate among
females was 8.0.
• Transmission category: From 2007 through
2010, among adult and adolescent males, the
annual number of diagnosed HIV infections
attributed to male-to-male sexual contact
increased. The numbers of infections attributed to
injection drug use, those attributed to male-tomale sexual contact and injection drug use, and
those attributed to heterosexual contact
decreased. Among adult and adolescent females,
the number of infections attributed to injection
drug use and the number of infections attributed
to heterosexual contact decreased. In 2010,
diagnosed infections attributed to male-to-male
sexual contact (61%) and the infections attributed
to heterosexual contact (27%) accounted for
approximately 88% of diagnosed HIV infections
in the 46 states.
AIDS diagnoses
From 2007 through 2010, the estimated number of
annual AIDS diagnoses in the United States remained
stable, and the rate of annual AIDS diagnoses
decreased (Table 2a). In 2010, the estimated rate of
AIDS diagnoses in the United States was 10.8 per
100,000 population.
• Age group: From 2007 through 2010, the rates
among persons aged 15–19, 20–24, 50–54, and
65 and older increased. The rates among persons
aged 13–14, 35–39, 40–44, and 45–49 decreased.
The rates remained stable for children (aged less
than 13 years) and persons aged 25–29, 30–34,
55–59, and 60–64. In 2010, the highest rate was
that for persons aged 40–44 years: 24.8 per
100,000 population.
• Race/ethnicity: From 2007 through 2010, the
rate among American Indians/Alaska Natives
increased. The rates among Hispanics/Latinos,
Native Hawaiians/other Pacific Islanders, whites,
and persons reporting multiple races decreased.
The rates among Asians and blacks/African
Americans remained stable. In 2010, the rates
were 43.0 in the black/African American
population, 13.7 in the Hispanic/Latino
population, 13.7 in the population of persons
reporting multiple races, 9.7 in the Native
Hawaiian/other Pacific Islander population, 7.2
in the American Indian/Alaska Native
population, 4.4 in the white population, and 3.5 in
the Asian population.
• Sex: From 2007 through 2010, the rate among
adult and adolescent females decreased; the rate
among males remained stable. Adult and
adolescent males accounted for 75% of all AIDS
diagnoses made during 2010. The rates among
adults and adolescents in 2010 were 20.0 among
males and 6.4 among females.
• Transmission category: From 2007 through
2010, among adult and adolescent males, the
annual number of AIDS diagnoses with infection
attributed to male-to-male sexual contact
increased. The numbers of AIDS diagnoses with
infection attributed to injection drug use or to
male-to-male sexual contact and injection drug
use decreased. The number of AIDS diagnoses
with infection attributed to heterosexual contact
remained stable. Among adult and adolescent
females, the numbers of AIDS diagnoses with
infection attributed to injection drug use or to
heterosexual contact decreased.
• Region: From 2007 through 2010, the rate in the
Midwest increased. The rates in the Northeast and
the South decreased. The rate in the West
remained stable.
Deaths
Deaths of persons with a diagnosis of HIV
infection
From 2007 through 2009, in the 46 states with confidential name-based HIV infection reporting, the
annual estimated number and rate of deaths of persons
with a diagnosis of HIV infection increased (Table
11a). In 2009, the estimated rate of deaths of persons
with a diagnosis of HIV infection was 7.2 per 100,000
population. Deaths of persons with a diagnosis of HIV
infection may be due to any cause (i.e., may or may
not be related to HIV infection).
• Age group: From 2007 through 2009, the rates of
deaths among persons aged 20–24, 50–54, 55–59,
60–64, and 65 and older increased. The rates of
deaths among persons aged 35–39 and 40–44
decreased. The rates remained stable among
Commentary
7
children (aged less than 13 years) and persons
aged 13–14, 15–19, 25–29, 30–34 and 45–49.
• Race/ethnicity: From 2007 through 2009, the
rates of deaths among Asians, whites, and
persons reporting multiple races increased. The
rates of deaths among American Indians/Alaska
Natives, blacks/African Americans, Hispanics/
Latinos, and Native Hawaiians/other Pacific
Islanders remained stable. In 2009, the highest
rate of deaths was that for blacks/African
Americans: 29.3 per 100,000 population.
• Sex and transmission category: From 2007
through 2009, among adult and adolescent males,
the rate of deaths remained stable. Among males
with diagnosed HIV infection attributed to maleto-male sexual contact, those with infection
attributed to male-to-male sexual contact and
injection drug use, and those with infection
attributed to heterosexual contact, deaths
increased. Deaths of males with diagnosed HIV
infection attributed to injection drug use
remained stable. Among adult and adolescent
females, the rate of deaths remained stable. The
number of deaths of females with infection
attributed to heterosexual contact increased; the
number of those with infection attributed to
injection drug use remained stable.
Deaths of persons with an AIDS diagnosis
During 2007–2009 in the United States, the annual
estimated number and rate of deaths among persons
with an AIDS diagnosis remained stable (Table 12a).
In 2009, the estimated rate of deaths of persons with
an AIDS diagnosis was 5.8 per 100,000 population.
Deaths of persons with an AIDS diagnosis may be due
to any cause.
• Age group: From 2007 through 2009, the rates of
deaths among persons aged 20–24, 55–59, 60–64,
and 65 and older increased. Rates among persons
aged 30–34, 35–39, and 40–44 decreased. Rates
remained stable among children (aged less than
13 years) and among persons aged 13–14, 15–19,
25–29, 45–49 and 50–54.
• Race/ethnicity: From 2007 through 2009, the
annual rate of deaths among persons reporting
multiple races increased. The rate among
American Indians/Alaska Natives decreased.
Rates among Asians, blacks/African Americans,
8
Hispanics/Latinos, Native Hawaiians/other
Pacific Islanders, and whites remained stable.
• Sex and transmission category: From 2007
through 2009, among adult and adolescent males,
the overall rate of deaths remained stable. The
numbers of deaths of males with an AIDS
diagnosis with infection attributed to male-tomale sexual contact or to male-to-male sexual
contact and injection drug use increased. The
numbers of deaths of males with infection
attributed to injection drug use or to heterosexual
contact remained stable. Among adult and
adolescent females, the overall rate of deaths
remained stable. The number of deaths of females
with infection attributed to injection drug use
decreased; the number of deaths of females with
infection attributed to heterosexual contact
remained stable.
• Region: The rates of deaths increased in the
West, decreased in the Northeast, and remained
stable in the Midwest and the South.
Survival
Survival after a diagnosis of HIV infection
Unadjusted data on diagnoses of HIV infection made
during 2002–2006 in the 46 states with confidential
name-based HIV infection reporting were used to
describe the proportions of persons surviving 12, 24,
and 36 months after a diagnosis of HIV infection
(Table 13a).
• Year of diagnosis: Survival increased with the
year of diagnosis for diagnoses made during
2002–2006, although year-to-year differences
were small.
• Age group: Survival decreased as age at
diagnosis increased, particularly among persons
aged 35 and older at time of diagnosis.
• Race/ethnicity: Survival was greatest among
Native Hawaiians/other Pacific Islanders and
Asians, followed by whites, Hispanics/Latinos,
blacks/African Americans, American Indians/
Alaska Natives, and persons reporting
multiple races.
• Transmission category: Survival was greatest
among adult and adolescent males with diagnosed HIV infection attributed to male-to-male
sexual contact, adult and adolescent females with
Commentary
infection attributed to heterosexual contact, and
children regardless of transmission category.
Survival was intermediate among adult and
adolescent males with infection attributed to
male-to-male sexual contact and injection drug
use and those with infection attributed to heterosexual contact. Survival was lowest among adult
and adolescent males and females with infection
attributed to injection drug use.
Survival after AIDS diagnosis
Unadjusted data from AIDS diagnoses made during
2002–2006 in the United States were used to describe
persons surviving 12, 24, and 36 months after an
AIDS diagnosis (Table 14a).
• Year of diagnosis: Survival increased with the
year of diagnosis for diagnoses made during
2002–2006, although year-to-year differences
were small.
• Age group: Survival decreased as age at diagnosis increased, particularly among persons aged 40
and older. Survival was greatest for persons aged
13–14 and 15–19 at time of diagnosis.
• Race/ethnicity: Survival was greatest among
Asians and Native Hawaiians/other Pacific
Islanders, followed by Hispanics/Latinos, whites,
blacks/African Americans, and persons reporting
multiple races. Survival was lowest among
American Indians/Alaska Natives.
• Transmission category: Survival was greatest
among children with infection attributed to
perinatal transmission, followed by adult and
adolescent males with infection attributed to maleto-male sexual contact. Survival was intermediate
among adult and adolescent males with infection
attributed to male-to-male sexual contact and
injection drug use and among adult and adolescent
males and females with infection attributed to
heterosexual contact. Survival was lowest among
males and females with infection attributed to
injection drug use.
Persons Living with a Diagnosis of HIV
Infection or AIDS (Prevalence)
Persons living with a diagnosis of
HIV infection
From 2007 through 2009, the estimated number of
persons living with a diagnosis of HIV infection (HIV
prevalence) increased in the 46 states with confidential
name-based HIV infection reporting (Table 15a). At
the end of 2009, an estimated 784,701 persons in these
states were living with a diagnosis of HIV infection.
• Age group: At the end of 2009, the largest
percentage was that among persons aged 45–49
(20%), followed by those aged 40–44 (17%).
From 2007 through 2009, the largest percentage
increase was among persons aged 60–64 years.
• Race/ethnicity: At the end of 2009, the largest
percentage—43%—was that among blacks/
African Americans. Among the remaining racial/
ethnic groups, the percentages were 35%, whites;
19%, Hispanics/Latinos; 1% each, Asians and
persons reporting multiple races; and less than
1% each, American Indians/Alaska Natives and
Native Hawaiians/other Pacific Islanders.
• Sex and transmission category: At the end of
2009, among a total of 585,197 males (diagnosis
made when they were aged 13 years or older),
68% of infections were attributed to male-to-male
sexual contact, 13% to injection drug use, 11% to
heterosexual contact, and 8% to male-to-male
sexual contact and injection drug use. Among a
total of 188,668 females (diagnosis made when
they were aged 13 years or older), 74% of infections were attributed to heterosexual contact and
26% to injection drug use. Among a total of
10,834 persons whose diagnosis was made when
they were aged less than 13 years, 88% of infections were attributed to perinatal transmission.
Prevalence rates of diagnosed HIV infection
At the end of 2009, in the 46 states with confidential
name-based HIV infection reporting, the estimated
prevalence rate of diagnosed HIV infection was
268.6 per 100,000 population (Table 15a). The estimated rates per 100,000 population were 496.1 among
adult and adolescent males, 153.6 among adult and
adolescent females, and 21.1 among children (aged
less than 13 years at the time of diagnosis). Among all
Commentary
9
racial/ethnic groups, the highest estimated prevalence
rate was that for blacks/African Americans: 951.9 per
100,000 population.
prevalence rate was that for blacks/African Americans: 547.5 per 100,000 population.
ADDITIONAL RESOURCES
Persons living with an AIDS diagnosis
From 2007 through 2009, the estimated number of per- The following were prepared by using HIV surveilsons living with an AIDS diagnosis (AIDS prevalence) lance data:
• MMWR articles (selected): http://www.cdc.gov/
increased steadily (Table 16a). At the end of 2009, an
hiv/resources/reports/mmwr/
estimated 476,732 persons in the United States were
living with an AIDS diagnosis.
• Other surveillance reports: http://www.cdc.gov/
hiv/topics/surveillance/resources/reports/
• Age group: At the end of 2009, the largest
percentage was that among persons aged 45–49
• Public-use slides updated annually: http://www
(22%), followed by persons aged 40–44 (18%)
.cdc.gov/hiv/topics/surveillance/resources/
and persons aged 50–54 (17%). From 2007
slides/index.htm
through 2009, the largest percentage increase was
among persons aged 60–64 years.
SUGGESTED READINGS
• Race/ethnicity: At the end of 2009, the largest
CDC. Establishing a holistic framework to reduce
percentage—43%—was that among blacks/
inequities in HIV, viral hepatitis, STDs, and
African Americans. Among the remaining racial/
tuberculosis in the United States. http://www
ethnic groups, the percentages were 34%, whites;
.cdc.gov/socialdeterminants/docs/SDH-White20%, Hispanics/Latinos; 2%, persons reporting
Paper-2010.pdf. Accessed December 1, 2011.
multiple races; 1%, Asians; and less than 1%
CDC. Guidelines for national HIV case surveileach, American Indians/Alaska Natives and
lance, including monitoring for HIV infection
Native Hawaiians/other Pacific Islanders.
and AIDS. MMWR 1999;48(RR-13):1–31.
• Sex and transmission category: At the end of
CDC. A heightened national response to the HIV/
2009, among a total of 361,960 males (diagnosis
AIDS crisis among African Americans.
made when they were aged 13 years or older),
http://www.cdc.gov/hiv/topics/aa/resources/
63% of infections were attributed to male-toreports/heightendresponse.htm. Revised June
male sexual contact, 17% to injection drug use,
2007. Accessed December 1, 2011.
11% to heterosexual contact, and 9% to male-tomale sexual contact and injection drug use.
CDC. HIV surveillance—United States, 1981–
Among a total of 110,945 females (diagnosis
2008. MMWR 2011;60(21):689–693.
made when they were aged 13 years or older),
CDC. Questions and answers: general surveillance
68% of infections were attributed to heterosexual
report questions. http://www.cdc.gov/hiv/topics/
contact, and 30% were attributed to injection
surveillance/resources/factsheets/summary_
drug use. Among a total of 3,827 persons whose
changes.htm. Published November 2009.
diagnosis was made when they were aged less
Accessed December 1, 2011.
than 13 years, 95% of infections were attributed
to perinatal transmission.
CDC. Revised recommendations for HIV testing of
adults, adolescents, and pregnant women in healthAIDS prevalence rates
care settings. MMWR 2006;55(RR-14):1–17.
At the end of 2009, the estimated rate of AIDS prevaCDC. Revised surveillance case definitions for HIV
lence was 155.3 per 100,000 population (Table 16a).
infection among adults, adolescents, and children
The estimated rates per 100,000 population were
aged <18 months and for HIV infection and
292.0 among adult and adolescent males, 85.8 among
AIDS among children aged 18 months to <13
adult and adolescent females, and 7.1 among children
years—United States, 2008. MMWR
(aged less than 13 years at the time of diagnosis).
2008;57(RR-10):1–12.
Among all racial/ethnic groups, the highest estimated
10
Commentary
CDC. Summary of changes to the national HIV
Surveillance Report. http://www.cdc.gov/hiv/
topics/surveillance/resources/factsheets/
summary_changes.htm. Published July 2010.
Accessed December 1, 2011.
CDC. Surveillance Brief: Terms, definitions, and
calculations used in CDC HIV surveillance
publications. http://www.cdc.gov/hiv/topics/
surveillance/resources/factsheets/surveillancetable.htm. Published March 2011. Accessed
December 1, 2011.
CDC. Twenty-five years of HIV/AIDS—United
States, 1981–2006. MMWR 2006;55(21):585–
589.
CDC. Vital Signs: HIV testing and diagnosis among
adults—United States. MMWR 2010;59(47):1550–
1555.
CDC. Vital Signs: HIV prevention through care
and treatment—United States. MMWR 2011;
60(47):1618–1623.
Glynn MK, Lee LM, McKenna MT. The status of
national HIV case surveillance, United States
2006. Public Health Rep 2007;122(suppl 1):63–
71.
Hall HI, Song R, Rhodes P, et al. Estimation of
HIV incidence in the United States. JAMA 2008;
300(5):520–529.
National HIV/AIDS strategy for the United States.
http://www.WhiteHouse.gov/administration/
eop/onap/nhas. Published July 2010. Accessed
December 1, 2011.
Prejean J, Song R, Hernandez A, et al. Estimated
HIV incidence in the United States, 2006–2009.
PLoS One 2011;6(8):e17502. doi:10.1371/
journal.pone.0017502.
Strategic plan: Division of HIV/AIDS Prevention,
2011–2015. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/
strategy/dhap/pdf/DHAP-strategic-plan.pdf.
Published August 2011. Accessed December 1,
2011.
Commentary
11
Technical Notes
SURVEILLANCE OF HIV INFECTION
This report includes data from case reports from 57
areas (50 states, the District of Columbia, American
Samoa, Guam, the Northern Mariana Islands, Puerto
Rico, the Republic of Palau, and the U.S. Virgin
Islands) that had laws or regulations requiring confidential reporting by name for adults, adolescents, and
children with confirmed diagnoses of HIV infection
(including AIDS) as of December 31, 2010. After the
removal of personal identifying information, data
from these reports were submitted to CDC. Although
AIDS cases have been reported to CDC since 1981,
the implementation of HIV infection reporting has differed from state to state. Before 1991, the surveillance
of HIV infection was not standardized, and reporting
was based primarily on passive surveillance. Since
then, CDC has assisted states in conducting active surveillance of HIV infection by the use of standardized
report forms and software. HIV surveillance was fully
integrated with AIDS surveillance in all states and
U.S. dependent areas by April 2008.
Data on diagnoses of HIV infection should be interpreted with caution. HIV surveillance reports may not
be representative of all persons infected with HIV
because not all infected persons have been tested.
Many states offer anonymous HIV testing; the results
of anonymous tests are not reported to the confidential
name-based HIV registries of state and local health
departments. Therefore, reports of confidential test
results may not represent all persons who tested positive for HIV infection. Furthermore, testing patterns
are influenced by many factors, including the extent to
which testing is routinely offered to specific groups, or
the availability of, and access to, medical care and
testing services. The data presented in this report provide a minimum estimate of persons for whom HIV
infection has been diagnosed and reported to the surveillance system. In addition, because surveillance
practices differ, the reporting and the updating of a
person's clinical and vital status differ among states.
The completeness of reporting of HIV infection is estimated at more than 80% [1].
Because states initiated confidential name-based
HIV infection reporting on different dates, the length
of time that reporting has been in place influences the
12
number of diagnoses of HIV infection reported to
CDC. For example, data presented for the first year a
state initiated reporting may include cases diagnosed
during only part of the year.
For this report, the 2008 revised HIV case definition was used to classify HIV infection among adults
and adolescents and among children [2]. The revised
definition increases the specificity of the case definition by requiring laboratory-confirmed evidence of
HIV infection. Increased specificity results in more
accurate data on the number of diagnoses of HIV
infection; these data, in turn, can be used to refine
public health policies and determine the most appropriate use of HIV resources.
TABULATION AND PRESENTATION OF DATA
The data in this report are provisional and include
information received by CDC through June 30, 2011.
The data are organized into 4 sections.
• Section 1 (Tables 1a/b–10a/b): numbers
(statistically adjusted and unadjusted) and rates
(adjusted) of diagnoses of HIV infection and AIDS
• Section 2 (Tables 11a/b–14a/b): numbers
(statistically adjusted and unadjusted) and rates
(adjusted) of deaths and proportions (unadjusted)
of survival among persons with a diagnosis of
HIV infection or AIDS
• Section 3 (Tables 15a/b–18a/b): numbers
(statistically adjusted and unadjusted) and rates
(adjusted) of persons living with a diagnosis of
HIV infection or AIDS
• Section 4 (Tables 19–24): numbers (statistically
adjusted and unadjusted) and rates (adjusted) of
diagnoses of HIV infection and AIDS and of
persons living with a diagnosis of HIV infection
or AIDS, presented by state and metropolitan
statistical area (MSA)
For the assessment of trends in diagnoses, deaths,
or prevalence, it is preferable to use statistically
adjusted (estimated) data to eliminate artifacts of
reporting in the surveillance system. Rates and trends
based on estimated numbers less than 12 should be
interpreted with caution because the estimates have
relative standard errors greater than 30% and are considered unreliable.
Columbia, and Puerto Rico to calculate numbers
(unadjusted) of diagnoses of HIV infection.
Areas with Mature HIV Infection
Reporting Systems
An area’s confidential name-based HIV infection
reporting is considered mature after 4 years—long
enough for the calculation of reporting-delay estimates and the determination of reliable trends (Song
R, Green TA, unpublished data, 2012). To estimate
the number of diagnoses of HIV infection, we used
data from 51 areas that have had laws or regulations
requiring confidential name-based HIV infection
reporting since at least January 2007 and that have
been reporting these data to CDC since at least June
2007. The 51 areas comprise 46 states (Alabama,
Alaska, Arizona, Arkansas, California, Colorado,
Connecticut, Delaware, Florida, Georgia, Idaho,
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana,
Maine, Michigan, Minnesota, Mississippi, Missouri,
Montana, Nebraska, Nevada, New Hampshire, New
Jersey, New Mexico, New York, North Carolina,
North Dakota, Ohio, Oklahoma, Oregon,
Pennsylvania, Rhode Island, South Carolina, South
Dakota, Tennessee, Texas, Utah, Virginia,
Washington, West Virginia, Wisconsin, Wyoming)
and 5 U.S. dependent areas (American Samoa, Guam,
the Northern Mariana Islands, Puerto Rico, and the
U.S. Virgin Islands). For Tables 1a/b, 3a/b, 5a/b, 8,
10a/b, 19, and 23, we used data from these 51 areas to
tabulate numbers (unadjusted), estimated numbers,
and estimated rates of diagnoses of HIV infection.
These data were also used to tabulate the numbers and
the estimated numbers and rates of persons living
with HIV infection (Tables 15a/b, 17a/b, 21, and 23).
Deaths
Persons reported to the national HIV surveillance system are assumed alive unless their deaths have been
reported to CDC. Death data (Tables 11a/b–12a/b)
include all deaths of persons with a diagnosis of HIV
infection or AIDS regardless of the cause of death.
Because of delays in the reporting of deaths, 3 years
(2007–2009) of death data are displayed. The exclusion
of data from the most recent year allowed at least 18
months for deaths to be reported to CDC. The estimated
numbers and rates of deaths resulted from statistical
adjustment for delays in reporting. Readers should use
caution when interpreting trend data on the estimated
numbers of deaths because the estimates for the most
recent year are most subject to uncertainty.
Areas with Confidential Name-Based HIV
Infection Reporting
As of April 2008, 57 areas (50 states, the District of
Columbia, and 6 U.S. dependent areas) had implemented confidential name-based HIV infection
reporting. All 57 areas were included in tabulations of
numbers (unadjusted) of diagnoses of HIV infection
by state and MSA. For Tables 19 and 21, we used data
from all 50 states, the District of Columbia, and 6
U.S. dependent areas to calculate numbers (unadjusted) of diagnoses of HIV infection. For Table 23,
we used data from all 50 states, the District of
Survival Analyses
For the survival analyses presented in section 2
(Tables 13a/b–14a/b), we used the Kaplan-Meier
method to estimate the probability of survival for 12,
24, and 36 months for persons with a diagnosis of HIV
infection or AIDS whose case data were reported by
June 30, 2011. Tables were limited to persons whose
diagnosis was made during 2002–2006 to allow at
least 3 years from the time of diagnosis to deaths
occurring through December 31, 2009. Data for each
HIV reporting area were included in the survival
tables beginning with the first full calendar year after
implementation of code-based or name-based HIV
infection reporting.
Persons Living with a Diagnosis of HIV
Infection or AIDS (Prevalence)
Because of delays in the reporting of deaths, 3 years
of prevalence data are displayed. The data reflect the
persons living with a diagnosis of HIV infection or
AIDS at the end of each year during 2007–2009. The
exclusion of data from the most recent year allowed at
least 18 months for deaths to be reported and for these
deaths to be factored into calculations of prevalence.
Age
The designation “adults and adolescents” refers to
persons aged 13 years and older; the designation
“children” refers to persons aged less than 13 years.
Technical Notes
13
For presentations of data on persons living with HIV
infection or AIDS (Tables 15a/b–18a/b, 21, and 22),
the age-group assignment (for example, 20–24 years)
or the age designation (for example, “adults and
adolescents”) is based on the person’s age as of
December 31 of the specified year. In Tables 11a/b
and 12a/b, which concern deaths of persons with a
diagnosis of HIV infection or AIDS, age-group
assignment is determined by the person's age at the
time of death. For all other tables, the age designation
or the specific age-group assignment is based on the
person's age at the time of diagnosis.
these cases were diagnosed after 2003 and were
reported to CDC in accordance with OMB’s Revisions to the Standards for the Classification of Federal
Data on Race and Ethnicity [3].
This report also presents data for persons who
reported multiple racial categories. Persons whose race
was unknown are included in the total numbers in
Tables 11a/b–18a/b, 21, and 22, and in the cumulative
totals of Tables 2a/b and 6a/b. The number of persons
reported in each race category may include persons
whose ethnicity was not reported. In this report, persons categorized by race were not Hispanic or Latino.
Race and Ethnicity
In the Federal Register for October 30, 1997 [3], the
Office of Management and Budget (OMB) announced
the Revisions to the Standards for the Classification
of Federal Data on Race and Ethnicity. Implementation by January 1, 2003, was mandated. At a minimum, data on the following racial categories should
be collected:
• American Indian or Alaska Native
• Asian
• black or African American
• Native Hawaiian or other Pacific Islander
• white
Additionally, systems must be able to retain information when multiple racial categories are reported.
In addition to data on race, data on 2 categories of ethnicity should be collected:
• Hispanic or Latino
• not Hispanic or Latino
The Asian or Pacific Islander category displayed in
previous surveillance reports has been split into 2 categories: (1) Asian and (2) Native Hawaiian or other
Pacific Islander. The Asian category (in tables where
footnoted) includes the cases in Asians/Pacific
Islanders (referred to as legacy cases) that were
reported before the implementation of the new racial
categories in 2003 (e.g., cases of HIV infection that
were diagnosed and reported to CDC before 2003 but
that progressed to AIDS after 2003) and a small percentage of cases that were reported after 2003 but that
were reported according to the old racial category
(Asian/Pacific Islander). In tables of diagnoses of
HIV infection during 2007–2010, the Asian category
does not include Asian/Pacific Islander cases because
Geographic Designations
In tables of diagnoses and tables of persons living
with HIV infection or AIDS, geographic designations
reflect the area of residence at the time of HIV or
AIDS diagnosis. In tables of deaths, the geographic
designations reflect the area of residence at the time
of death. The areas of residence included in the report
are defined as follows:
Northeast: Connecticut, Maine, Massachusetts,
New Hampshire, New Jersey, New York, Pennsylvania,
Rhode Island, and Vermont
Midwest: Illinois, Indiana, Iowa, Kansas, Michigan,
Minnesota, Missouri, Nebraska, North Dakota, Ohio,
South Dakota, and Wisconsin
South: Alabama, Arkansas, Delaware, District of
Columbia, Florida, Georgia, Kentucky, Louisiana,
Maryland, Mississippi, North Carolina, Oklahoma,
South Carolina, Tennessee, Texas, Virginia, and
West Virginia
West: Alaska, Arizona, California, Colorado,
Hawaii, Idaho, Montana, Nevada, New Mexico,
Oregon, Utah, Washington, and Wyoming
U.S. dependent areas: American Samoa, Guam,
the Northern Mariana Islands, Puerto Rico, the
Republic of Palau, and the U.S. Virgin Islands
14
Metropolitan Statistical Areas
In the Federal Register for December 27, 2000, the
OMB published revised standards for defining MSAs
in federal statistical activities [4]. These standards,
which provided for the identification of MSAs in the
United States and Puerto Rico, replaced the 1990 standards. The adoption of the new standards was effective
as of December 27, 2000. On June 6, 2003, the OMB
announced new MSA definitions based on the new
Technical Notes
standards and Census 2000 data [5]. Tables 23 (HIV
diagnosis data) and 24 (AIDS data) present numbers
and rates of diagnoses, by MSA, for areas with populations of 500,000 or more. The MSAs listed in Tables
23 and 24 are defined according to the OMB’s most
recent update (December 2009) of statistical areas [6].
Transmission Categories
Transmission category is the term for the classification of cases that summarizes a person’s possible HIV
risk factors; the summary classification results from
selecting, from the presumed hierarchical order of
probability, the one risk factor most likely to have
been responsible for transmission. For surveillance
purposes, a diagnosis of HIV infection or AIDS is
counted only once in the hierarchy of transmission categories. Persons with more than one reported risk factor for HIV infection are classified in the transmission
category listed first in the hierarchy. The exception is
men who report sexual contact with other men and
injection drug use; this group makes up a separate
transmission category.
Persons whose transmission category is classified as
male-to-male sexual contact include men who report
sexual contact with other men (i.e., homosexual contact) and men who report sexual contact with both men
and women (i.e., bisexual contact). Persons whose
transmission category is classified as heterosexual
contact are persons who report specific heterosexual
contact with a person known to have, or to be at high
risk for, HIV infection (e.g., an injection drug user).
Cases in persons with no reported risk factor for
HIV infection listed in the hierarchy of transmission
categories are classified as “no risk factor reported or
identified” [7]. No identified risk factor (NIR) cases
include cases that have been followed up by local
health department officials; cases in persons whose
risk-factor information is missing because they died,
declined to be interviewed, or were lost to follow-up;
and cases in persons who were interviewed or for
whom other follow-up information was available but
for whom no risk factor was identified.
Because a substantial proportion of cases of HIV
infection and AIDS are reported to CDC without an
identified risk factor, multiple imputation is used to
assign a risk factor for these cases [8]. Multiple imputation is a statistical approach in which each missing
risk factor is replaced with a set of plausible values that
represent the uncertainty about the true, but missing,
value [9]. The plausible values are analyzed by using
standard procedures, and the results from these analyses are then combined to produce the final results. In
this report, multiple imputation has been used in tables
displaying estimated values, by transmission category,
for adults and adolescents, but not in tables displaying
data for children (because the number of cases in children is small, missing risk factors were not imputed).
Reporting Delays
Reporting delays (time between diagnosis or death
and the reporting of diagnosis or death to CDC) may
differ among demographic and geographic categories;
for some, delays in reporting have been as long as
several years. The statistical adjustment of the data
on diagnoses and deaths is based on estimates of
reporting-delay distributions, which are calculated by
using a modified semiparametric life-table statistical
procedure. This procedure takes into account differences in reporting delays due to sex, race/ethnicity,
and HIV transmission categories; reporting city, state,
or territory; geographic region; the size of the MSA;
and the type of facility where the diagnosis was made
or death occurred (Song R, Green TA, unpublished
data, 2012).
Rates
Rates per 100,000 population were calculated for the
numbers of diagnoses of HIV infection and AIDS, the
deaths of persons with a diagnosis of HIV infection or
AIDS, and persons living with a diagnosis of HIV
infection or AIDS. At the time of this report, complete
2010 census data were not available from the U.S.
Census Bureau. Therefore, the population denominators used to compute these rates for the 50 states, the
District of Columbia, and Puerto Rico were based on
the official postcensus estimates for 2009 from the
U.S. Census Bureau [10]. The population denominators for American Samoa, Guam, the Northern
Mariana Islands, The Republic of Palau, and the
U.S. Virgin Islands were based on estimates and projections from the U.S. Census Bureau's International
Data Base [11]. Each rate was calculated by dividing
the estimated total number of diagnoses (or deaths, or
persons living with a diagnosis of HIV infection or
AIDS) for the calendar year by the population for that
calendar year and then multiplying the number by
100,000. The denominators used for calculating age-,
Technical Notes
15
sex-, and race/ethnicity-specific rates were computed
by applying the 2009 postcensus estimates for age,
sex, and race/ethnicity for the 50 states and the
District of Columbia [10]. The same method was used
to calculate the denominators for Puerto Rico, with
the exception of race/ethnicity estimates; these data
are not available for Puerto Rico. For the other 5 U.S.
dependent areas, estimates from the U.S. Census
Bureau's International Data Base were used for ageand sex-specific population denominators [11].
CDC currently does not provide subpopulation
rates by race/ethnicity for the 6 U.S. dependent areas
because the U.S. Census Bureau does not collect
information from all U.S. dependent areas. Similarly,
rates for transmission categories are not provided
because of the absence of denominator data (i.e., the
denominator data used in this report come from the
U.S. Census Bureau, but the U.S. Census Bureau does
not collect data on transmission categories).
REFERENCES
16
1.
Hall HI, Song R, Gerstle JE III, Lee LM; on behalf
of the HIV/AIDS Reporting System Evaluation
Group. Assessing the completeness of reporting of
human immunodeficiency virus diagnoses in 2002–
2003: capture-recapture methods. Am J Epidemiol
2006;164:391–397.
2.
CDC. Revised surveillance case definitions for HIV
infection among adults, adolescents, and children
aged <18 months and for HIV infection and AIDS
among children aged 18 months to <13 years—
United States, 2008. MMWR 2008;57(RR-10):1–12.
3.
Office of Management and Budget. Revisions to the
standards for the classification of federal data on race
and ethnicity. Federal Register 1997;62:58781–
58790. http://www.whitehouse.gov/omb/fedreg_
1997standards. Accessed December 5, 2011.
4.
Office of Management and Budget. Standards for
defining metropolitan and micropolitan statistical
areas. Federal Register 2000;65(249):82228–
82238. http://www.whitehouse.gov/sites/default/
files/omb/fedreg/metroareas122700.pdf. Accessed
December 5, 2011.
5.
Office of Management and Budget. Revised definitions of metropolitan statistical areas, new definitions of micropolitan statistical areas and combined
statistical areas, and guidance on uses of the statistical definitions of these areas. OMB Bulletin 03-04.
http://www.whitehouse.gov/omb/bulletins/b03-
04.html. Published June 6, 2003. Accessed December 5, 2011.
6.
Office of Management and Budget. Update of statistical area definitions and guidance on their uses.
OMB Bulletin 10-02. http://www.whitehouse.gov/
sites/default/files/omb/assets/bulletins/b10-02.pdf.
Published December 1, 2009. Accessed December
5, 2011.
7.
CDC. Current trends: heterosexually acquired
AIDS—United States, 1993. MMWR 1994;43:155–
160.
8.
McDavid Harrison K, Kajese T, Hall HI, Song R.
Risk factor redistribution of the national HIV/AIDS
surveillance data: an alternative approach. Public
Health Rep 2008;123(5):618–627.
9.
Rubin, DB. Multiple Imputation for Nonresponse in
Surveys. New York: John Wiley & Sons Inc; 1987.
10. U.S. Census Bureau. Population estimates [entire
data set]. July 1, 2010. http://www.census.gov/
popest/estbygeo.html. Accessed December 5, 2011.
11. U.S. Census Bureau. International Data Base.
http://www.census.gov/ipc/www/idb/. Published
June 2010. Accessed December 5, 2011.
Technical Notes
Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2007–2010—46 states with confidential name-based HIV infection
reporting
2007
2008
Estimated
No.
No.
a
Rate
2009
Estimated
No.
No.
a
Rate
2010
Estimated
No.
No.
a
Rate
Estimateda
No.
No.
Rate
Age at diagnosis (yr)
<13
Diagnoses of HIV Infection and AIDS
215
223
0.4
218
230
0.5
185
200
0.4
185
217
0.4
13–14
37
39
0.5
37
39
0.5
26
28
0.4
30
34
0.4
15–19
1,932
2,002
9.8
2,034
2,146
10.4
1,979
2,131
10.4
1,878
2,200
10.7
20–24
5,527
5,707
28.2
6,007
6,338
31.2
6,181
6,697
32.7
6,415
7,565
36.9
25–29
6,444
6,661
33.3
6,297
6,635
32.5
6,043
6,555
31.7
5,758
6,823
33.0
30–34
5,695
5,883
31.9
5,595
5,914
31.8
5,223
5,654
29.9
5,039
5,954
31.4
35–39
6,633
6,853
34.3
5,905
6,235
31.4
5,172
5,624
28.8
4,660
5,523
28.3
40–44
6,844
7,073
34.1
6,144
6,488
32.0
5,444
5,915
29.7
4,830
5,720
28.7
45–49
5,472
5,652
26.1
5,353
5,654
26.1
4,742
5,151
23.8
4,460
5,296
24.4
50–54
3,583
3,708
18.6
3,372
3,558
17.5
3,276
3,568
17.3
3,124
3,671
17.8
55–59
1,996
2,062
11.9
1,998
2,106
12.0
1,924
2,091
11.6
1,825
2,154
12.0
60–64
952
982
7.2
991
1,040
7.3
890
961
6.4
945
1,119
7.5
65
840
868
2.4
774
818
2.2
732
795
2.1
718
853
2.3
American Indian/Alaska Native
202
207
9.1
211
221
9.6
196
208
9.0
201
225
9.7
Asian
744
773
6.5
724
769
6.3
661
724
5.8
668
814
6.5
20,733
21,414
62.0
20,937
22,094
63.2
19,448
21,093
59.8
18,527
21,854
62.0
9,429
9,772
22.0
8,908
9,441
20.6
8,614
9,413
19.9
8,052
9,653
20.4
Race/ethnicity
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
65
67
21.3
59
62
19.2
67
72
22.0
51
64
19.3
14,222
14,665
7.7
13,172
13,853
7.3
12,195
13,161
6.9
11,821
13,878
7.3
775
816
20.8
714
761
18.8
636
697
16.7
547
642
15.4
20,664
26,320
—
20,309
26,750
—
19,757
26,739
—
19,304
28,782
—
Injection drug use
2,025
3,146
—
1,591
2,753
—
1,258
2,413
—
1,081
2,373
—
Male-to-male sexual contact and injection drug use
1,361
1,782
—
1,125
1,567
—
995
1,445
—
919
1,443
—
Heterosexual contactc
3,261
4,865
—
3,071
4,798
—
2,711
4,423
—
2,375
4,416
—
White
Multiple races
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Other
d
Subtotal
7,679
48
—
7,938
46
—
7,580
33
—
7,600
31
—
34,990
36,160
31.3
34,034
35,914
30.7
32,301
35,054
29.7
31,279
37,045
31.4
17
18
Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2007–2010—46 states with confidential name-based HIV infection
reporting (cont)
2007
2008
Estimateda
Rate
2009
Estimateda
No.
No.
Rate
2010
Estimateda
No.
No.
Rate
Estimateda
No.
No.
No.
No.
Rate
1,082
1,911
—
965
1,792
—
780
1,561
—
592
1,393
—
5,269
9,382
—
4,941
9,235
—
4,183
8,534
—
3,701
8,459
—
4,614
36
—
4,567
30
—
4,368
20
—
4,110
16
—
10,965
11,329
9.4
10,473
11,057
9.1
9,331
10,116
8.2
8,403
9,868
8.0
182
189
—
174
183
—
152
164
—
143
162
—
Female adult or adolescent
Injection drug use
Heterosexual contact
c
Otherd
Subtotal
Child (<13 yrs at diagnosis)
Perinatal
Diagnoses of HIV Infection and AIDS
Other
e
Subtotal
Totalf
33
34
—
44
46
—
33
35
—
42
54
—
215
223
0.4
218
230
0.5
185
200
0.4
185
217
0.4
46,170
47,712
16.6
44,725
47,200
16.3
41,817
45,369
15.5
39,867
47,129
16.1
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2007–2010—46 states and 5 U.S. dependent areas with confidential
name-based HIV infection reporting
2007
2008
Estimated
No.
No.
a
Rate
2009
Estimated
No.
No.
a
Rate
2010
Estimated
No.
No.
a
Rate
Estimateda
No.
No.
Rate
Age at diagnosis (yr)
<13
223
232
0.5
221
233
0.5
185
200
0.4
187
219
0.4
13–14
37
39
0.5
40
42
0.5
27
29
0.4
30
34
0.4
15–19
1,958
2,030
9.7
2,060
2,175
10.4
1,996
2,151
10.3
1,899
2,232
10.7
20–24
5,621
5,808
28.3
6,086
6,426
31.2
6,256
6,788
32.6
6,482
7,675
36.9
25–29
6,413
6,765
32.6
6,140
6,673
31.8
5,847
6,972
33.3
Diagnoses of HIV Infection and AIDS
6,571
6,797
33.4
30–34
5,811
6,008
32.1
5,711
6,044
32.0
5,349
5,808
30.2
5,134
6,118
31.8
35–39
6,775
7,005
34.6
6,037
6,382
31.7
5,276
5,750
29.0
4,753
5,671
28.6
40–44
6,992
7,231
34.4
6,293
6,654
32.3
5,566
6,064
30.0
4,925
5,873
29.1
45–49
5,600
5,790
26.4
5,476
5,791
26.4
4,840
5,271
24.0
4,558
5,461
24.9
50–54
3,675
3,806
18.9
3,455
3,651
17.7
3,350
3,658
17.5
3,182
3,767
18.0
55–59
2,045
2,114
12.1
2,042
2,155
12.1
1,967
2,144
11.7
1,862
2,217
12.1
60–64
986
1,019
7.3
1,028
1,082
7.4
912
988
6.5
978
1,171
7.7
65
875
906
2.5
810
858
2.3
761
831
2.2
739
887
2.3
202
207
—
211
221
—
196
208
—
201
225
—
Race/ethnicity
American Indian/Alaska Native
Asian
747
776
—
724
769
—
663
727
—
670
818
—
Black/African American
20,759
21,442
—
20,956
22,116
—
19,464
21,112
—
18,542
21,877
—
Hispanic/Latinob
10,392
10,806
—
9,828
10,470
—
9,396
10,367
—
8,740
10,788
—
Native Hawaiian/Other Pacific Islander
White
Multiple races
69
71
—
62
65
—
69
75
—
53
67
—
14,225
14,668
—
13,177
13,858
—
12,199
13,166
—
11,823
13,881
—
775
816
—
714
761
—
638
700
—
547
642
—
Transmission category
Male adult or adolescent
Male-to-male sexual contact
20,868
26,578
—
20,540
27,038
—
19,968
27,030
—
19,520
29,194
—
Injection drug use
2,226
3,417
—
1,782
3,012
—
1,400
2,633
—
1,173
2,581
—
Male-to-male sexual contact and injection drug use
1,388
1,817
—
1,145
1,592
—
1,018
1,480
—
933
1,474
—
Heterosexual contactc
3,381
5,034
—
3,195
4,965
—
2,818
4,583
—
2,478
4,630
—
Other
d
Subtotal
7,810
48
—
8,033
46
—
7,675
33
—
7,698
31
—
35,673
36,894
31.5
34,695
36,653
30.9
32,879
35,760
29.9
31,802
37,910
31.7
19
20
Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2007–2010—46 states and 5 U.S. dependent areas with confidential
name-based HIV infection reporting (cont)
2007
2008
a
Estimated
No.
No.
Injection drug use
1,125
1,967
Heterosexual contactc
5,474
Otherd
4,674
Rate
2009
a
Estimated
Rate
2010
Estimated
No.
No.
a
Rate
Estimateda
No.
No.
No.
No.
Rate
—
1,004
1,844
—
802
1,595
—
607
1,426
—
9,657
—
5,130
9,499
—
4,345
8,779
—
3,830
8,727
—
36
—
4,622
31
—
4,414
20
—
4,150
16
—
11,273
11,660
9.5
10,756
11,373
9.2
9,561
10,395
8.3
8,587
10,168
8.2
186
193
—
177
187
—
152
164
—
144
164
—
Female adult or adolescent
Subtotal
Child (<13 yrs at diagnosis)
Perinatal
Diagnoses of HIV Infection and AIDS
Othere
Subtotal
Totalf
37
39
—
44
46
—
33
35
—
43
56
—
223
232
0.5
221
233
0.5
185
200
0.4
187
219
0.4
47,169
48,785
16.7
45,672
48,259
16.4
42,625
46,355
15.6
40,576
48,298
16.3
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 2a. AIDS diagnoses, by year of diagnosis and selected characteristics, 2007–2010 and cumulative—United States
2007
2008
Estimateda
Diagnoses of HIV Infection and AIDS
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Race/ethnicity
American Indian/Alaska Native
Asianc
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific
Islander
White
Multiple races
No.
No.
34
75
422
1,748
3,135
3,811
5,265
6,139
5,252
3,336
1,848
914
720
36
79
445
1,832
3,286
3,996
5,524
6,447
5,514
3,502
1,940
960
758
123
419
15,686
6,444
45
Rate
2009
Estimateda
No.
No.
0.1
1.0
2.1
8.6
15.6
20.6
26.3
29.5
24.2
16.7
10.7
6.6
2.0
37
55
433
1,706
3,106
3,767
4,830
5,561
4,922
3,307
1,910
964
733
39
60
465
1,828
3,331
4,034
5,180
5,970
5,294
3,549
2,050
1,029
784
127
445
16,458
6,790
47
5.5
3.4
44.6
14.9
11.0
158
446
15,219
6,139
39
9,245
737
9,675
777
4.9
18.1
12,613
2,352
1,449
15,966
3,332
1,786
2,628
4,756
23,798
3,747
148
24,979
Rate
2010
Estimateda
No.
No.
0.1
0.7
2.1
8.6
15.5
20.7
24.8
27.9
23.2
16.6
11.1
6.8
2.0
12
44
425
1,841
2,980
3,507
4,175
4,804
4,656
3,339
1,855
885
726
14
52
482
2,064
3,350
3,938
4,687
5,419
5,257
3,766
2,094
998
820
167
485
16,304
6,642
42
7.2
3.6
43.7
14.1
9.5
125
386
14,083
5,967
45
8,654
676
9,244
729
4.6
16.5
—
—
—
12,102
2,074
1,349
15,908
3,103
1,713
—
—
20.6
2,637
4,887
23,049
3,846
164
24,735
Rate
Estimateda
Rate
Cumulativeb
No.
Est. No.a
No.
No.
0.0
0.6
2.2
9.6
15.5
19.8
22.8
25.8
23.0
17.3
11.0
6.3
2.1
18
41
410
1,755
2,613
3,066
3,445
3,965
3,970
2,924
1,585
828
677
23
52
529
2,262
3,379
4,009
4,464
5,198
5,194
3,825
2,100
1,094
889
0.0
0.6
2.5
10.5
15.6
20.2
21.7
24.8
22.7
17.6
11.1
6.9
2.2
9,428
1,356
7,397
43,637
129,899
213,165
232,649
191,860
126,239
72,740
39,355
20,868
17,906
9,475
1,399
7,686
44,845
132,099
216,176
236,291
195,833
129,681
75,059
40,644
21,508
18,431
136
445
15,794
6,802
52
5.8
3.2
41.9
14.0
11.6
133
343
12,549
4,920
34
170
480
16,188
6,636
44
7.2
3.5
43.0
13.7
9.7
3,639
8,422
462,647
192,586
843
3,721
8,759
473,229
197,449
870
7,991
652
8,976
736
4.5
16.2
6,835
483
8,875
622
4.4
13.7
423,517
14,676
429,804
15,125
—
—
—
11,837
1,663
1,131
16,317
2,738
1,543
—
—
—
10,274
1,353
880
16,796
2,745
1,446
—
—
—
485,083
161,194
72,576
541,330
186,122
79,048
—
—
20.1
2,459
4,650
21,740
3,771
138
24,507
—
—
19.8
1,924
4,495
18,926
3,629
133
24,749
—
—
20.0
58,353
98,910
876,116
74,708
11,851
893,058
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact
and injection drug use
Heterosexual contacte
Otherf
Subtotal
21
22
Table 2a. AIDS diagnoses, by year of diagnosis and selected characteristics, 2007–2010 and cumulative—United States (cont)
2007
2008
a
Estimated
Diagnoses of HIV Infection and AIDS
No.
No.
Female adult or adolescent
Injection drug use
Heterosexual contacte
Otherf
Subtotal
1,496
4,420
2,951
8,867
2,306
6,835
163
9,304
Child (<13 yrs at diagnosis)
Perinatal
Otherg
Subtotal
32
2
34
Region of residence
Northeast
Midwest
South
West
Totalh
Rate
2009
a
Estimated
No.
No.
—
—
—
7.3
1,269
4,072
2,904
8,245
2,097
6,624
117
8,839
34
2
36
—
—
0.1
32
5
37
8,255
3,645
15,253
5,546
8,824
3,811
15,843
5,840
16.1
5.7
14.3
8.4
32,699
34,319
11.4
Rate
2010
a
Estimateda
Estimated
No.
No.
—
—
—
6.9
1,061
3,726
2,710
7,497
1,878
6,410
133
8,421
34
5
39
—
—
0.1
11
1
12
7,126
3,715
14,925
5,565
7,909
3,962
15,721
6,021
14.4
5.9
14.0
8.5
31,331
33,613
11.0
Rate
Rate
Cumulativeb
No.
Est. No.a
No.
No.
—
—
—
6.5
812
3,041
2,500
6,353
1,752
6,364
127
8,242
—
—
—
6.4
72,022
100,024
48,909
220,955
88,400
131,904
6,289
226,593
13
1
14
—
—
0.0
14
4
18
18
4
23
—
—
0.0
8,573
855
9,428
8,617
859
9,475
6,532
3,624
13,723
5,370
7,742
4,019
15,018
6,163
14.0
6.0
13.3
8.6
5,367
3,322
12,059
4,549
7,824
4,178
14,722
6,292
14.2
6.3
13.0
8.8
335,458
115,881
432,559
222,601
343,357
118,260
440,261
227,249
29,249
32,942
10.7
25,297
33,015
10.8
1,106,499i 1,129,127
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
From the beginning of the epidemic through 2010.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d
Hispanics/Latinos can be of any race.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
i Includes persons of unknown race/ethnicity.
Table 2b. AIDS diagnoses, by year of diagnosis and selected characteristics, 2007–2010 and cumulative—United States and 6 U.S. dependent areas
2007
2008
Estimateda
No.
No.
Rate
2009
Estimateda
No.
No.
Rate
2010
Estimateda
No.
No.
Rate
Estimateda
No.
No.
Rate
Cumulativeb
No.
Est. No.a
Age at diagnosis (yr)
Diagnoses of HIV Infection and AIDS
<13
34
36
0.1
38
40
0.1
12
14
0.0
18
23
0.0
9,848
9,898
13–14
76
80
1.0
56
61
0.7
44
52
0.6
41
52
0.6
1,413
1,457
15–19
430
454
2.1
442
475
2.2
428
486
2.2
411
531
2.4
7,616
7,911
20–24
1,775
1,861
8.6
1,728
1,852
8.6
1,855
2,081
9.5
1,768
2,280
10.4
44,978
46,211
25–29
3,194
3,350
15.7
3,150
3,380
15.5
3,030
3,410
15.5
2,639
3,415
15.5
133,989
136,250
30–34
3,887
4,078
20.8
3,855
4,132
20.9
3,572
4,013
19.9
3,108
4,065
20.1
219,837
222,946
35–39
5,384
5,654
26.6
4,929
5,290
25.0
4,256
4,782
23.0
3,509
4,552
21.9
239,594
243,363
40–44
6,284
6,604
29.8
5,685
6,107
28.2
4,918
5,552
26.1
4,042
5,301
24.9
197,363
201,467
45–49
5,370
5,641
24.4
5,050
5,436
23.5
4,760
5,379
23.3
4,067
5,329
23.0
129,836
133,401
50–54
3,417
3,590
16.9
3,396
3,647
16.8
3,417
3,857
17.5
2,981
3,902
17.7
74,818
77,214
55–59
1,891
1,987
10.8
1,947
2,091
11.1
1,899
2,146
11.2
1,612
2,138
11.1
40,595
41,926
60–64
948
996
6.8
986
1,054
6.9
909
1,026
6.4
853
1,128
7.0
21,567
22,233
65
746
786
2.0
766
821
2.1
747
844
2.1
695
913
2.3
18,749
19,299
American Indian/Alaska Native
123
127
—
158
167
—
125
136
—
133
170
—
3,640
3,722
Asianc
419
445
—
447
486
—
386
445
—
343
480
—
8,457
8,795
15,708
16,482
—
15,229
16,316
—
14,097
15,811
—
12,558
16,201
—
463,111
473,707
7,156
7,561
—
6,818
7,396
—
6,547
7,481
—
5,354
7,233
—
225,619
231,204
48
51
—
42
45
—
46
53
—
35
45
—
860
889
9,245
9,675
—
8,657
9,247
—
7,994
8,979
—
6,838
8,879
—
423,643
429,933
737
777
—
677
730
—
652
736
—
483
622
—
14,704
15,154
Race/ethnicity
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific
Islander
White
Multiple races
Transmission category
Male adult or adolescent
Male-to-male sexual contact
12,749
16,120
—
12,237
16,067
—
11,962
16,470
—
10,367
16,935
—
490,588
547,061
Injection drug use
2,559
3,573
—
2,277
3,346
—
1,806
2,918
—
1,461
2,906
—
174,022
199,428
Male-to-male sexual contact
and injection drug use
1,486
1,828
—
1,370
1,738
—
1,158
1,577
—
899
1,474
—
75,036
81,567
Heterosexual contacte
2,724
3,863
—
2,729
3,960
—
2,550
3,887
—
1,994
3,738
—
61,937
78,497
Otherf
4,792
150
—
4,926
167
—
4,677
139
—
4,520
133
—
99,527
12,028
24,310
25,534
20.7
23,539
25,278
20.3
22,153
24,992
19.9
19,241
25,186
20.0
901,110
918,581
Subtotal
23
24
Table 2b. AIDS diagnoses, by year of diagnosis and selected characteristics, 2007–2010 and cumulative—United States and 6 U.S. dependent areas (cont)
2007
2008
Estimated
No.
No.
1,551
2,367
a
Rate
2009
Estimated
No.
No.
—
1,308
2,145
a
Rate
2010
Estimated
a
Rate
Estimateda
No.
No.
Rate
Cumulativeb
Est. No.a
No.
No.
No.
—
1,100
1,927
—
837
1,790
—
74,917
91,415
Female adult or adolescent
Injection drug use
Heterosexual contact
e
4,579
7,016
—
4,222
6,805
—
3,858
6,576
—
3,136
6,506
—
105,085
137,253
Otherf
2,962
164
—
2,921
118
—
2,724
134
—
2,512
127
—
49,243
6,428
Subtotal
9,092
9,547
7.4
8,451
9,068
7.0
7,682
8,636
6.6
6,485
8,422
6.4
229,245
235,096
32
34
—
33
35
—
11
13
—
14
18
—
8,969
9,015
Child (<13 yrs at diagnosis)
Perinatal
Other
g
Diagnoses of HIV Infection and AIDS
2
2
—
5
5
—
1
1
—
4
4
—
879
883
34
36
0.1
38
40
0.1
12
14
0.0
18
23
0.0
9,848
9,898
Northeast
8,255
8,824
16.1
7,126
7,909
14.4
6,532
7,742
14.0
5,367
7,824
14.2
335,458
343,357
Midwest
3,645
3,811
5.7
3,715
3,962
5.9
3,624
4,019
6.0
3,322
4,178
6.3
115,881
118,260
South
15,253
15,843
14.3
14,925
15,721
14.0
13,723
15,018
13.3
12,059
14,722
13.0
432,559
440,261
West
5,546
5,840
8.4
5,565
6,021
8.5
5,370
6,163
8.6
4,549
6,292
8.8
222,601
227,249
737
798
18.3
697
774
17.7
598
700
15.9
447
616
14.0
33,704
Subtotal
Region of residence
U.S. dependent areas
Total
h
33,436
35,117
11.5
32,028
34,387
11.1
29,847
33,642
10.8
25,744
33,630
10.8
34,448
i
1,140,203 1,163,575
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
From the beginning of the epidemic through 2010.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d
Hispanics/Latinos can be of any race.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
i Includes persons of unknown race/ethnicity.
Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2010—46 states with confidential name-based HIV infection reporting
American Indian/
Alaska Native
Estimatedb
Asian
Estimatedb
Black/African American
Estimatedb
Diagnoses of HIV Infection and AIDS
No.
No.
Rate
No.
No.
Rate
No.
0
0
2
33
32
42
28
15
19
16
4
5
5
0
0
2
36
36
47
30
16
23
19
4
5
5
0.0
0.0
1.1
17.9
19.4
30.5
20.2
10.9
13.8
12.2
3.4
5.5
2.8
2
0
14
74
114
113
130
88
63
30
23
11
6
2
0
16
87
145
137
159
105
79
37
28
13
7
0.1
0.0
2.1
10.6
14.2
12.3
13.7
10.4
8.5
4.4
4.0
2.3
0.6
127
24
1,287
3,662
2,627
2,030
1,853
1,994
1,867
1,426
858
461
311
84
4
14
119
6
20
—
—
—
392
13
15
583
22
21
—
—
—
14
30
146
19
0
164
—
—
18.1
29
105
554
51
1
678
—
—
13.7
Female adult or adolescent
Injection drug use
Heterosexual contactd
Othere
Subtotal
7
25
23
55
15
46
0
61
—
—
—
6.4
4
65
43
112
8
125
1
134
—
—
—
2.5
235
2,312
2,814
5,361
723
5,539
5
6,268
Child (<13 yrs at diagnosis)
Perinatal
f
Other
Subtotal
0
0
0
0
0
0
—
—
0.0
1
1
2
1
1
2
—
—
0.1
97
30
127
108
35
142
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact
and injection drug use
d
Heterosexual contact
e
Other
Subtotal
No.
Rate
Hispanic/Latinoa
Estimatedb
Native Hawaiian/
Other Pacific Islander
Estimatedb
White
No.
No.
Rate
No.
No.
Rate
No.
No.
27
3
286
1,196
1,350
1,312
1,101
1,021
748
476
279
134
119
33
4
342
1,434
1,622
1,563
1,329
1,218
897
571
332
162
146
0.3
0.2
8.7
37.9
40.1
39.8
36.3
37.8
31.8
25.7
19.8
13.0
5.4
0
0
1
13
11
8
5
3
8
1
1
0
0
0
0
1
17
13
11
6
3
11
1
1
0
0
0.0
0.0
4.1
62.5
46.3
37.5
22.5
14.3
46.1
5.4
6.7
0.0
0.0
25
2
264
1,338
1,550
1,468
1,477
1,643
1,693
1,136
634
324
267
—
—
—
4,309
295
170
6,399
632
279
—
—
—
36
2
1
52
2
2
—
—
—
1,466 2,977
—
4,150
10
—
13,039 15,444 116.0
479
1,499
6,752
771
5
8,087
—
—
44.7
1
6
46
2
0
58
—
—
44.4
356
1,722
10,315
—
—
—
41.7
73
621
579
1,273
190
1,342
2
1,533
—
—
—
9.2
1
2
2
5
1
4
1
6
—
—
—
4.5
—
—
2.0
27
0
27
33
0
33
—
—
0.3
0
0
0
0
0
0
—
—
0.0
142
2.0
28
2.5
1,506 48.8
4,325 148.3
3,100 112.1
2,396 99.7
2,188 90.5
2,348 97.3
2,215 87.3
1,683 72.6
1,011 53.5
545 39.2
366 11.9
6,811 10,838
430 1,199
182
419
Multiple races
Estimatedb
Total
Estimatedb
Rate
No.
No.
Rate
No.
34
2
305
1,550
1,821
1,723
1,731
1,951
1,998
1,316
747
383
316
0.1
0.0
2.5
12.5
14.8
15.5
14.5
15.1
13.3
8.8
5.6
3.3
1.0
4
1
24
99
74
66
66
66
62
39
26
10
10
5
1
27
116
86
77
79
79
73
44
30
12
12
0.3
0.6
6.5
33.7
29.1
34.7
40.1
45.2
40.5
26.6
21.9
10.9
5.3
185
30
1,878
6,415
5,758
5,039
4,660
4,830
4,460
3,124
1,825
945
718
7,396 10,396
326
486
515
670
—
—
—
276
11
22
396
25
32
546
13
12,111
—
—
15.3
30
88
427
260
619
602
1,481
432
1,295
6
1,733
—
—
—
2.1
15
10
25
17
18
34
—
—
0.1
Estimatedb
No.c
Rate
217
34
2,200
7,565
6,823
5,954
5,523
5,720
5,296
3,671
2,154
1,119
853
0.4
0.4
10.7
36.9
33.0
31.4
28.3
28.7
24.4
17.8
12.0
7.5
2.3
—
—
—
19,304 28,782
1,081 2,373
919 1,443
—
—
—
50
0
504
—
—
39.3
2,375 4,416
7,600
31
31,279 37,045
—
—
31.4
12
57
47
116
24
109
0
133
—
—
—
9.7
592
3,701
4,110
8,403
1,393
8,459
16
9,868
—
—
—
8.0
3
1
4
4
1
5
—
—
0.3
143
42
185
162
54
217
—
—
0.4
25
g
Total
201 225
9.7
668 814
6.5 18,527 21,854 62.0
8,052 9,653
20.4
51
64 19.3 11,821 13,878
7.3
547 642 15.4 39,867 47,129
16.1
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC since at least June 2007.
a
Hispanics/Latinos can be of any race.
b
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
c
Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
26
Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2010—46 states and 5 U.S. dependent areas with confidential name-based HIV
infection reporting
American Indian/
Alaska Native
No. Est. No.b
Diagnoses of HIV Infection and AIDS
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Black/African
American
Asian
No.
Est. No.b
No.
Est. No.b
Hispanic/Latinoa
No. Est. No.b
Native Hawaiian/
Other Pacific Islander
No.
Est. No.b
White
Multiple races
Total
No.
Est. No.b
No.
Est. No.b
No.
Est. No.b,c
0
0
2
33
32
42
28
15
19
16
4
5
5
0
0
2
36
36
47
30
16
23
19
4
5
5
2
0
14
74
115
114
130
88
63
30
23
11
6
2
0
16
87
147
138
159
105
79
37
28
13
7
128
24
1,287
3,663
2,629
2,031
1,857
1,996
1,867
1,428
859
461
312
143
28
1,506
4,326
3,103
2,398
2,194
2,351
2,215
1,686
1,013
545
368
28
3
307
1,261
1,436
1,405
1,189
1,113
845
532
315
167
139
35
4
374
1,541
1,766
1,724
1,469
1,367
1,061
664
393
213
179
0
0
1
14
11
8
6
3
8
1
1
0
0
0
0
1
18
13
11
8
3
11
1
1
0
0
25
2
264
1,338
1,550
1,468
1,477
1,644
1,694
1,136
634
324
267
34
2
305
1,550
1,821
1,723
1,731
1,952
1,999
1,316
747
383
316
4
1
24
99
74
66
66
66
62
39
26
10
10
5
1
27
116
86
77
79
79
73
44
30
12
12
187
30
1,899
6,482
5,847
5,134
4,753
4,925
4,558
3,182
1,862
978
739
219
34
2,232
7,675
6,972
6,118
5,671
5,873
5,461
3,767
2,217
1,171
887
84
4
14
119
6
20
393
13
15
584
22
21
6,813
430
182
10,842
1,203
420
4,521
387
184
6,803
836
310
37
2
1
53
2
2
7,396
326
515
10,396
487
670
276
11
22
396
25
32
19,520
1,173
933
29,194
2,581
1,474
14
30
146
19
0
164
29
105
555
51
1
679
1,466
4,158
13,049
2,984
10
15,460
582
1,588
7,262
978
5
8,932
1
6
47
2
0
59
356
1,723
10,316
546
13
12,112
30
88
427
50
0
504
2,478
7,698
31,802
4,630
31
37,910
Female adult or adolescent
Injection drug use
Heterosexual contactd
Othere
Subtotal
7
25
23
55
15
46
0
61
4
65
44
113
9
127
1
137
236
2,312
2,817
5,365
725
5,544
5
6,274
87
748
615
1,450
220
1,598
2
1,820
1
3
2
6
1
6
1
8
260
620
602
1,482
432
1,297
6
1,735
12
57
47
116
24
109
0
133
607
3,830
4,150
8,587
1,426
8,727
16
10,168
Child (<13 yrs at diagnosis)
Perinatal
f
Other
Subtotal
0
0
0
0
0
0
1
1
2
1
1
2
98
30
128
109
35
143
27
1
28
33
1
35
0
0
0
0
0
0
15
10
25
17
18
34
3
1
4
4
1
5
144
43
187
164
56
219
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection
drug use
d
Heterosexual contact
e
Other
Subtotal
g
Total
201
225
670
818
18,542 21,877
8,740 10,788
53
67
11,823 13,881
547
642
40,576
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC since at least June 2007.
a
Hispanics/Latinos can be of any race.
b
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.
c Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
48,298
Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2010—United States
American Indian/
Alaska Native
Estimated
a
Asian
c
Black/African American
Estimated
c
c
Estimated
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
b
Hispanic/Latino
Estimated
No.
No.
Rate
No.
No.
Rate
No.
<13
0
0
0.0
1
1
0.1
10
12
0.2
4
13–14
0
0
0.0
0
0
0.0
31
39
3.3
5
15–19
1
1
0.5
2
3
0.3
293
371
11.3
20–24
10
12
6.1
22
30
3.3
1,088
1,380
25–29
15
17
9.0
46
63
5.7
1,375
1,755
30–34
24
33
20.8
56
85
7.1
1,402
35–39
21
27
17.7
69
91
7.3
1,563
40–44
14
17
10.9
52
73
6.6
45–49
20
26
15.3
50
72
7.1
50–54
16
23
14.7
24
33
55–59
3
3
2.7
15
21
60–64
5
6
5.9
3
65
4
5
2.3
3
51
78
—
8
12
—
Male-to-male sexual contact
and injection drug use
e
Heterosexual contact
f
Other
10
15
10
18
Subtotal
97
No.
c
White
c
Estimated
Multiple races
c
Estimated
No.
No.
Rate
Total
Estimated
No.
No.
c
Rate
c
Estimated
No.
No.
d
Rate
No.
No.
Rate
Rate
6
0.0
0
0
0.0
3
4
0.0
0
0
0.0
18
23
0.0
7
0.4
0
0
0.0
4
5
0.1
1
1
0.5
41
52
0.6
74
100
2.5
1
1
3.2
34
47
0.4
5
6
1.3
410
529
2.5
44.5
346
465
12.0
2
3
8.0
257
334
2.6
30
38
10.0
1,755
2,262
10.5
59.5
626
836
20.2
4
5
12.4
498
638
4.9
49
64
19.5
2,613
3,379
15.6
1,797
69.9
782
1,057
26.2
6
8
20.8
743
961
8.3
53
68
27.6
3,066
4,009
20.2
1,992
77.0
786
1,047
27.9
7
9
27.7
922
1,199
9.6
77
99
45.0
3,445
4,464
21.7
1,851
2,415
93.1
783
1,052
31.8
6
8
24.3
1,185
1,540
11.3
74
94
48.2
3,965
5,198
24.8
1,854
2,396
87.9
621
842
29.1
6
8
24.2
1,344
1,751
11.1
75
99
49.1
3,970
5,194
22.7
3.6
1,519
1,979
79.6
431
595
26.2
2
2
8.3
881
1,126
7.2
51
67
36.0
2,924
3,825
17.6
2.7
798
1,055
52.0
231
314
18.3
0
0
0.0
503
660
4.7
35
46
30.1
1,585
2,100
11.1
4
0.6
432
567
37.9
132
179
14.0
0
0
0.0
241
319
2.6
15
19
16.1
828
1,094
6.9
4
0.3
333
432
13.1
99
136
4.9
0
0
0.0
220
290
0.9
18
23
9.3
677
889
2.2
179
317
—
3,644
6,236
—
2,224
3,749
—
19
28
—
3,966
6,094
—
191
294
—
10,274 16,796
—
12
26
—
655
1,458
—
332
707
—
1
1
—
315
491
—
30
49
—
1,353
2,745
—
—
16
26
—
277
530
—
147
252
—
3
4
—
401
578
—
26
42
—
880
1,446
—
17
—
21
37
—
1,231
2,466
—
393
670
—
1
1
—
245
400
—
23
38
—
1,924
3,629
—
4
—
63
2
—
2,507
64
—
919
28
—
2
-
—
926
33
—
60
2
—
4,495
133
—
126
13.6
291
408
7.5
8,314 10,754
75.6
4,015
5,406
29.1
26
34
19.0
5,853
7,596
9.1
330
426
30.1
18,926 24,749
20.0
5
11
—
4
8
—
405
989
—
121
261
—
3
4
—
252
430
—
22
48
—
812
1,752
—
19
32
—
26
62
—
2,044
4,352
—
431
941
—
4
5
—
438
825
—
79
148
—
3,041
6,364
—
Age at diagnosis (yr)
Diagnoses of HIV Infection and AIDS
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Female adult or adolescent
Injection drug use
e
Heterosexual contact
f
Other
12
1
—
21
1
—
1,776
81
—
349
21
—
1
1
—
289
20
—
52
1
—
2,500
127
—
36
44
4.6
51
70
1.2
4,225
5,422
33.7
901
1,224
7.1
8
10
5.4
979
1,275
1.5
153
197
13.1
6,353
8,242
6.4
Perinatal
Otherg
0
0
—
1
1
—
7
9
—
4
6
—
0
0
—
2
3
—
0
0
—
14
18
—
0
0
—
0
0
—
3
3
—
0
0
—
0
0
—
1
1
—
0
0
—
4
4
—
Subtotal
0
0
0.0
1
1
0.1
10
12
0.2
4
6
0.0
0
0
0.0
3
4
0.0
0
0
0.0
18
23
0.0
Subtotal
Child (<13 yrs at diagnosis)
27
28
Table 4a. AIDS diagnoses, by race/ethnicity and selected characteristics, 2010—United States (cont)
American Indian/
Alaska Native
Estimated
Asian
c
a
Black/African American
c
Estimated
No.
No.
Rate
No.
No.
Rate
Northeast
3
4
3.1
55
92
Midwest
14
18
4.5
40
South
27
34
4.6
68
West
89
113
10.5
133
170
7.2
Estimated
No.
No.
3.2
2,595
50
3.1
86
2.9
180
252
4.0
343
480
3.5
Native Hawaiian/
Other Pacific Islander
b
Hispanic/Latino
c
Estimated
c
White
c
Estimated
Multiple races
Estimated
c
Total
c
Estimated
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
3,741
60.9
1,434
2,096
31.8
2
2
11.1
1,154
1,712
4.4
1,687
2,119
31.1
320
414
9.4
3
4
16.0
1,183
1,478
2.8
75
95
11.1
7,416
9,102
42.5
1,658
1,980
11.5
4
5
7.5
2,667
3,247
4.7
219
268
18.7
851
1,226
37.0
1,508
2,145
10.6
25
32
9.5
1,831
2,438
6.3
65
85
5.2
12,549 16,188
43.0
4,920
6,636
13.7
34
44
9.7
6,835
8,875
4.4
483
622
13.7
Estimated
d
c
No.
No.
Rate
No.
No.
Rate
124
175
27.5
5,367
7,824
3,322
4,178
6.3
12,059 14,722
13.0
Region of residence
Total
h
4,549
14.2
6,292
8.8
25,297 33,015
10.8
Diagnoses of HIV Infection and AIDS
a
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
d
Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f
g
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2010—United States and 6 U.S. dependent areas
American Indian/
Alaska Native
No.
Est. No.
c
Asian
No.
Black/African
American
a
c
Est. No.
Hispanic/Latino
c
Est. No.
No.
No.
b
Est. No.
c
Native Hawaiian/
Other Pacific Islander
No.
Est. No.
c
White
No.
Multiple races
Est. No.
c
No.
Est. No.
Total
c
No.
Est. No.
c,d
Age at diagnosis (yr)
<13
0
0
1
1
10
12
4
6
0
0
3
4
0
0
18
23
13–14
0
0
0
0
31
39
5
7
0
0
4
5
1
1
41
52
Diagnoses of HIV Infection and AIDS
15–19
1
1
2
3
293
371
75
102
1
1
34
47
5
6
411
531
20–24
10
12
22
30
1,088
1,380
359
483
2
3
257
334
30
38
1,768
2,280
25–29
15
17
46
63
1,377
1,758
650
870
4
5
498
638
49
64
2,639
3,415
30–34
24
33
56
85
1,402
1,797
823
1,112
7
9
743
961
53
68
3,108
4,065
35–39
21
27
69
91
1,565
1,994
848
1,133
7
9
922
1,199
77
99
3,509
4,552
40–44
14
17
52
73
1,852
2,416
858
1,153
6
8
1,186
1,541
74
94
4,042
5,301
45–49
20
26
50
72
1,854
2,396
717
976
6
8
1,345
1,753
75
99
4,067
5,329
50–54
16
23
24
33
1,520
1,980
487
671
2
2
881
1,126
51
67
2,981
3,902
55–59
3
3
15
21
799
1,057
257
351
0
0
503
660
35
46
1,612
2,138
60–64
5
6
3
4
433
568
156
212
0
0
241
319
15
19
853
1,128
65
4
5
3
4
334
433
115
158
0
0
221
291
18
23
695
913
51
78
179
317
3,646
6,239
2,314
3,883
19
28
3,967
6,096
191
294
10,367
16,935
8
12
12
26
655
1,461
440
864
1
1
315
492
30
49
1,461
2,906
10
15
16
26
277
530
166
280
3
4
401
578
26
42
899
1,474
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection
drug use
Heterosexual contacte
10
17
21
37
1,231
2,470
463
774
1
1
245
400
23
38
1,994
3,738
f
Other
18
4
63
2
2,512
64
938
28
2
0
927
33
60
2
4,520
133
Subtotal
97
126
291
408
8,321
10,764
4,321
5,830
26
34
5,855
7,599
330
426
19,241
25,186
Female adult or adolescent
Injection drug use
5
11
4
8
405
989
146
299
3
4
252
430
22
48
837
1,790
Heterosexual contacte
f
Other
19
32
26
62
2,045
4,354
523
1,077
5
7
439
827
79
148
3,136
6,506
12
1
21
1
1,777
81
360
21
1
1
289
20
52
1
2,512
127
Subtotal
36
44
51
70
4,227
5,425
1,029
1,398
9
11
980
1,277
153
197
6,485
8,422
Perinatal
Otherg
0
0
1
1
7
9
4
6
0
0
2
3
0
0
14
18
0
0
0
0
3
3
0
0
0
0
1
1
0
0
4
4
Subtotal
0
0
1
1
10
12
4
6
0
0
3
4
0
0
18
23
Child (<13 yrs at diagnosis)
29
30
Table 4b. AIDS diagnoses, by race/ethnicity and selected characteristics, 2010—United States and 6 U.S. dependent areas (cont)
American Indian/
Alaska Native
No.
c
Est. No.
Black/African
American
Asiana
No.
c
Est. No.
No.
c
Est. No.
3,741
Hispanic/Latinob
No.
c
Est. No.
1,434
Native Hawaiian/
Other Pacific Islander
White
Multiple races
No.
c
Est. No.
No.
Est. No.
2,096
2
2
1,154
1,712
c
No.
Est. No.
Total
c
No.
Est. No.
c,d
Region of residence
Northeast
3
4
55
92
2,595
Midwest
14
18
40
50
1,687
2,119
320
414
3
4
1,183
1,478
75
95
3,322
4,178
South
27
34
68
86
7,416
9,102
1,658
1,980
4
5
2,667
3,247
219
268
12,059
14,722
West
89
113
180
252
851
1,226
1,508
2,145
25
32
1,831
2,438
65
85
4,549
6,292
0
0
0
0
9
12
434
598
1
2
3
4
0
0
447
616
133
170
343
480
12,558
16,201
5,354
7,233
35
45
6,838
8,879
483
622
25,744
33,630
U.S. dependent areas
Totalh
Diagnoses of HIV Infection and AIDS
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.
d
Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
124
175
5,367
7,824
Table 5a. Diagnoses of HIV infection among children <13 years of age, by race/ethnicity, 2007–2010—46 states with confidential name-based HIV infection
reporting
2007
2008
Estimateda
Race/ethnicity
American Indian/Alaska Native
Asian
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
Diagnoses of HIV Infection and AIDS
Totalc
2009
Estimateda
2010
Estimateda
Estimateda
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
0
0
0.0
2
2
0.5
0
0
0.0
0
0
0.0
8
8
0.4
7
7
0.3
5
5
0.2
2
2
0.1
142
147
2.1
147
155
2.2
130
141
2.0
127
142
2.0
36
38
0.3
28
29
0.2
32
35
0.3
27
33
0.3
0
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
25
26
0.1
25
26
0.1
16
17
0.1
25
34
0.1
4
4
0.3
9
10
0.7
2
2
0.1
4
5
0.3
215
223
0.4
218
230
0.5
185
200
0.4
185
217
0.4
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b
Hispanics/Latinos can be of any race.
c
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 5b. Diagnoses of HIV infection among children <13 years of age, by race/ethnicity, 2007–2010—46 states and 5 U.S. dependent areas with confidential
name-based HIV infection reporting
2007
Race/ethnicity
No.
2008
Est. No.
a
No.
2009
Est. No.
a
No.
2010
Est. No.
a
No.
Est. No.a
American Indian/Alaska Native
0
0
2
2
0
0
0
0
Asian
9
9
7
7
5
5
2
2
142
147
147
155
130
141
128
143
43
45
31
33
32
35
28
35
0
0
0
0
0
0
0
0
25
26
25
26
16
17
25
34
4
4
9
10
2
2
4
5
223
232
221
233
185
200
187
219
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
Totalc
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
31
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
b Hispanics/Latinos can be of any race.
c
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
32
Table 6a. AIDS diagnoses among children <13 years of age, by race/ethnicity, 2007–2010 and cumulative—United States
Race/ethnicity
American Indian/Alaska Native
Asianc
2007
2008
2009
2010
Estimateda
Estimateda
Estimateda
Estimateda
No.
No.
Rate
0
0
0.0
No.
No.
0
0
Rate
No.
No.
Rate
0.0
0
0
0.0
No.
No.
Rate
0
0
0.0
Cumulativeb
No.
Est. No.a
31
31
0
0
0.0
2
2
0.1
0
0
0.0
1
1
0.1
48
49
26
27
0.4
23
25
0.3
7
8
0.1
10
12
0.2
5,702
5,731
Hispanic/Latinod
4
4
0.0
3
3
0.0
4
4
0.0
4
6
0.0
1,918
1,929
Native Hawaiian/Other Pacific Islander
0
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
7
7
White
4
4
0.0
5
5
0.0
1
1
0.0
3
4
0.0
1,593
1,599
Multiple races
0
0
0.0
4
4
0.3
0
0
0.0
0
0
0.0
128
129
34
36
0.1
37
39
0.1
12
14
0.0
18
23
0.0
9,428f
Black/African American
Diagnoses of HIV Infection and AIDS
Totale
9,475
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b From the beginning of the epidemic through 2010.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
f Includes children of unknown race/ethnicity.
Table 6b. AIDS diagnoses among children <13 years of age, by race/ethnicity, 2007–2010 and cumulative—United States and 6 U.S. dependent areas
2007
Race/ethnicity
No.
2008
Est. No.b
No.
2009
Est. No.b
No.
Cumulativea
2010
Est. No.b
No.
Est. No.b
No.
Est. No.b
American Indian/Alaska Native
0
0
0
0
0
0
0
0
31
31
Asianc
0
0
2
2
0
0
1
1
48
49
26
27
23
25
7
8
10
12
5,712
5,741
Hispanic/Latinod
Black/African American
4
4
4
4
4
4
4
6
2,327
2,340
Native Hawaiian/Other Pacific Islander
0
0
0
0
0
0
0
0
7
7
White
4
4
5
5
1
1
3
4
1,593
1,599
Multiple races
0
0
4
4
0
0
0
0
129
130
34
36
38
40
12
14
18
23
9,848f
9,898
Totale
a From the beginning of the epidemic through 2010.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
f Includes children of unknown race/ethnicity.
Table 7. AIDS diagnoses among children <13 years of age, by year of diagnosis, 1992–2010—United States and
6 U.S. dependent areas
United States and
dependent areas
United States
Year of diagnosis
No.
Est. No.a
No.
Est. No.a
1992
910
913
958
961
1993
893
896
931
934
1994
822
825
847
850
1995
684
687
706
709
1996
523
526
537
540
1997
341
343
353
355
1998
251
253
258
260
1999
201
203
206
208
2000
133
134
136
137
2001
129
130
130
131
2002
111
112
118
119
2003
72
73
74
75
2004
58
59
59
60
2005
55
57
55
57
2006
37
38
40
41
2007
34
36
34
36
2008
37
39
38
40
2009
12
14
12
14
2010
18
23
18
23
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
Diagnoses of HIV Infection and AIDS
33
34
Table 8. Diagnoses of HIV infection among adult and adolescent Hispanics/Latinos, by transmission category and place of birth, 2010—46 states and
5 U.S. dependent areas with confidential name-based HIV infection reporting
Central America
Cuba
Mexico
Puerto Rico
No.
Est.
No.a
%
No.
Est.
No.a
%
218
395
73.8
142
173
76.3
Injection drug use
6
28
5.3
8
15
6.4
48
Male-to-male sexual contact
and injection drug use
0
5
1.0
3
4
1.9
62
106
19.7
24
35
Otherd
157
1
0.1
28
0
Subtotal
443
534
205
227
0
8
4.4
0
1
4.7
3
10
5.0
21
39
Heterosexual contact
75
166
95.6
10
19
95.3
101
194
94.6
147
Otherd
69
0
0.0
8
0
0.0
64
1
0.4
58
Subtotal
144
174
100
18
20
100
Totale
587
709
100
223
247
100
Transmission category
No.
Est.
No.a
United States
Total
%
No.b
Est.
No.a,b
%
79.7
4,521
6,803
76.2
284
8.2
387
836
9.4
116
173
5.0
184
310
3.5
8.2
180
246
7.1
582
978
10.9
0.2
479
1
0.0
1,588
5
0.1
7,262
8,932 100
%
No.
Est.
No.a
%
No.
548
50.4
230
297
87.2
1,982 2,760
140
269
24.7
3
9
2.5
131
2.2
20
39
3.6
5
6
1.8
183
11.9
112
231
21.3
18
28
1
0.1
137
0
0.0
25
1
728
1,086 100
281
340
11.6
0
2
4.5
50
109
17.3
87
220
12.1
295
88.3
22
53
95.3
274
521
82.6
748
1,598
87.8
0
0.0
24
0
0.2
198
0
0.1
615
2
0.1
%
No.
80.1
319
87
5.7
18
34
15.4
101
0.0
295
Est.
No.a
South America
Est.
No.a
Male adult or adolescent
Male-to-male sexual contact
Diagnoses of HIV Infection and AIDS
Heterosexual contactc
100
100
826 1,230
1,288 1,535 100
100
2,888 3,464 100
Female adult or adolescent
Injection drug use
c
168
205 100
226
334 100
46
55
100
1,456 1,740 100
954
1,420 100
327
395
100
522
631 100
3,410 4,094 100
1,450
1,820 100
8,712 10,753 100
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.
b
Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
c
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 9. AIDS diagnoses among adult and adolescent Hispanics/Latinos, by transmission category and place of birth, 2010—United States and 6 U.S.
dependent areas
Central America
Cuba
No.
Est.
No.a
%
146
315
68.0
68
Injection drug use
5
31
6.7
Male-to-male sexual contact and
injection drug use
4
10
58
Otherd
Subtotal
%
No.
Est.
No.a
86
64.2
507
9
13
9.6
2.2
3
5
106
22.9
23
131
1
0.1
344
463
2
11
Heterosexual contact
47
Otherd
Puerto Rico
South America
%
No.
Est.
No.a
%
860
77.2
152
233
32.4
29
63
5.7
189
305
3.6
19
40
3.6
22
30
22.6
82
150
13.4
9
0
0.0
190
1
0.1
112
133
8.3
0
1
12.6
1
7
125
90.6
4
9
87.4
54
51
1
1.1
5
0
0.0
35
Subtotal
100
138
100
9
11
100
90
Totale
444
601
100
121
144
100
917
Transmission category
No.
Est.
No.a
Mexico
Est.
No.a
%
79
120
74.2
42.5
0
7
33
4.6
6
88
146
20.4
56
2
0.2
507
719
6.2
42
68
111
93.2
118
1
0.6
United States
Est.
No.a
Total
Est.
No.a,b %
%
No.b
981 1,502
70.4
2,314 3,883
4.1
147
284
13.3
440
864
14.8
9
5.5
90
141
6.6
166
280
4.8
15
26
15.8
125
184
8.6
463
774
13.3
20
1
0.4
271
22
1.1
938
28
0.5
120
162
24.8
1
3
7.4
84
160
28.8
146
299
21.4
205
74.7
18
33
92.2
198
380
68.4
523 1,077
77.1
29
1
0.5
9
0
0.4
138
16
2.8
120 100
189
274
100
28
36
100
1,233 100
696
993
100
148
197
100
No.
No.
Male adult or adolescent
Male-to-male sexual contact
Heterosexual contactc
Diagnoses of HIV Infection and AIDS
100
100
827
1,114 100
100
100
1,614 2,134 100
66.6
4,321 5,830 100
Female adult or adolescent
Injection drug use
c
a
b
420
e
21
1.5
555 100
1,029 1,398 100
2,034 2,689 100
5,350 7,228 100
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.
Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
360
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
35
Table 10a. Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2009—46 states
with confidential name-based HIV infection reporting
<12 Monthsa
12 Monthsb
Total
Est. No.
%
Est. No.
%
Est. No.c
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
14
8
310
1,145
1,561
1,721
2,044
2,310
2,149
1,617
946
444
418
7
31
15
17
24
30
36
39
42
45
45
46
53
186
18
1,818
5,546
4,990
3,931
3,575
3,601
3,000
1,947
1,146
514
377
93
69
85
83
76
70
64
61
58
55
55
54
47
200
27
2,128
6,691
6,551
5,652
5,619
5,910
5,150
3,564
2,091
958
795
Race/ethnicity
American Indian/Alaska Native
Asian
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific Islander
White
Multiple races
60
248
6,469
3,456
25
4,174
255
29
34
31
37
34
32
37
148
477
14,605
5,950
47
8,981
442
71
66
69
63
66
68
63
208
724
21,074
9,406
72
13,155
697
8,181
1,085
449
1,868
26
11,611
31
45
31
42
79
33
18,546
1,326
993
2,548
7
23,419
69
55
69
58
21
67
26,727
2,411
1,442
4,416
33
35,030
Female adult or adolescent
Injection drug use
Heterosexual contacte
Otherf
Subtotal
552
2,492
18
3,062
35
29
89
30
1,008
6,035
2
7,045
65
71
11
70
1,560
8,527
20
10,107
Child (<13 yrs at diagnosis)
Perinatal
Otherg
Subtotal
12
2
14
7
6
7
152
33
186
93
94
93
164
35
200
14,686
32
30,650
68
45,336
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contacte
Otherf
Subtotal
Totalh
Note. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for
incomplete reporting.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
January 2007 and that have reported these data to CDC since at least June 2007.
Data exclude 32 persons whose month of diagnosis of HIV infection is unknown.
a Includes persons whose diagnoses of HIV infection and AIDS were made at the same time.
b
Includes persons in whom AIDS has not developed.
c
Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not
sum to the totals shown here.
d
Hispanics/Latinos can be of any race.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may
not sum to the column total.
36
Diagnoses of HIV Infection and AIDS
Table 10b. Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2009—46 states
and 5 U.S. dependent areas with confidential name-based HIV infection reporting
<12 Monthsa
12 Monthsb
Total
Est. No.
%
Est. No.
%
Est. No.c
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
14
8
310
1,153
1,584
1,752
2,078
2,372
2,206
1,667
970
460
435
7
30
14
17
24
30
36
39
42
46
45
47
52
186
20
1,839
5,628
5,086
4,054
3,668
3,687
3,063
1,987
1,172
525
396
93
70
86
83
76
70
64
61
58
54
55
53
48
200
28
2,149
6,782
6,670
5,806
5,745
6,059
5,269
3,654
2,142
985
831
Race/ethnicity
American Indian/Alaska Native
Asian
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific Islander
White
Multiple races
60
248
6,483
3,760
25
4,178
255
29
34
31
36
33
32
36
148
479
14,610
6,598
50
8,982
444
71
66
69
64
67
68
64
208
727
21,093
10,358
75
13,160
700
8,256
1,152
458
1,931
26
11,824
31
44
31
42
79
33
18,762
1,478
1,019
2,645
7
23,911
69
56
69
58
21
67
27,018
2,630
1,477
4,576
33
35,734
Female adult or adolescent
Injection drug use
Heterosexual contacte
Otherf
Subtotal
563
2,590
18
3,171
35
30
89
31
1,031
6,182
2
7,216
65
70
11
69
1,594
8,772
20
10,386
Child (<13 yrs at diagnosis)
Perinatal
Otherg
Subtotal
12
2
14
7
6
7
152
33
186
93
94
93
164
35
200
15,008
32
31,312
68
46,320
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contacte
Otherf
Subtotal
Totalh
Note. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for
incomplete reporting.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
January 2007 and that have reported these data to CDC since at least June 2007.
Data exclude 33 persons whose month of diagnosis of HIV infection is unknown.
a
Includes persons whose diagnoses of HIV infection and AIDS were made at the same time.
b
Includes persons in whom AIDS has not developed.
c Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not
sum to the totals shown here.
d
Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may
not sum to the column total.
Diagnoses of HIV Infection and AIDS
37
38
Table 11a. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2007–2009—46 states with confidential namebased HIV infection reporting
2007
2008
Estimated
No.
No.
a
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Rate
Age at death (yr)
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
<13
9
10
0.0
5
6
0.0
5
8
0.0
13–14
7
8
0.1
0
0
0.0
2
3
0.0
15–19
43
49
0.2
44
54
0.3
27
37
0.2
20–24
173
196
1.0
163
201
1.0
160
235
1.1
25–29
524
592
3.0
470
579
2.8
435
624
3.0
30–34
896
1,010
5.5
786
967
5.2
732
1,037
5.5
35–39
1,919
2,165
10.8
1,521
1,863
9.4
1,255
1,766
9.0
40–44
3,113
3,498
16.9
2,600
3,172
15.6
2,123
2,994
15.0
45–49
3,458
3,881
18.0
3,071
3,756
17.4
2,786
3,905
18.0
50–54
3,009
3,377
17.0
2,895
3,538
17.4
2,648
3,719
18.0
55–59
2,013
2,263
13.1
2,159
2,627
14.9
2,072
2,894
16.1
60–64
1,101
1,237
9.0
1,246
1,528
10.7
1,258
1,765
11.8
65
1,161
1,304
3.6
1,316
1,612
4.4
1,432
2,028
5.4
85
96
4.2
93
116
5.0
69
100
4.3
Race/ethnicity
American Indian/Alaska Native
Asian
b
78
88
0.7
88
109
0.9
63
94
0.8
Black/African American
8,800
9,888
28.6
7,972
9,715
27.8
7,390
10,351
29.3
Hispanic/Latinoc
2,696
3,002
6.8
2,646
3,193
7.0
2,372
3,238
6.9
Native Hawaiian/Other Pacific Islander
White
Multiple races
7
8
2.6
6
7
2.2
4
6
1.9
5,278
5,973
3.2
5,032
6,230
3.3
4,556
6,569
3.5
480
534
13.6
436
528
13.0
478
653
15.6
Table 11a. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2007–2009—46 states with confidential namebased HIV infection reporting (cont)
2007
2008
Estimateda
No.
No.
Male-to-male sexual contact
5,470
7,451
Injection drug use
2,553
Male-to-male sexual contact and injection drug use
1,238
1,286
2009
Estimateda
Rate
No.
No.
—
5,010
7,562
3,395
—
2,322
1,535
—
1,104
1,930
—
1,301
Estimateda
Rate
No.
No.
Rate
—
4,707
8,220
—
3,366
—
2,065
3,397
—
1,506
—
1,084
1,691
—
2,117
—
1,071
2,068
—
Transmission category
Male adult or adolescent
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
d
Heterosexual contact
Other
e
Subtotal
2,269
118
—
2,225
109
—
2,031
104
—
12,816
14,429
12.5
11,962
14,659
12.5
10,958
15,480
13.1
Female adult or adolescent
Injection drug use
1,429
1,979
—
1,360
2,043
—
1,162
1,986
—
Heterosexual contactd
1,941
3,052
—
1,747
3,052
—
1,718
3,412
—
Othere
1,165
48
—
1,129
54
—
1,025
38
—
Subtotal
4,535
5,078
4.2
4,236
5,148
4.2
3,905
5,435
4.4
Perinatal
56
63
—
62
75
—
55
76
—
Otherf
19
22
—
16
20
—
17
24
—
Subtotal
75
84
0.2
78
95
0.2
72
100
0.2
17,426
19,591
6.8
16,276
19,902
6.9
14,935
21,015
7.2
Child (<13 yrs at diagnosis)
Totalg
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with a diagnosis of HIV infection may be due to any cause.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
39
40
Table 11b. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2007–2009—46 states and 5 U.S. dependent
areas with confidential name-based HIV infection reporting
2007
2008
Estimated
No.
No.
a
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Rate
Age at death (yr)
<13
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
10
12
0.0
6
7
0.0
5
8
0.0
13–14
7
8
0.1
0
0
0.0
2
3
0.0
15–19
45
51
0.2
48
59
0.3
28
39
0.2
20–24
179
203
1.0
165
203
1.0
166
243
1.2
25–29
543
614
3.0
484
596
2.9
449
642
3.1
30–34
927
1,046
5.6
820
1,009
5.3
752
1,062
5.5
35–39
1,978
2,233
11.0
1,562
1,912
9.5
1,301
1,826
9.2
40–44
3,215
3,616
17.2
2,687
3,279
15.9
2,198
3,094
15.3
45–49
3,548
3,986
18.2
3,174
3,882
17.7
2,863
4,010
18.3
50–54
3,087
3,468
17.2
2,979
3,640
17.7
2,728
3,828
18.3
55–59
2,048
2,304
13.1
2,210
2,690
15.1
2,119
2,957
16.2
60–64
1,134
1,275
9.1
1,270
1,557
10.7
1,283
1,799
11.8
65
1,200
1,349
3.7
1,348
1,652
4.4
1,478
2,090
5.5
85
96
—
93
116
—
69
100
—
Race/ethnicity
American Indian/Alaska Native
Asian
b
79
89
—
88
109
—
63
94
—
Black/African American
8,809
9,899
—
7,978
9,722
—
7,405
10,374
—
Hispanic/Latinoc
3,176
3,558
—
3,110
3,762
—
2,788
3,792
—
Native Hawaiian/Other Pacific Islander
White
Multiple races
8
9
—
7
8
—
5
8
—
5,280
5,975
—
5,035
6,234
—
4,558
6,572
—
482
536
—
439
532
—
481
657
—
Table 11b. Deaths of persons with a diagnosis of HIV infection, by year of death and selected characteristics, 2007–2009—46 states and 5 U.S. dependent
areas with confidential name-based HIV infection reporting (cont)
2007
2008
Estimateda
No.
No.
Male-to-male sexual contact
5,527
7,521
Injection drug use
2,730
Male-to-male sexual contact and injection drug use
1,271
1,346
2009
Estimateda
Rate
No.
No.
—
5,071
7,639
3,610
—
2,509
1,574
—
1,139
2,006
—
1,355
Estimateda
Rate
No.
No.
Rate
—
4,759
8,296
—
3,599
—
2,206
3,604
—
1,548
—
1,113
1,729
—
2,184
—
1,123
2,149
—
Transmission category
Male adult or adolescent
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
d
Heterosexual contact
Other
e
Subtotal
2,288
120
—
2,232
109
—
2,056
104
—
13,162
14,830
12.6
12,306
15,080
12.7
11,257
15,882
13.3
Female adult or adolescent
Injection drug use
1,488
2,049
—
1,399
2,092
—
1,192
2,027
—
Heterosexual contactd
2,019
3,150
—
1,830
3,160
—
1,815
3,546
—
Othere
1,173
48
—
1,135
54
—
1,031
39
—
Subtotal
4,680
5,246
4.3
4,364
5,306
4.3
4,038
5,612
4.5
Perinatal
60
67
—
67
81
—
60
82
—
Otherf
19
22
—
16
20
—
17
24
—
Subtotal
79
89
0.2
83
101
0.2
77
106
0.2
17,921
20,165
6.9
16,753
20,486
7.0
15,372
21,601
7.3
Child (<13 yrs at diagnosis)
Totalg
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with a diagnosis of HIV infection may be due to any cause.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
41
42
Table 12a. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2007–2009 and cumulative—United States
2007
2008
Estimated
No.
No.
a
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Cumulativeb
Rate
No.
Est. No.a
Age at death (yr)
<13
6
7
0.0
3
4
0.0
3
4
0.0
4,952
4,986
13–14
9
10
0.1
0
0
0.0
2
3
0.0
288
294
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
15–19
36
40
0.2
36
43
0.2
25
33
0.2
1,212
1,248
20–24
150
169
0.8
141
171
0.8
135
191
0.9
9,237
9,432
25–29
448
503
2.4
416
506
2.4
369
513
2.4
45,465
46,125
30–34
808
905
4.7
689
837
4.3
631
869
4.4
98,922
100,273
35–39
1,765
1,979
9.4
1,387
1,680
8.1
1,132
1,555
7.6
123,353
125,612
40–44
2,848
3,179
14.5
2,386
2,881
13.5
1,882
2,584
12.3
114,050
117,093
45–49
3,207
3,577
15.7
2,845
3,441
15.1
2,530
3,454
15.1
83,845
87,022
50–54
2,730
3,042
14.5
2,582
3,115
14.5
2,339
3,176
14.6
53,444
56,017
55–59
1,751
1,950
10.7
1,929
2,316
12.5
1,804
2,429
12.8
31,497
33,217
60–64
957
1,065
7.4
1,071
1,292
8.6
1,072
1,445
9.1
17,870
18,842
65
966
1,074
2.8
1,115
1,341
3.5
1,126
1,517
3.8
18,205
19,221
American Indian/Alaska Native
73
82
3.6
77
94
4.0
56
79
3.4
1,814
1,893
Asianc
72
81
0.6
84
102
0.8
58
84
0.6
3,097
3,187
Black/African American
8,122
9,064
24.5
7,345
8,843
23.7
6,497
8,782
23.3
242,516
250,745
Hispanic/Latinod
2,438
2,697
5.9
2,358
2,810
6.0
2,142
2,853
5.9
92,853
95,376
9
10
2.3
12
14
3.3
5
7
1.6
346
355
4,552
5,111
2.6
4,330
5,293
2.7
3,850
5,380
2.7
254,819
260,572
415
457
10.6
392
468
10.6
439
584
12.8
6,823
7,177
Male-to-male sexual contact
4,966
6,537
—
4,512
6,533
—
4,144
6,863
—
271,486
296,222
Injection drug use
2,398
3,120
—
2,215
3,112
—
1,945
3,030
—
109,572
123,713
Male-to-male sexual contact
and injection drug use
1,149
1,398
—
1,049
1,391
—
991
1,498
—
43,305
46,949
Heterosexual contacte
1,166
1,672
—
1,188
1,836
—
942
1,679
—
23,724
30,505
Race/ethnicity
Native Hawaiian/Other Pacific
Islander
White
Multiple races
Transmission category
Male adult or adolescent
Otherf
Subtotal
1,810
116
—
1,764
115
—
1,600
109
—
45,251
8,960
11,489
12,842
10.6
10,728
12,986
10.6
9,622
13,179
10.6
493,338
506,349
Table 12a. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2007–2009 and cumulative—United States (cont)
2007
2008
Estimateda
No.
No.
Injection drug use
1,399
1,887
Heterosexual contacte
1,772
2,650
2009
Estimateda
Rate
No.
No.
—
1,339
1,945
—
1,558
2,566
Estimateda
Rate
No.
No.
—
1,067
1,729
—
1,518
2,755
Cumulativeb
No.
Est. No.a
—
45,100
52,948
—
39,941
50,210
Rate
Female adult or adolescent
f
Other
972
66
—
924
70
—
809
66
—
18,406
4,248
4,143
4,603
3.6
3,821
4,581
3.6
3,394
4,550
3.5
103,447
107,406
42
47
—
47
56
—
30
40
—
4,906
4,968
7
8
—
4
5
—
4
6
—
649
657
49
55
0.1
51
61
0.1
34
46
0.1
5,555
5,626
Northeast
4,322
4,734
8.6
4,078
4,778
8.7
3,425
4,276
7.7
194,149
198,038
Midwest
1,572
1,828
2.8
1,368
1,766
2.7
1,206
1,901
2.8
60,192
62,513
South
7,397
8,275
7.5
6,840
8,238
7.4
6,312
8,578
7.6
225,531
233,485
West
2,390
2,664
3.8
2,314
2,846
4.0
2,107
3,019
4.2
122,468
125,344
Totalh
15,681
17,501
5.8
14,600
17,628
5.8
13,050
17,774
5.8
602,340
619,380
Subtotal
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
Child (<13 yrs at diagnosis)
Perinatal
Otherg
Subtotal
Region of Residence
Note. Deaths of persons with an AIDS diagnosis may be due to any cause.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
From the beginning of the epidemic through 2009.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d
Hispanics/Latinos can be of any race.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
43
44
Table 12b. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2007–2009 and cumulative—United States and 6 U.S.
dependent areas
2007
2008
a
Estimated
No.
No.
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Cumulativeb
Rate
No.
Est. No.a
Age at death (yr)
<13
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
7
8
0.0
13–14
9
10
0.1
15–19
38
43
0.2
20–24
156
176
0.8
25–29
462
519
30–34
833
934
35–39
1,815
40–44
2,934
45–49
5
0.0
4
0.0
0
0
0.0
39
47
0.2
2
3
0.0
297
303
26
35
0.2
1,269
1,307
143
173
0.8
140
197
0.9
9,712
9,918
2.4
425
517
4.8
715
868
2.4
382
530
2.4
47,504
48,202
4.4
649
891
4.4
102,705
104,135
2,037
9.6
1,424
3,278
14.8
2,462
1,725
8.2
1,172
1,606
7.7
127,990
130,373
2,974
13.7
1,943
2,662
12.5
118,024
3,285
3,668
15.9
121,213
2,943
3,561
15.4
2,595
3,539
15.3
86,558
89,862
50–54
2,800
3,123
55–59
1,784
1,989
14.7
2,661
3,210
14.8
2,401
3,255
14.8
55,105
57,771
10.8
1,974
2,371
12.6
1,841
2,476
12.9
32,402
60–64
988
34,172
1,101
7.5
1,089
1,314
8.6
1,093
1,472
9.2
18,452
19,457
1,000
1,113
2.9
1,143
1,375
3.5
1,162
1,563
3.9
18,974
20,034
American Indian/Alaska Native
73
82
—
77
94
—
56
79
—
1,814
1,893
Asianc
73
82
—
84
102
—
58
84
—
3,113
3,203
Black/African American
8,129
9,072
—
7,350
8,849
—
6,506
8,794
—
242,778
251,018
Hispanic/Latinod
2,857
3,181
—
2,770
3,310
—
2,488
3,293
—
114,318
117,575
10
11
—
13
16
—
6
9
—
352
363
4,553
5,112
—
4,332
5,295
—
3,852
5,384
—
254,896
260,652
416
458
—
394
471
—
440
586
—
6,841
7,197
Male-to-male sexual contact
5,015
6,596
—
4,569
6,604
—
4,190
6,926
—
274,864
299,737
Injection drug use
2,553
3,306
—
2,375
3,309
—
2,063
3,189
—
118,866
133,448
Male-to-male sexual contact and
injection drug use
1,177
1,430
—
1,082
1,431
—
1,018
1,532
—
45,059
48,767
Heterosexual contacte
1,220
1,738
—
1,236
1,895
—
983
1,734
—
25,784
32,683
Otherf
1,822
117
—
1,770
115
—
1,613
112
—
45,584
9,086
11,787
13,187
10.7
11,032
13,354
10.7
9,867
13,492
10.7
510,157
523,721
65
4
3
5,192
5,230
Race/ethnicity
Native Hawaiian/Other Pacific
Islander
White
Multiple races
Transmission category
Male adult or adolescent
Subtotal
Table 12b. Deaths of persons with an AIDS diagnosis, by year of death and selected characteristics, 2007–2009 and cumulative—United States and 6 U.S.
dependent areas (cont)
2007
2008
Estimateda
No.
No.
1,452
1,949
1,844
975
2009
Estimateda
Rate
Estimateda
Cumulativeb
No.
Est. No.a
46,996
54,946
—
42,619
53,049
—
18,586
4,357
3.6
108,201
112,352
43
—
5,157
5,225
6
—
669
678
36
48
0.1
5,826
5,903
8.7
3,425
4,276
7.7
194,149
198,038
2.7
1,206
1,901
2.8
60,192
62,513
7.4
6,312
8,578
7.6
225,531
233,485
2,846
4.0
2,107
3,019
4.2
122,468
125,344
512
11.7
359
459
10.4
21,844
22,596
18,140
5.9
13,409
18,234
5.9
624,184
641,976
No.
No.
Rate
No.
No.
—
1,372
1,987
2,736
—
1,634
67
—
930
4,271
4,751
3.7
46
52
7
8
53
60
Northeast
4,322
Midwest
1,572
South
West
Rate
—
1,089
1,757
2,663
—
1,602
2,866
71
—
815
70
3,936
4,721
3.6
3,506
4,693
—
50
60
—
32
—
4
5
—
4
0.1
54
65
0.1
4,734
8.6
4,078
4,778
1,828
2.8
1,368
1,766
7,397
8,275
7.5
6,840
8,238
2,390
2,664
3.8
2,314
430
497
11.4
422
16,111
17,997
5.9
15,022
Female adult or adolescent
Injection drug use
e
Heterosexual contact
Otherf
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
Subtotal
—
Child (<13 yrs at diagnosis)
Perinatal
Otherg
Subtotal
Region of Residence
U.S. dependent areas
Totalh
Note. Deaths of persons with an AIDS diagnosis may be due to any cause.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
From the beginning of the epidemic through 2009.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d
Hispanics/Latinos can be of any race.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
45
Table 13a. Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2002–2006, by
selected characteristics—46 states with confidential name-based HIV infection reporting
Proportion survived
(in months)
No. of persons
>12
>24
>36
1,314
255
6,673
21,732
27,122
32,143
38,481
36,147
25,675
15,895
8,510
4,212
3,706
0.98
0.99
0.99
0.99
0.98
0.97
0.95
0.94
0.91
0.88
0.85
0.81
0.71
0.98
0.98
0.99
0.98
0.97
0.95
0.93
0.92
0.88
0.85
0.81
0.77
0.65
0.98
0.98
0.98
0.97
0.96
0.94
0.92
0.90
0.86
0.82
0.78
0.73
0.60
Race/ethnicity
American Indian/Alaska Native
Asiana
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
1,014
2,541
102,604
43,447
275
68,442
3,542
0.92
0.95
0.94
0.94
0.97
0.94
0.93
0.91
0.94
0.91
0.92
0.95
0.93
0.90
0.88
0.93
0.90
0.91
0.93
0.91
0.88
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactc
Otherd
Subtotal
91,709
13,384
8,218
16,168
33,773
163,252
0.96
0.90
0.96
0.93
0.88
0.94
0.95
0.87
0.94
0.91
0.85
0.92
0.94
0.84
0.92
0.89
0.84
0.90
Female adult or adolescent
Injection drug use
Heterosexual contactc
Otherd
Subtotal
7,472
28,399
21,428
57,299
0.93
0.96
0.92
0.94
0.90
0.95
0.90
0.92
0.87
0.93
0.89
0.91
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
1,135
179
1,314
0.98
0.99
0.98
0.98
0.98
0.98
0.98
0.98
0.98
41,107
43,716
45,653
45,629
45,760
0.93
0.94
0.94
0.94
0.94
0.91
0.92
0.92
0.92
0.93
0.89
0.90
0.90
0.91
0.92
221,865
0.94
0.92
0.90
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Year of diagnosis
2002
2003
2004
2005
2006
Totalf
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Data exclude persons whose month of
diagnosis or month of death is unknown.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
January 2007 and that have reported these data to CDC since at least June 2007.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Includes persons of unknown race/ethnicity.
46
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
Table 13b. Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2002–2006, by selected
characteristics—46 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting
Proportion survived
(in months)
No. of persons
>12
>24
>36
1,349
267
6,811
22,213
27,883
33,015
39,517
37,121
26,415
16,410
8,840
4,383
3,916
0.98
0.99
0.99
0.99
0.98
0.96
0.95
0.93
0.90
0.88
0.84
0.81
0.71
0.97
0.99
0.99
0.98
0.97
0.95
0.93
0.91
0.88
0.85
0.81
0.77
0.65
0.97
0.99
0.98
0.97
0.96
0.94
0.92
0.90
0.86
0.82
0.78
0.73
0.60
Race/ethnicity
American Indian/Alaska Native
Asiana
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
1,014
2,546
102,723
49,568
280
68,463
3,546
0.92
0.95
0.94
0.93
0.97
0.94
0.93
0.91
0.94
0.91
0.91
0.94
0.93
0.90
0.88
0.93
0.90
0.90
0.93
0.91
0.88
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactc
Otherd
Subtotal
92,767
15,092
8,422
17,156
34,145
167,582
0.96
0.89
0.96
0.93
0.88
0.93
0.95
0.86
0.94
0.91
0.85
0.92
0.94
0.83
0.92
0.89
0.84
0.90
Female adult or adolescent
Injection drug use
Heterosexual contactc
Otherd
Subtotal
7,909
29,661
21,639
59,209
0.93
0.96
0.92
0.94
0.89
0.94
0.90
0.92
0.87
0.93
0.89
0.90
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
1,166
183
1,349
0.98
0.98
0.98
0.97
0.98
0.97
0.97
0.98
0.97
42,492
45,037
46,829
46,895
46,887
0.93
0.93
0.93
0.94
0.94
0.91
0.91
0.92
0.92
0.93
0.89
0.90
0.90
0.91
0.91
228,140
0.94
0.92
0.90
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Year of diagnosis
2002
2003
2004
2005
2006
Totalf
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Data exclude persons whose month of
diagnosis or month of death is unknown.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least
January 2007 and that have reported these data to CDC since at least June 2007.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f
Includes persons of unknown race/ethnicity.
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
47
Table 14a. Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2002–2006, by selected
characteristics—United States
Proportion survived
(in months)
No. of persons
>12
>24
>36
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
331
370
1,747
7,845
15,638
24,977
35,541
36,683
27,250
16,879
8,916
4,385
3,727
0.93
0.98
0.97
0.95
0.94
0.93
0.91
0.90
0.86
0.83
0.79
0.75
0.66
0.92
0.97
0.95
0.93
0.91
0.90
0.88
0.86
0.83
0.78
0.75
0.70
0.60
0.91
0.96
0.94
0.91
0.89
0.88
0.86
0.83
0.79
0.75
0.71
0.66
0.54
Race/ethnicity
American Indian/Alaska Native
Asiana
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
796
1,869
90,099
35,146
213
52,735
3,429
0.87
0.91
0.88
0.89
0.92
0.89
0.88
0.83
0.89
0.84
0.87
0.88
0.86
0.84
0.79
0.88
0.81
0.85
0.86
0.84
0.81
68,485
17,556
9,459
15,200
24,273
134,973
0.91
0.85
0.92
0.88
0.81
0.89
0.89
0.80
0.88
0.85
0.78
0.85
0.87
0.76
0.85
0.82
0.75
0.83
Female adult or adolescent
Injection drug use
Heterosexual contactc
Otherd
Subtotal
10,069
24,350
14,566
48,985
0.87
0.91
0.86
0.89
0.82
0.88
0.82
0.85
0.77
0.85
0.79
0.82
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
310
21
331
0.94
0.86
0.93
0.93
0.81
0.92
0.92
0.81
0.91
Region of residence
Northeast
Midwest
South
West
47,627
20,536
84,989
31,137
0.90
0.90
0.87
0.90
0.87
0.87
0.83
0.88
0.84
0.84
0.80
0.86
Year of diagnosis
2002
2003
2004
2005
2006
38,299
38,870
37,541
35,632
33,947
0.88
0.89
0.89
0.89
0.89
0.84
0.85
0.85
0.86
0.86
0.81
0.82
0.82
0.84
0.84
184,289
0.89
0.85
0.82
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactc
Otherd
Subtotal
Totalf
Note. Data exclude persons whose month of diagnosis or month of death is unknown.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f
Includes persons of unknown race/ethnicity.
48
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
Table 14b. Survival for more than 12, 24, and 36 months after an AIDS diagnosis during 2002–2006, by selected
characteristics—United States and 6 U.S. dependent areas
Proportion survived
(in months)
No. of persons
>12
>24
>36
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
344
383
1,785
7,982
15,977
25,606
36,444
37,573
27,958
17,361
9,228
4,533
3,907
0.92
0.98
0.97
0.95
0.93
0.92
0.91
0.89
0.86
0.83
0.79
0.75
0.65
0.91
0.97
0.95
0.93
0.91
0.90
0.88
0.86
0.82
0.78
0.75
0.70
0.59
0.90
0.96
0.94
0.91
0.89
0.87
0.85
0.83
0.79
0.75
0.71
0.66
0.54
Race/ethnicity
American Indian/Alaska Native
Asiana
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
797
1,872
90,181
39,828
220
52,747
3,434
0.87
0.91
0.88
0.88
0.93
0.89
0.88
0.83
0.89
0.84
0.85
0.88
0.86
0.84
0.79
0.88
0.81
0.83
0.86
0.84
0.81
69,259
19,068
9,676
15,951
24,395
138,349
0.91
0.84
0.91
0.88
0.81
0.88
0.89
0.79
0.87
0.84
0.78
0.85
0.87
0.75
0.84
0.81
0.75
0.82
Female adult or adolescent
Injection drug use
Heterosexual contactc
Otherd
Subtotal
10,443
25,302
14,643
50,388
0.87
0.91
0.86
0.89
0.81
0.87
0.82
0.85
0.76
0.84
0.79
0.81
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
322
22
344
0.92
0.86
0.92
0.92
0.77
0.91
0.90
0.77
0.90
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
47,627
20,536
84,989
31,137
4,792
0.90
0.90
0.87
0.90
0.73
0.87
0.87
0.83
0.88
0.69
0.84
0.84
0.80
0.86
0.66
Year of diagnosis
2002
2003
2004
2005
2006
39,360
39,941
38,450
36,565
34,765
0.87
0.88
0.88
0.89
0.89
0.83
0.85
0.85
0.86
0.86
0.80
0.82
0.82
0.83
0.84
189,081
0.88
0.85
0.82
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactc
Otherd
Subtotal
Totalf
Note. Data exclude persons whose month of diagnosis or month of death is unknown.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Includes persons of unknown race/ethnicity.
Deaths and Survival after a Diagnosis of HIV Infection or AIDS
49
50
Table 15a. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2007–2009—46 states with confidential name-based HIV
infection reporting
2007
2008
Estimated
No.
No.
<13
3,684
3,729
13–14
1,450
1,459
15–19
6,514
6,611
20–24
20,657
25–29
a
2009
Estimated
Rate
No.
No.
7.4
3,267
3,318
18.4
1,351
1,362
32.2
6,808
6,947
21,047
104.1
22,751
42,415
42,992
214.7
30–34
60,793
61,326
35–39
101,003
40–44
a
Estimateda
Rate
No.
No.
Rate
6.5
2,888
2,945
5.7
17.4
1,207
1,218
15.7
33.7
6,790
6,983
34.1
23,374
115.1
24,893
25,866
126.1
43,906
44,701
218.8
45,272
46,394
224.7
332.8
61,640
62,330
335.4
62,665
63,541
335.6
101,426
508.4
96,144
96,619
487.3
91,039
91,523
468.2
145,034
145,078
700.0
140,485
140,427
692.1
134,486
134,215
673.8
45–49
140,434
139,947
647.2
149,740
148,956
688.4
157,131
155,757
719.0
50–54
101,201
100,497
505.0
110,057
108,912
535.2
119,175
117,290
567.7
55–59
59,938
59,313
343.1
67,027
66,005
374.9
75,504
73,759
409.3
60–64
28,317
27,935
203.5
33,259
32,581
227.5
38,271
37,066
246.9
65
22,195
21,688
60.2
25,649
24,816
67.3
29,645
28,143
74.8
2,838
2,825
124.7
2,956
2,930
127.7
3,083
3,039
130.8
7,016
7,075
59.5
7,652
7,736
63.3
8,250
8,366
66.7
313,268
312,677
904.7
326,233
325,056
930.4
338,291
335,798
951.9
138,154
138,707
312.2
144,416
144,955
316.1
150,658
151,130
319.9
483
486
155.8
536
541
168.6
599
607
184.5
260,249
259,586
136.9
268,389
267,208
140.6
276,028
273,800
143.9
10,852
10,916
278.5
11,130
11,150
275.5
11,288
11,194
268.4
Age at end of year
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Race/ethnicity
American Indian/Alaska Native
Asian
b
Black/African American
Hispanic/Latino
c
Native Hawaiian/Other Pacific Islander
White
Multiple races
Table 15a. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2007–2009—46 states with confidential name-based HIV
infection reporting (cont)
2007
2008
Estimateda
No.
No.
314,182
359,103
65,527
2009
Estimateda
Rate
No.
No.
—
329,481
378,291
80,128
—
64,796
40,178
45,044
—
Heterosexual contact
45,257
57,639
Othere
80,013
2,456
545,157
Injection drug use
Heterosexual contactd
Othere
Estimateda
Rate
No.
No.
Rate
—
344,531
396,810
—
79,515
—
63,989
78,532
—
40,199
45,105
—
40,110
44,859
—
—
47,027
60,320
—
48,667
62,674
—
—
85,726
2,392
—
91,275
2,321
—
544,369
470.9
567,229
565,623
484.1
588,572
585,197
496.1
36,412
48,843
—
36,017
48,592
—
35,635
48,168
—
91,041
127,830
—
94,235
134,013
—
96,700
139,135
—
50,471
1,406
—
53,909
1,383
—
57,252
1,365
—
177,924
178,078
147.5
184,161
183,987
151.0
189,587
188,668
153.6
9,280
9,325
—
9,392
9,433
—
9,489
9,522
—
Transmission category
Male adult or adolescent
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
d
Subtotal
Female adult or adolescent
Subtotal
Child (<13 yrs at diagnosis)
Perinatal
f
Other
Subtotal
Totalg
1,272
1,275
—
1,300
1,301
—
1,316
1,313
—
10,552
10,599
20.9
10,692
10,734
21.0
10,805
10,834
21.1
733,635
733,049
255.5
762,084
760,347
262.5
788,966
784,701
268.6
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
51
52
Table 15b. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2007–2009—46 states and 5 U.S. dependent areas with
confidential name-based HIV infection reporting
2007
2008
a
Estimated
No.
No.
<13
3,753
3,799
13–14
1,488
1,497
15–19
6,717
6,817
20–24
21,062
25–29
2009
a
Estimateda
Estimated
Rate
No.
No.
7.4
3,319
3,371
18.6
1,388
1,399
32.7
7,008
7,151
21,464
104.6
23,156
43,419
44,022
216.4
30–34
62,393
62,951
35–39
103,413
40–44
Rate
No.
No.
Rate
6.5
2,929
2,987
5.7
17.6
1,237
1,249
15.8
34.2
6,957
7,155
34.3
23,796
115.4
25,329
26,329
126.5
44,861
45,691
220.3
46,158
47,328
225.9
336.3
63,210
63,933
338.6
64,226
65,161
338.7
103,850
513.0
98,437
98,936
491.7
93,258
93,780
472.7
148,585
148,610
706.9
143,952
143,881
699.0
137,749
137,477
680.3
45–49
143,841
143,314
654.2
153,302
152,470
695.4
160,843
159,418
726.1
50–54
103,679
102,937
510.4
112,779
111,587
541.2
122,025
120,082
573.6
55–59
61,437
60,784
346.7
68,639
67,580
378.5
77,369
75,575
413.6
60–64
29,120
28,720
205.9
34,201
33,502
230.2
39,298
38,067
249.6
65
23,011
22,478
61.5
26,585
25,720
68.6
30,712
29,164
76.3
2,839
2,826
—
2,957
2,931
—
3,084
3,040
—
Age at end of year
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Race/ethnicity
American Indian/Alaska Native
Asianb
7,069
7,129
—
7,705
7,789
—
8,305
8,422
—
Black/African American
313,601
313,012
—
326,579
325,405
—
338,638
336,144
—
Hispanic/Latinoc
155,934
156,396
—
162,652
163,104
—
169,260
169,679
—
493
497
—
548
553
—
612
620
—
260,327
259,665
—
268,469
267,289
—
276,110
273,883
—
10,877
10,941
—
11,152
11,170
—
11,309
11,213
—
Native Hawaiian/Other Pacific Islander
White
Multiple races
Table 15b. Persons living with a diagnosis of HIV infection, by year and selected characteristics, 2007–2009—46 states and 5 U.S. dependent areas with
confidential name-based HIV infection reporting (cont)
2007
2008
Estimateda
No.
No.
317,163
362,255
70,931
2009
Estimateda
Rate
No.
No.
—
332,632
381,655
85,728
—
70,204
41,156
46,038
—
Heterosexual contact
47,440
59,979
Othere
80,664
2,476
557,354
Injection drug use
Heterosexual contactd
Othere
Estimateda
Rate
No.
No.
Rate
—
347,841
400,388
—
85,141
—
69,398
84,170
—
41,162
46,082
—
41,067
45,833
—
—
49,280
62,760
—
50,975
65,195
—
—
86,465
2,412
—
92,084
2,341
—
556,477
474.4
579,743
578,050
487.7
601,365
597,928
499.6
37,948
50,428
—
37,553
50,180
—
37,163
49,748
—
94,855
131,955
—
98,155
138,295
—
100,685
143,528
—
50,845
1,422
—
54,332
1,399
—
57,715
1,380
—
183,648
183,805
149.9
190,040
189,873
153.5
195,563
194,656
156.0
9,577
9,621
—
9,687
9,726
—
9,779
9,809
—
Transmission category
Male adult or adolescent
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
d
Subtotal
Female adult or adolescent
Subtotal
Child (<13 yrs at diagnosis)
Perinatal
Other
f
Subtotal
Totalg
1,337
1,340
—
1,365
1,367
—
1,381
1,378
—
10,914
10,960
21.3
11,052
11,093
21.4
11,160
11,186
21.4
751,918
751,244
257.9
780,837
779,018
264.9
808,090
803,771
271.0
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC
since at least June 2007.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
53
54
Table 16a. Persons living with an AIDS diagnosis, by year and selected characteristics, 2007–2009—United States
2007
2008
Estimated
No.
No.
a
2009
Estimated
Rate
No.
No.
a
Estimateda
Rate
No.
No.
Rate
Age at end of year
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
<13
904
911
1.7
690
698
1.3
538
546
1.0
13–14
681
685
8.3
606
612
7.5
467
477
5.9
15–19
2,695
2,727
12.6
2,714
2,759
12.8
2,660
2,732
12.7
20–24
5,703
5,832
27.5
6,208
6,398
30.0
6,788
7,096
32.9
25–29
14,645
14,917
71.0
15,074
15,452
72.1
15,359
15,929
73.5
30–34
27,649
27,994
144.6
27,526
27,976
143.4
27,576
28,227
141.9
35–39
55,716
56,086
267.2
52,578
53,031
254.4
49,071
49,621
241.6
40–44
91,850
92,032
421.0
87,887
88,049
411.6
83,278
83,478
397.7
45–49
95,092
94,868
416.3
100,887
100,527
440.9
105,497
104,934
459.6
50–54
71,447
71,006
338.7
77,635
76,922
358.9
83,719
82,623
379.7
55–59
43,036
42,620
234.1
48,197
47,512
256.2
54,519
53,413
281.5
60–64
20,469
20,212
139.8
24,133
23,686
157.0
27,848
27,089
171.3
65
16,045
15,691
41.4
18,528
17,943
46.2
21,542
20,565
52.0
1,542
1,528
66.4
1,623
1,601
68.6
1,692
1,658
70.2
Race/ethnicity
American Indian/Alaska Native
Asian
b
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
4,292
4,349
33.4
4,654
4,732
35.4
4,982
5,093
37.2
192,122
191,822
519.4
199,996
199,283
534.0
207,582
206,295
547.5
87,207
87,656
192.6
90,988
91,488
194.7
94,813
95,437
197.1
396
399
92.6
423
426
97.0
463
471
105.1
153,398
152,811
76.7
157,722
156,761
78.6
161,863
160,357
80.2
6,873
6,913
160.9
7,157
7,174
162.0
7,370
7,326
160.7
188,040
209,483
—
195,630
218,859
—
203,323
228,313
—
50,692
59,964
—
50,551
59,956
—
50,269
59,664
—
27,951
30,285
—
28,251
30,607
—
28,391
30,653
—
Heterosexual contact
29,739
36,471
—
31,188
38,481
—
32,705
40,573
—
Othere
42,991
2,679
—
46,114
2,729
—
49,164
2,757
—
339,413
338,883
278.9
351,734
350,631
285.6
363,852
361,960
292.0
White
Multiple races
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
d
Subtotal
Table 16a. Persons living with an AIDS diagnosis, by year and selected characteristics, 2007–2009—United States (cont)
2007
2008
Estimated
No.
No.
a
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Rate
Female adult or adolescent
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Injection drug use
26,186
33,400
—
26,116
33,552
—
26,110
33,700
—
Heterosexual contactd
52,320
67,617
—
54,834
71,675
—
57,042
75,330
—
Othere
24,122
1,800
—
26,102
1,848
—
28,003
1,914
—
102,628
102,816
80.9
107,052
107,074
83.5
111,155
110,945
85.8
3,687
3,680
—
3,672
3,657
—
3,653
3,630
—
204
201
—
205
202
—
202
197
—
3,891
3,881
7.3
3,877
3,859
7.2
3,855
3,827
7.1
129,787
130,898
238.5
132,835
134,029
243.4
135,942
137,495
248.7
Subtotal
Child (<13 yrs at diagnosis)
Perinatal
Otherf
Subtotal
Region of residence
Northeast
Midwest
47,602
47,256
71.2
49,949
49,452
74.3
52,367
51,569
77.2
South
179,473
178,131
161.1
187,558
185,614
165.7
194,969
192,055
169.5
West
89,070
89,294
128.0
92,321
92,469
130.8
95,584
95,613
133.6
Totalg
445,932
445,580
147.7
462,663
461,565
151.6
478,862
476,732
155.3
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
55
56
Table 16b. Persons living with an AIDS diagnosis, by year and selected characteristics, 2007–2009—United States and 6 U.S. dependent areas
2007
2008
a
Estimated
No.
No.
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Rate
Age at end of year
<13
926
933
1.7
703
711
1.3
546
554
1.0
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
13–14
697
702
8.3
623
629
7.5
481
491
5.9
15–19
2,783
2,816
12.9
2,799
2,845
13.0
2,719
2,791
12.8
20–24
5,844
5,975
27.8
6,360
6,554
30.3
6,945
7,258
33.2
25–29
14,918
15,197
71.2
15,323
15,710
72.2
15,612
16,194
73.6
30–34
28,259
28,612
145.6
28,117
28,580
144.2
28,133
28,805
142.7
35–39
56,940
57,311
269.2
53,711
54,172
256.2
50,128
50,694
243.3
40–44
94,110
94,271
425.5
90,019
90,164
415.7
85,222
85,413
401.3
45–49
97,368
97,100
420.8
103,289
102,881
445.5
108,006
107,395
464.4
50–54
73,172
72,688
342.4
79,519
78,755
362.9
85,698
84,549
383.7
55–59
44,138
43,692
236.7
49,367
48,643
258.9
55,885
54,733
284.7
60–64
21,043
20,765
141.4
24,804
24,333
158.9
28,584
27,796
173.2
65
16,633
16,251
42.3
19,203
18,584
47.2
22,316
21,294
53.0
1,543
1,529
—
1,624
1,602
—
1,693
1,659
—
Race/ethnicity
American Indian/Alaska Native
Asian
b
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
4,310
4,367
—
4,673
4,751
—
5,001
5,112
—
192,305
192,006
—
200,184
199,472
—
207,775
206,488
—
97,840
98,122
—
101,888
102,208
—
105,947
106,396
—
404
407
—
433
437
—
473
481
—
153,442
152,855
—
157,767
156,807
—
161,909
160,402
—
6,885
6,925
—
7,168
7,184
—
7,380
7,335
—
Transmission category
Male adult or adolescent
189,917
211,381
—
197,585
220,844
—
205,357
230,389
—
Injection drug use
54,050
63,309
—
53,952
63,346
—
53,695
63,075
—
Male-to-male sexual contact and injection drug use
28,650
30,974
—
28,938
31,281
—
29,078
31,326
—
Heterosexual contactd
31,099
37,858
—
32,592
39,923
—
34,159
42,076
—
Male-to-male sexual contact
Other
e
Subtotal
43,203
2,728
—
46,359
2,781
—
49,423
2,808
—
346,919
346,250
281.0
359,426
358,174
287.7
371,712
369,674
294.1
Table 16b. Persons living with an AIDS diagnosis, by year and selected characteristics, 2007–2009—United States and 6 U.S. dependent areas (cont)
2007
2008
Estimated
No.
No.
a
2009
a
Estimateda
Estimated
Rate
No.
No.
Rate
No.
No.
Rate
Female adult or adolescent
Injection drug use
d
Heterosexual contact
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Other
e
Subtotal
27,137
34,352
—
27,073
34,510
—
27,084
34,679
—
54,486
69,846
—
57,074
73,988
—
59,330
77,698
—
24,245
1,834
—
26,236
1,881
—
28,145
1,945
—
105,868
106,032
82.2
110,383
110,379
84.8
114,559
114,322
87.1
3,836
3,826
—
3,819
3,801
—
3,798
3,772
—
208
205
—
209
206
—
206
201
—
4,044
4,031
7.5
4,028
4,007
7.4
4,004
3,972
7.3
129,787
130,898
238.5
132,835
134,029
243.4
135,942
137,495
248.7
47,602
47,256
71.2
49,949
49,452
74.3
52,367
51,569
77.2
Child (<13 yrs at diagnosis)
Perinatal
Otherf
Subtotal
Region of residence
Northeast
Midwest
South
179,473
178,131
161.1
187,558
185,614
165.7
194,969
192,055
169.5
West
89,070
89,294
128.0
92,321
92,469
130.8
95,584
95,613
133.6
U.S. dependent areas
10,899
10,733
245.7
11,174
10,995
251.0
11,413
11,236
255.8
456,831
456,313
149.1
473,837
472,560
153.1
490,275
487,968
156.7
Totalg
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Includes persons of unknown race/ethnicity. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
57
58
Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 2009—46 states with confidential namebased HIV infection reporting
American Indian/
Alaska Native
Asiana
d
Estimated
No.
No.
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Age at end of year
<13
8
8
13–14
6
6
15–19
22
22
88
20–24
86
25–29
233 235
30–34
319 322
35–39
432 429
40–44
581 573
45–49
587 576
50–54
406 393
55–59
238 230
60–64
96
92
65
69
64
Transmission category
Male adult or adolescent
Male-to-male sexual contact 1,310 1,438
Injection drug use
234 250
334 363
Male-to-male sexual contact
and injection drug use
Heterosexual contactf
139 158
Otherg
235
8
Subtotal
2,252 2,218
Female adult or adolescent
Injection drug use
219 266
389 508
Heterosexual contactf
Otherg
185
9
Subtotal
793 782
Child (<13 yrs at diagnosis)
Perinatal
30
31
8
8
Otherh
Subtotal
38
38
Totali
Black/African American
Estimated
d
Estimated
d
Estimated
Rate
No.
No.
Rate
No.
No.
1.8
8.7
11.1
43.7
125.8
208.6
285.9
380.6
348.6
258.5
180.5
93.3
32.7
42
8
34
227
552
987
1,523
1,572
1,261
912
559
332
241
43
8
36
240
574
1,019
1,551
1,594
1,270
913
556
329
234
2.0
2.7
4.7
29.2
56.5
91.7
134.0
157.8
136.7
110.4
78.5
59.9
20.1
1,918
790
4,552
15,252
23,251
29,008
39,115
54,135
60,940
49,859
32,218
15,377
11,876
1,956
797
4,684
15,797
23,734
29,254
39,173
53,854
60,286
48,952
31,334
14,795
11,183
28.1
71.8
151.7
541.5
858.0
1,217.0
1,620.7
2,231.5
2,375.8
2,111.9
1,658.1
1,065.3
363.7
4,551 5,587
189 280
242 288
—
—
—
93,909 117,124
31,143 40,424
12,588 15,273
—
—
—
—
—
—
—
—
244.6
—
—
—
82.7
—
—
8.2
3,083 3,039 130.8
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
No.
No.
4.4
14.9
32.3
124.9
252.4
388.2
562.6
868.0
998.8
887.8
690.4
477.0
178.8
1
0
1
28
65
81
104
97
94
66
31
17
14
1
0
1
29
66
84
105
97
95
67
31
17
14
1.5
0.0
4.8
107.2
233.6
295.5
405.0
412.7
411.5
343.6
200.6
149.4
63.8
314
150
840
4,339
10,493
16,370
28,069
48,167
63,559
46,339
29,534
15,824
12,030
319
151
859
4,518
10,783
16,634
28,227
48,062
62,955
45,592
28,895
15,353
11,451
1.2
3.4
7.1
36.4
87.6
149.9
236.5
372.0
419.6
304.9
214.7
132.2
37.9
62
19
105
445
772
972
1,367
1,925
2,213
1,557
1,031
479
341
64
4.2
2,888 2,945
5.7
19 10.5
1,207 1,218 15.7
108 26.2
6,790 6,983 34.1
465 134.7 24,893 25,866 126.1
799 270.5 45,272 46,394 224.7
988 442.1 62,665 63,541 335.6
1,376 695.4 91,039 91,523 468.2
1,920 1,102.6 134,486 134,215 673.8
2,185 1,206.8 157,131 155,757 719.0
1,516 905.8 119,175 117,290 567.7
993 728.1 75,504 73,759 409.3
459 424.8 38,271 37,066 246.9
304 133.5 29,645 28,143 74.8
65,150 76,922
16,885 20,927
6,614 7,598
—
—
—
364
15
30
419
17
33
— 174,640 189,886
— 14,438 15,366
— 19,511 20,400
—
—
—
493 610
— 30,249 41,111
—
9,442 11,372
1,247
51
— 48,349
532
— 18,662
282
6,722 6,816 137.6 216,238 214,464 1,611.5 116,753 117,101
—
—
646.8
24
58
491
27
1
498
—
7,603 8,544
— 21,360 1,414
382.6 237,552 235,610
—
—
297.2
703 816
— 48,667 62,674
—
959
27
— 91,275 2,321
—
7,981 7,908 617.2 588,572 585,197 496.1
62 125
829 1,273
545
59
1,436 1,457
—
—
—
189.9
14
63
29
106
17
89
2
108
—
—
—
82.8
—
—
—
43.9
732 925
— 35,635 48,168
—
1,599 2,138
— 96,700 139,135
—
775
21
— 57,252 1,365
—
3,106 3,083 225.3 189,587 188,668 153.6
2,059
217
2,275
—
—
18.3
2
0
2
2
0
2
—
—
2.9
951.9 150,658 151,130
319.9
599
607
8,250 8,366
—
—
4.2
5,949
638
6,587
5,970
642
6,612
66.7 338,291 335,798
—
—
95.1
6,209 8,368
16,871 23,179
8,558
206
31,638 31,753
2,050
217
2,267
10,178 12,173
18,423 23,927
8,265
487
36,866 36,587
1,223
387
1,610
1,223
380
1,603
184.5 276,028 273,800
—
—
5.8
170
31
201
171
31
203
143.9 11,288 11,194
No.
No.e
Rate
4,475 5,032
1,062 1,189
782 845
Rate
Estimatedd
No.
62
31
93
552
235
1,271
4,728
10,199
15,223
20,609
27,993
28,204
19,717
11,609
5,947
4,843
Estimated
No.
61
31
92
541
232
1,234
4,514
9,902
14,909
20,376
27,887
28,290
19,896
11,781
6,073
5,023
Rate
Estimated
d
Rate
—
—
—
764.0
No.
Estimated
Totalc
Multiple races
d
No.
18,209 26,236
58,494 87,905
38,762
579
115,465 114,721
No.
White
d
No.
—
—
—
27.0
Rate
d
— 344,531 396,810
— 63,989 78,532
— 40,110 44,859
—
—
13.3
9,489 9,522
1,316 1,313
10,805 10,834
Rate
—
—
—
—
—
21.1
268.4 788,966 784,701 268.6
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC since at least June 2007.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c
Includes persons of unknown race/ethnicity.
d Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
e Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
f Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
g
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
h Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
i Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 17b. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 2009—46 states and 5 U.S. dependent
areas with confidential name-based HIV infection reporting
American Indian/
Alaska Native
No.
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Age at end of year
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection
drug use
Heterosexual contactf
Otherg
Subtotal
Female adult or adolescent
Injection drug use
Heterosexual contactf
Otherg
Subtotal
Child (<13 yrs at diagnosis)
Perinatal
Otherh
Subtotal
Totali
Est. No.
d
Black/African
American
Asiana
d
No.
Est. No.
No.
Hispanic/Latinob
d
Est. No.
No.
Native Hawaiian/
Other Pacific Islander
d
Est. No.
No.
Est. No.
d
White
No.
Est. No.
No.
Est. No.d,e
64
19
108
464
800
989
1,377
1,928
2,187
1,519
995
460
304
2,929
1,237
6,957
25,329
46,158
64,226
93,258
137,749
160,843
122,025
77,369
39,298
30,712
2,987
1,249
7,155
26,329
47,328
65,161
93,780
137,477
159,418
120,082
75,575
38,067
29,164
No.
Est. No.
319
151
859
4,518
10,788
16,636
28,234
48,078
62,968
45,605
28,905
15,364
11,458
62
19
105
445
773
973
1,369
1,934
2,215
1,560
1,033
480
341
d
8
6
22
86
233
319
432
581
588
406
238
96
69
8
6
22
88
235
322
429
573
577
393
230
92
64
43
8
34
228
559
992
1,537
1,583
1,266
918
560
333
244
44
8
36
241
581
1,024
1,566
1,605
1,274
919
557
330
237
1,921
791
4,555
15,257
23,276
29,029
39,164
54,192
60,995
49,905
32,250
15,404
11,899
1,959
798
4,687
15,802
23,761
29,276
39,224
53,912
60,339
48,997
31,365
14,821
11,205
578
261
1,398
4,944
10,750
16,438
22,521
31,053
31,923
22,677
13,600
7,060
6,057
590
264
1,441
5,185
11,092
16,809
22,791
31,157
31,788
22,443
13,380
6,909
5,832
1
0
1
28
66
84
104
102
97
66
32
17
14
1
0
1
29
67
87
105
103
98
66
32
17
14
1,310
234
334
1,438
250
363
4,566
189
242
5,609
286
290
93,964 117,188
31,162 40,473
12,592 15,281
68,326
22,269
7,561
80,347
26,499
8,555
370
15
30
425
18
33
174,683 189,933
14,443 15,373
19,517 20,407
4,488
1,063
782
5,045
1,190
845
347,841
69,398
41,067
400,388
84,170
45,833
140
235
2,253
159
8
2,219
496
1,267
6,760
618
51
6,854
30,293 41,190
48,427
532
216,438 214,663
11,698 13,800
19,362
302
129,216 129,503
25
60
500
28
1
506
7,606
8,548
21,367
1,414
237,616 235,675
703
961
7,997
816
27
7,923
50,975
92,084
601,365
65,195
2,341
597,928
219
389
185
793
266
508
9
782
62
831
559
1,452
127
1,287
60
1,473
18,219 26,255
58,563 88,024
38,821
581
115,603 114,859
30
8
38
31
8
38
62
31
93
63
31
94
3,084
3,040
8,305
8,422
5,956
640
6,596
5,977
644
6,621
338,638 336,144
314
150
840
4,339
10,497
16,372
28,076
48,182
63,572
46,352
29,544
15,835
12,037
Totalc
Multiple races
d
7,723
20,773
8,936
37,432
9,920
27,421
218
37,559
14
65
31
110
17
92
2
112
10,182
18,430
8,272
36,884
12,180
23,938
487
36,605
732
1,602
777
3,111
925
2,142
21
3,088
37,163
100,685
57,715
195,563
49,748
143,528
1,380
194,656
2,332
280
2,612
2,337
280
2,617
2
0
2
2
0
2
1,223
387
1,610
1,223
380
1,603
170
31
201
171
31
203
9,779
1,381
11,160
9,809
1,378
11,186
169,260 169,679
612
620
276,110 273,883
11,309
11,213
808,090
803,771
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC since at least June 2007.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Includes persons of unknown race/ethnicity.
d Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.
e Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
f Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
g Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
h Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
i
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
59
60
Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2009—United States
American Indian/
Alaska Native
Estimated
No.
No.
Asiana
d
Rate
Black/African American
Estimated
No.
No.
d
Rate
Estimated
No.
No.
d
Estimated
Rate
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
No.
No.
d
Estimated
Rate
White
d
No.
No.
Rate
Estimated
No.
No.
Totalc
Multiple races
d
Rate
d
Estimated
No.
No.
Rate
Estimated
No.
e
No.
d
Rate
Age at end of year
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
<13
2
2
0.4
6
6
0.3
366
372
5.0
96
97
0.8
2
2
2.2
55
56
0.2
11
11
0.7
538
546
1.0
13–14
1
1
1.4
1
1
0.3
317
324
27.5
90
93
5.8
1
1
7.7
51
51
1.1
6
6
3.1
467
477
5.9
15–19
8
8
4.0
11
11
1.4
1,836
1,885
57.4
471
488
12.1
2
2
5.6
285
289
2.3
46
47
10.5
2,660
2,732
12.7
20–24
21
21
10.5
47
51
5.7
4,302
4,478
144.4
1,375
1,456
37.5
4
4
11.9
895
935
7.2
144
150
39.7
6,788
7,096
32.9
8,206
25–29
76
77
40.3
178
190
17.3
8,455
286.8
3,801
3,985
96.0
30
32
83.4
2,784
2,896
22.4
284
294
90.5
15,359 15,929
73.5
30–34
113
115
73.5
413
434
36.1
13,357 13,565
528.1
7,240
7,498
186.1
39
40
109.1
5,914
6,063
52.1
500
512 207.3
27,576 28,227
141.9
35–39
247
247 161.5
817
846
67.5
21,941 22,081
853.7
11,712 11,934
317.6
58
59
172.0
13,433 13,579
108.3
856
868 396.3
49,071 49,621
241.6
40–44
322
314 205.0
977 1,002
91.3
34,886 34,862 1,344.5
18,254 18,435
557.6
91
91
289.9
27,424 27,444
201.6
1,305 1,312 675.6
83,278 83,478
397.7
45–49
372
364 216.1
894
909
89.6
42,197 41,913 1,536.9
19,978 20,021
691.8
98
99
310.2
40,318 40,001
253.3
1,622 1,610 799.2
105,497 104,934
459.6
50–54
271
261 168.7
676
682
75.2
36,161 35,665 1,434.1
14,519 14,439
635.0
69
70
259.6
30,814 30,319
192.8
1,183 1,161 625.7
83,719 82,623
379.7
55–59
144
138 106.6
477
478
61.5
23,846 23,303 1,148.9
8,871
8,779
510.4
34
34
153.6
20,354 19,909
140.8
779
757 500.3
54,519 53,413
281.5
60–64
69
66
65.7
284
284
46.7
11,356 11,009
736.4
4,590
4,518
354.6
19
19
115.5
11,141 10,818
88.7
382
368 307.3
27,848 27,089
171.3
65
46
43
21.7
201
198
14.9
8,384
254.2
3,816
3,695
133.8
16
17
50.6
7,996
25.2
252
229
91.4
21,542 20,565
52.0
Male-to-male sexual contact
717
760
—
2,630 3,275
—
55,335 65,906
—
39,018 45,757
—
277
313
—
102,535 109,154
—
2,763 3,089
—
203,323 228,313
—
Injection drug use
159
166
—
150
227
—
25,852 31,665
—
12,846 15,645
—
17
20
—
10,383 10,976
—
858
955
—
50,269 59,664
—
Male-to-male sexual contact
and injection drug use
Heterosexual contactf
224
232
—
177
210
—
9,736 10,988
—
12,861 13,200
—
581
628
—
28,391 30,653
—
79
88
—
355
442
—
20,264 26,232
107
13
—
811
58
—
25,501
822
4,123 4,212
77.9
136,688 135,612
953.6
8,811
8,395
Transmission category
Male adult or adolescent
g
Other
Subtotal
1,286 1,260 136.5
4,785
5,364
—
25
26
—
—
6,698
7,933
—
22
25
—
4,797
5,288
—
485
560
—
32,705 40,573
—
—
11,321
428
—
38
3
—
10,731
1,382
—
633
51
—
49,164
2,757
—
74,668 75,127
404.9
379
386
216.4
141,307 140,000
168.1
363,852 361,960
292.0
5,848
—
11
14
—
6,505
7,550
—
563
703
—
26,110 33,700
—
10,390 13,376
5,320 5,283 373.4
Female adult or adolescent
Injection drug use
122
144
—
Heterosexual contactf
g
Other
50
89
—
14,363 19,346
—
—
511
707
—
35,020 47,884
—
—
280
65
—
18,988
945
—
387
40.3
841
862
14.6
68,371 68,175
424.0
10
—
14
14
—
4,492
198
234
75
10
Subtotal
395
Perinatal
Otherh
10
1
1
—
4
4
—
98
97
—
43
Subtotal
11
11
2.3
18
18
0.8
2,523
2,508
34.0
717
—
49
63
—
9,905 11,812
—
964 1,246
—
57,042 75,330
—
375
—
19
3
—
3,623
477
—
466
—
28,003
1,914
—
19,428 19,599
114.3
79
80
44.7
20,033 19,839
22.7
111,155 110,945
85.8
—
5
5
—
41
—
0
0
—
53
51
—
3
3
—
202
197
—
711
5.6
5
5
5.5
523
517
1.8
57
57
3.5
3,855
3,827
7.1
4,546
37
1,993 1,986 131.9
Child (<13 yrs at diagnosis)
2,425
2,411
—
674
669
470
466
—
54
54
—
3,653
3,630
—
Table 18a. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2009—United States (cont)
American Indian/
Alaska Native
Asian
Estimatedd
No.
No.
Rate
a
Black/African American
Estimatedd
No.
No.
Rate
b
Hispanic/Latino
Estimatedd
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedd
No.
No.
Rate
White
Estimatedd
Estimatedd
No.
No.
c
Total
Multiple races
No.
No.
Rate
Rate
31
34
150.5
33,851 34,067
87.6
Estimatedd
No.
No.
Rate
Estimatedd
No.
No.
e
Rate
Region of residence
Northeast
114
116
86.8
1,152 1,196
41.5
59,459 60,112
979.1
37,906 38,510
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Midwest
199
192
47.3
407
415
25.5
23,330 22,919
336.8
5,326
121.5
18
18
67.9
22,237 21,808
41.4
South
429
416
56.2
715
728
25.0
109,010 107,536
502.1
24,647 24,351
141.2
70
72
110.2
57,792 56,708
81.6
West
950
934
86.4
2,708 2,753
44.0
15,783 15,728
474.0
26,976 27,250
134.9
344
347
104.0
47,983 47,774
123.3
1,692 1,658
70.2
4,982 5,093
37.2
207,582 206,295
547.5
94,813 95,437
197.1
463
471
105.1
161,863 160,357
80.2
i
Total
5,284
585.0
3,375 3,405 534.4
891
135,942 137,495
248.7
890 104.5
52,367 51,569
77.2
2,291 2,230 155.4
194,969 192,055
169.5
49.0
95,584 95,613
133.6
7,370 7,326 160.7
478,862 476,732
155.3
813
801
a
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c
Includes persons of unknown race/ethnicity.
d
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
e Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
f
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
g
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
h Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
i
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
61
62
Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2009—United States and 6 U.S. dependent areas
American Indian/
Alaska Native
No.
Est. No.
d
Asian
No.
Black/African
American
a
Est. No.
d
No.
Est. No.
Hispanic/Latino
d
No.
b
Est. No.
d
Native Hawaiian/
Other Pacific Islander
No.
Est. No.
d
White
No.
Multiple races
Est. No.
d
No.
Est. No.
Total
d
No.
c
Est. No.
d,e
Age at end of year
<13
2
2
6
6
366
372
104
105
2
2
55
56
11
11
546
554
13–14
1
1
1
1
318
325
103
106
1
1
51
51
6
6
481
491
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
15–19
8
8
11
11
1,837
1,886
529
546
2
2
285
289
46
47
2,719
2,791
20–24
21
21
47
51
4,303
4,479
1,531
1,617
4
4
895
935
144
150
6,945
7,258
25–29
76
77
180
192
8,211
8,460
4,047
4,243
30
32
2,784
2,896
284
294
15,612
16,194
30–34
113
115
414
435
13,364
13,572
7,787
8,065
40
41
5,914
6,063
501
513
28,133
28,805
35–39
247
247
821
850
21,967
22,108
12,737
12,974
59
60
13,434
13,580
856
867
50,128
50,694
40–44
322
314
983
1,008
34,927
34,904
20,132
20,302
96
97
27,432
27,452
1,311
1,318
85,222
85,413
45–49
373
365
897
912
42,232
41,948
22,442
22,438
100
101
40,322
40,005
1,622
1,609
108,006
107,395
50–54
271
261
677
683
36,188
35,691
16,458
16,327
69
70
30,825
30,329
1,184
1,161
85,698
84,549
55–59
144
138
477
478
23,871
23,328
10,202
10,065
35
35
20,361
19,916
781
759
55,885
54,733
60–64
69
66
284
284
11,371
11,024
5,302
5,201
19
19
11,150
10,827
382
368
28,584
27,796
65
46
43
203
200
8,820
8,392
4,573
4,408
16
17
8,401
8,001
252
229
22,316
21,294
Male-to-male sexual contact
717
760
2,636
3,283
55,374
65,947
40,968
47,745
281
317
102,561 109,181
2,772
3,098
205,357
230,389
Injection drug use
159
166
150
228
25,866
31,691
16,256
19,023
17
21
10,384
10,979
859
956
53,695
63,075
Male-to-male sexual contact and injection
drug use
Heterosexual contactf
224
232
177
211
9,739
10,992
5,464
6,027
25
27
12,866
13,205
581
628
29,078
31,326
Transmission category
Male adult or adolescent
80
90
358
446
20,293
26,275
8,117
9,385
23
26
4,798
5,289
485
560
34,159
42,076
107
13
816
59
25,532
822
11,538
478
40
3
10,735
1,382
633
51
49,423
2,808
1,287
1,261
4,137
4,226
136,804 135,728
82,343
82,658
386
393
141,344 140,037
5,330
5,292
371,712
369,674
Injection drug use
122
144
50
90
14,369
19,357
5,458
6,811
11
14
6,507
7,554
563
703
27,084
34,679
Heterosexual contactf
g
Other
198
234
512
711
35,060
47,946
12,632
15,670
50
66
9,909
11,817
964
1,246
59,330
77,698
75
10
284
65
19,016
947
4,651
404
21
3
3,626
477
466
37
28,145
1,945
Subtotal
395
387
846
867
68,445
68,250
22,741
22,885
82
83
20,042
19,849
1,993
1,986
114,559
114,322
Perinatal
Otherh
10
10
14
14
2,427
2,413
817
809
5
5
470
466
54
54
3,798
3,772
1
1
4
4
99
98
46
44
0
0
53
51
3
3
206
201
Subtotal
11
11
18
18
2,526
2,511
863
853
5
5
523
517
57
57
4,004
3,972
g
Other
Subtotal
Female adult or adolescent
Child (<13 yrs at diagnosis)
Table 18b. Persons living with an AIDS diagnosis, by race/ethnicity and selected characteristics, year-end 2009—United States and 6 U.S. dependent areas (cont)
American Indian/
Alaska Native
d
Est. No.
No.
Black/African
American
Asiana
No.
Est. No.
d
No.
Est. No.
Hispanic/Latinob
d
No.
Est. No.
d
Native Hawaiian/
Other Pacific Islander
No.
Est. No.
d
White
No.
Totalc
Multiple races
d
Est. No.
No.
d
Est. No.
No.
3,375
3,405
135,942
Est. No.
d,e
Region of residence
Persons Living with a Diagnosis of HIV Infection or AIDS (Prevalence)
Northeast
114
116
1,152
1,196
Midwest
199
192
407
415
South
429
416
715
728
West
950
934
2,708
2,753
15,783
15,728
1
1
19
19
193
193
1,693
1,659
5,001
5,112
U.S. dependent areas
Totali
59,459
60,112
23,330
22,919
5,284
5,326
18
18
22,237
21,808
891
890
52,367
51,569
109,010 107,536
24,647
24,351
70
72
57,792
56,708
2,291
2,230
194,969
192,055
26,976
27,250
344
347
47,983
47,774
813
801
95,584
95,613
11,134
10,959
10
10
46
45
10
9
11,413
11,236
105,947 106,396
473
481
161,909 160,402
7,380
7,335
490,275
487,968
207,775 206,488
37,906
38,510
31
34
33,851
a
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c Includes persons of unknown race/ethnicity.
d Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.
e
Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
f
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
g Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
h
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
i
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
34,067
137,495
63
Table 19. Diagnoses of HIV infection, by area of residence, 2010—United States and 6 U.S. dependent areas
Estimateda
Area of residence (date confidential name-based HIV infection reporting initiated)
b
No.
No.
Rate
Alabama (January 1988)
Alaska (February 1999)
Arizona (January 1987)
Arkansas (July 1989)
California (April 2006)
Colorado (November 1985)
Connecticut (January 2005)
Delaware (February 2006)
District of Columbia (November 2006)
Florida (July 1997)
Georgia (December 2003)
Hawaii (March 2008)
Idaho (June 1986)
Illinois (January 2006)
Indiana (July 1988)
Iowa (July 1998)
Kansas (July 1999)
Kentucky (October 2004)
Louisiana (February 1993)
Maine (January 2006)
Maryland (April 2007)
Massachusetts (January 2007)
Michigan (April 1992)
Minnesota (October 1985)
Mississippi (August 1988)
Missouri (October 1987)
Montana (September 2006)
Nebraska (September 1995)
Nevada (February 1992)
New Hampshire (January 2005)
New Jersey (January 1992)
New Mexico (January 1998)
New York (June 2000)
North Carolina (February 1990)
North Dakota (January 1988)
Ohio (June 1990)
Oklahoma (June 1988)
Oregon (April 2006)
Pennsylvania (October 2002)c
Rhode Island (July 2006)
South Carolina (February 1986)
South Dakota (January 1988)
Tennessee (January 1992)
Texas (January 1999)
Utah (April 1989)
Vermont (April 2008)
Virginia (July 1989)
Washington (March 2006)
West Virginia (January 1989)
Wisconsin (November 1985)
Wyoming (June 1989)
Subtotal
U.S. dependent areas
American Samoa (August 2001)
Guam (March 2000)
Northern Mariana Islands (October 2001)
Puerto Rico (January 2003)
Republic of Palau (September 2005)
U.S. Virgin Islands (December 1998)
Subtotal
705
38
620
214
5,015
429
414
141
822
5,251
1,843
77
44
1,536
488
116
141
340
1,178
55
1,495
626
749
358
504
592
20
113
383
53
1,315
153
4,313
1,504
12
1,039
289
233
1,521
120
815
36
885
4,250
83
11
1,036
550
78
274
21
42,898
788
41
675
243
6,417
470
539
161
—
5,782
2,581
—
51
1,897
542
128
158
389
1,279
66
—
—
803
395
564
652
25
128
424
62
2,207
171
5,321
1,669
13
1,126
317
254
1,673
153
914
42
976
4,651
90
—
1,272
607
88
305
23
47,129
16.7
5.9
10.2
8.4
17.4
9.4
15.3
18.2
—
31.2
26.3
—
3.3
14.7
8.4
4.3
5.6
9.0
28.5
5.0
—
—
8.1
7.5
19.1
10.9
2.6
7.1
16.0
4.6
25.3
8.5
27.2
17.8
2.0
9.8
8.6
6.6
13.3
14.5
20.0
5.2
15.5
18.8
3.2
—
16.1
9.1
4.8
5.4
4.1
16.1
0
2
0
678
0
29
709
0
4
0
1,118
—
47
1,169
0.0
2.1
0.0
28.2
—
42.8
26.7
Totald
43,607
48,298
16.3
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a Includes data from areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and
that have reported these data to CDC since at least June 2007. Estimated numbers resulted from statistical adjustment that accounted for reporting
delays, but not for incomplete reporting. Rates are per 100,000 population.
b
Includes data from areas with confidential name-based HIV infection reporting as of April 2008.
c Pennsylvania implemented confidential name-based HIV infection reporting in October 2002 in all areas except Philadelphia, where confidential
name-based HIV infection reporting was not implemented until October 2005.
d
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may
not sum to the column total.
64
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Table 20. AIDS diagnoses, by area of residence, 2010 and cumulative—United States and 6 U.S. dependent areas
Cumulativea
2010
Estimatedb
Area of residence
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Subtotal
U.S. dependent areas
American Samoa
Guam
Northern Mariana Islands
Puerto Rico
Republic of Palau
U.S. Virgin Islands
Subtotal
Totald
No.
236
31
469
140
2,818
278
302
93
469
3,122
807
53
40
968
312
74
85
184
814
25
861
343
505
176
349
344
18
83
230
27
881
91
2,824
814
5
609
136
172
913
50
590
14
545
2,315
56
2
536
282
48
147
11
25,297
No.
288
37
555
157
4,243
329
396
134
674
3,658
955
62
48
1,364
362
88
102
223
900
35
1,259
842
554
209
415
412
21
100
271
34
1,352
107
4,018
979
6
784
150
200
1,074
69
708
21
638
2,745
65
3
769
339
71
176
14
33,015
Ratec
0
1
0
429
0
17
447
25,744
0
2
0
590
0
24
616
33,630
0.0
0.9
0.0
14.9
0.0
21.6
14.0
10.8
6.1
5.3
8.4
5.4
11.5
6.5
11.3
15.1
112.5
19.7
9.7
4.8
3.1
10.6
5.6
2.9
3.6
5.2
20.0
2.7
22.1
12.8
5.6
4.0
14.1
6.9
2.1
5.5
10.3
2.5
15.5
5.3
20.6
10.4
0.9
6.8
4.1
5.2
8.5
6.6
15.5
2.6
10.1
11.1
2.3
0.5
9.8
5.1
3.9
3.1
2.5
10.8
Estimatedb
Adults or adolescents Children
10,195
78
763
7
12,709
47
4,582
38
164,707
703
10,166
32
16,400
188
4,242
27
20,917
190
122,793
1,570
39,250
252
3,332
17
747
3
39,823
290
9,802
57
2,082
14
16
3,343
5,685
38
21,381
135
1,308
9
37,129
338
23,037
231
17,512
118
5,867
29
8,191
58
13,028
63
500
3
1,831
13
7,004
29
1,254
10
55,440
811
3,096
9
199,176
2,437
20,578
133
180
2
18,358
150
5,681
27
6,929
19
39,162
378
2,969
28
16,422
117
332
6
15,089
61
82,258
398
2,607
20
512
6
20,373
188
13,484
34
1,837
11
5,309
34
280
2
1,119,652
9,475
2
85
4
33,193
3
738
34,025
1,153,677
0
1
0
404
0
17
422
9,898
Total
10,273
770
12,756
4,620
165,410
10,198
16,588
4,269
21,107
124,363
39,502
3,349
750
40,113
9,859
2,096
3,359
5,723
21,516
1,317
37,467
23,267
17,630
5,896
8,249
13,091
503
1,844
7,033
1,264
56,251
3,105
201,613
20,711
182
18,508
5,708
6,948
39,540
2,997
16,539
338
15,150
82,656
2,627
518
20,561
13,518
1,848
5,343
282
1,129,127
2
86
4
33,597
3
755
34,448
1,163,575
a
From the beginning of the epidemic through 2010.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
c
Rates are per 100,000 population.
d
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may
not sum to the column total.
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
65
66
Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, year-end 2009—United States and 6 U.S. dependent
areas
American Indian/
Alaska Native
Estimated
Area of residence
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Alabama
No.
No.
12
d
Rate
12
Asiana
Black/African American
Estimated
No.
No.
d
Rate
Estimated
No.
No.
Native Hawaiian/
Other Pacific
Islander
Hispanic/Latinob
d
Estimated
Rate
No.
No.
d
White
d
Estimated
Rate
No. No.
d
Estimated
d
Estimated
Rate
No.
No.
Rate
3,296 121.4
61.8
19
19
49.0
6,977
6,870
691.5
224
222
223.0
4
4
347.1
3,330
Alaska
147
143 177.0
10
10
36.2
68
68
334.3
52
52
167.4
5
5
147.9
320
Arizona
432
430 204.2
65
66
50.2
1,187
1,174
620.2
3,163
3,144
215.7
14
14
200.9
6,758
14
14
52.0
2,021
1,960
554.2
192
190
163.3
6
6
283.9
2,316
2,257 123.1
3,432 3,451
89.1
19,376
19,154 1,043.1
32,702
32,766
321.7
244 247
242.7
49,068
48,555 360.0
66.2
No.
No.
Rate
No.
d
Estimated
e
No.
Rate
10,616 272.3
141
139
444.5
10,761
82.2
10
10
50.3
612
602 106.4
6,704 205.6
126
120
202.7
11,799
11,707 220.2
44
41
164.5
4,623
4,498 189.5
874
861
165.3
314
Arkansas
11
California
470
463 281.4
Colorado
83
83 267.1
81
82
77.4
1,511
1,503
962.0
1,967
1,963
267.4
7
7
162.4
7,031
6,980 229.9
48
47
88.7
10,791
10,728 260.3
Connecticut
10
10 153.6
46
51
50.8
3,384
3,435 1,279.2
3,338
3,388 1,035.1
0
0
0.0
3,566
3,581 161.2
87
89
327.0
10,432
10,554 357.5
5
5 222.9
9
9
45.1
1,920
1,864 1,263.5
201
199
450.8
0
0
0.0
832
816 158.7
21
20
285.0
2,988
2,913 395.8
—
779
—
—
9
—
—
2,381
123
—
—
14,097
32
32
355.5
28,371
27,978 289.9
1,269 1,221
864.0
94,282
92,874 594.8
8,247 174.7
35,129 442.6
Delaware
11
Totalc
Multiple races
District of Columbia
12
—
—
49
—
—
10,737
Florida
81
81 177.5
228
228
64.1
46,036
45,262 2,032.7
18,262
18,068
567.5
Georgia
34
35 170.3
102
104
45.8
24,347
24,613 1,052.2
1,538
1,574
283.7
7
7
172.7
8,176
538
535
759.5
34,754
Hawaii
11
—
—
336
—
—
106
—
—
203
—
—
211
—
—
1,272
—
—
117
—
—
2,256
Idaho
14
14
95.4
5
6
40.9
36
37
509.6
99
99
87.8
0
0
0.0
610
609
56.8
4
5
32.7
768
770 62.2
Illinois
46
45 237.2
353
354
77.7
15,839
15,550 1,033.1
4,913
4,897
342.5
33
33
882.0
10,177
10,063 141.2
650
649
743.1
32,016
31,597 297.4
Indiana
11
11
79.9
56
56
76.5
2,902
2,838
630.4
575
569
236.0
3
3
183.8
4,711
4,588 103.0
155
153
350.0
8,413
8,218 155.6
4
4
47.7
29
30
77.7
298
296
509.4
137
136
150.3
1
1
99.6
1,139
1,131
49.6
24
24
137.1
1,632
1,623 65.0
Kansas
18
18
92.9
19
19
37.9
655
654
505.1
361
362
198.2
4
4
318.8
1,472
1,457
76.9
66
65
221.9
2,603
2,587 112.2
Kentucky
15
15 179.3
23
24
66.0
1,700
1,680
636.1
239
241
307.7
1
1
66.8
3,064
3,028
95.6
28
27
100.0
5,071
5,017 140.0
Louisiana
21
19
48
48
91.5
11,482
11,004
973.9
582
578
464.9
3
3
264.2
4,632
4,481 192.7
80
73
269.2
16,854
16,211 440.4
1,098 97.2
Iowa
Maine
8
87.1
2
2
21.4
99
—
118
—
—
22,858
—
—
216
—
—
4,534
36
79.4
63
63
33.3
8,186
115
112 250.5
95
94
63.5
13
13 117.9
14
14
70.2
Missouri
27
27 119.9
49
49
69.3
Montana
23
23
50.5
0
0
0.0
Nebraska
26
25 219.8
23
23 101.6
Nevada
49
48 215.9
150
150 104.1
1,551
Maryland
36
Massachusetts
18
Michigan
37
Minnesota
Mississippi
New Hampshire
1
8 129.9
—
1
103 1,068.0
—
—
51
387.8
0
0
0.0
909
930
85.9
3
3
34.3
1,072
—
—
19
—
—
4,750
—
—
611
—
—
29,542
—
—
3,782
—
—
4
—
—
6,662
—
—
37
—
—
15,261
7,949
707.5
578
568
187.8
4
4
178.7
4,867
4,771
72.7
236
227
240.8
13,994
13,642 163.9
2,109
2,090 1,183.6
552
548
363.0
5
5
241.8
3,388
3,343
88.2
53
52
114.6
6,323
6,251 143.4
6,077
5,961
697.4
150
150
282.4
2
2
294.5
1,765
1,736 120.3
85
85
555.1
8,142
7,996 333.6
4,737
4,646
862.1
476
479
338.3
2
2
60.7
5,530
5,445 131.7
72
66
125.9
10,900
10,721 216.0
12
12
289.6
14
14
65.2
0
0
0.0
311
308
42.1
3
3
24.1
363
359 43.8
446
444
743.1
210
209
208.9
2
2
216.9
916
912
72.4
15
15
123.3
1,640
1,634 111.3
1,529
3,510 276.7
6,661 311.0
964.1
1,361
1,356
271.8
20
20
207.9
3,563
38.5
159
161 1,434.6
106
104
387.8
0
0
0.0
799
199
213
38.8
18,868
19,096 2,044.6
7,777
7,938
710.8
19
21
737.6
8,097
9
9
41.7
132
389.2
1,071
1,059
149.8
1
1
85.3
950
930 129.4
1,463 1,518 134.1
55,284
56,223 2,376.0
40,519
41,165 1,604.7
22
23
303.3
27,272
27,866 275.1
6,156 115.6
New Mexico
169
165 120.7
New York
108
111 214.8
North Carolina
203
200 234.5
North Dakota
11
38.7
—
50
8
32 274.3
—
—
1,146
8
31
—
—
—
36.6
New Jersey
10
—
106,191 105,522 349.8
133
102
103
69.5
15,757
15,427
955.2
1,340
1,344
283.8
14
14
373.5
6,231
1
1
24.1
32
33
635.7
4
4
37.2
0
0
0.0
127
—
—
—
—
44
44
110.4
6,742
75.0
9
9
100.4
1,082
1,074 95.5
8,212 179.6
406
400
632.0
35,527
36,041 497.1
16
17
95.0
2,349
2,314 141.4
791
127
25.8
3,592 3,659 2,306.0
128,302 130,608 795.9
152
150
241.3
23,858
23,454 304.0
0
0
0.0
175
175 32.2
Table 21. Adults and adolescents living with a diagnosis of HIV infection, by race/ethnicity and area of residence, year-end 2009—United States and 6 U.S. dependent
areas (cont)
American Indian/
Alaska Native
Estimated
Area of residence
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Ohio
No.
No.
d
Rate
18
a
Black/African American
Estimated
No.
No.
d
Rate
Estimated
No.
No.
Hispanic/Latino
d
b
Estimated
Rate
No.
No.
d
Estimated
Rate
No. No.
White
d
Rate
Multiple races
Estimated
No.
No.
d
Total
d
Estimated
Rate
No.
No.
c
Rate
No.
d
Estimated
e
No.
Rate
16,265 169.1
87.9
71
71
48.6
7,299
7,118
650.5
769
749
324.9
0
0
0.0
8,212
8,010
99.7
176
175
194.8
16,671
280
270 120.6
28
28
56.3
1,085
1,061
473.1
369
367
177.7
7
7
298.2
2,822
2,737 123.9
114
110
111.6
4,705
4,580 151.9
Oregon
55
54 150.1
79
80
69.1
363
363
687.1
589
591
200.8
13
13
161.9
3,901
3,866 147.0
39
38
64.0
5,040
5,007 156.6
159
1,132 1,118 1,514.6
31,498
31,177 292.5
Oklahoma
19
Asian
Native Hawaiian/
Other Pacific
Islander
Pennsylvania
31
31 198.3
161
63.5
15,435
15,235 1,448.3
4,620
4,593
993.4
22
22
774.2
10,097
10,019 113.8
Rhode Island
8
8 235.5
26
28 120.4
492
499 1,179.7
444
457
483.7
1
1
215.0
850
863 119.5
14
14
157.3
1,835
1,869 209.0
South Carolina
14
19
19
949.4
421
420
300.0
2
2
135.6
3,374
3,317 131.6
80
78
280.9
13,917
13,639 360.7
13
98.8
40.9
9,996
9,778
South Dakota
69
67 140.4
3
3
56.8
87
89 1,398.6
11
11
71.3
0
0
0.0
248
42.4
1
1
14.0
419
420 62.8
Tennessee
10
10
67.1
24
24
35.3
8,855
8,818 1,060.3
453
458
265.4
9
9
435.5
5,872
5,838 142.8
249
107
106
253.7
15,331
15,265 292.5
Texas
95
94 118.6
508
509
74.4
23,644
23,128 1,027.7
16,271
16,047
240.6
37
38
277.6
21,472
20,951 213.8
326
298
176.8
62,363
61,076 310.6
Utah
27
26 107.5
20
20
46.6
207
209 1,063.1
405
406
175.6
3
3
17.3
1,632
1,622
91.6
13
13
54.1
2,311
2,302 108.2
—
—
5
—
—
402
—
—
Vermont
1
—
—
0
—
—
41
—
—
19
—
—
1
—
—
335
Virginia
18
18
95.3
203
211
65.6
11,896
11,992
955.0
1,265
1,300
315.6
11
12
299.0
6,238
6,307 141.6
196
196
254.0
19,866
20,073 306.8
164 212.9
289
289
76.1
1,539
1,535
823.6
1,120
1,118
237.1
36
36
151.5
7,187
7,116 166.6
112
108
88.2
10,458
10,376 187.5
Washington
West Virginia
166
2
2
58.4
1
1
9.7
398
392
756.9
32
32
191.3
0
0
0.0
1,001
989
68.2
11
11
97.0
1,449
1,431 92.6
Wisconsin
37
36
93.3
59
59
65.3
1,877
1,843
721.0
575
572
276.1
2
2
139.9
2,351
2,313
56.5
46
44
118.9
4,948
4,872 103.2
Wyoming
9
9
96.7
0
0
0.0
12
13
302.1
20
20
63.4
0
0
0.0
159
162
41.0
8
8
172.3
208
212 47.3
8,927 8,323
80.4
156,046 150,578
432.3
842 606
233.1
12,119 11,130
420.0
Subtotal
3,153 3,030 163.6
374,649 333,842 1,178.6
291,114 273,480 168.3
847,636 781,756 324.6
f
U.S. dependent areas
American Samoa
0
0
—
2
2
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
2
Guam
0
0
—
38
38
—
5
5
—
4
4
—
11
11
—
13
13
—
20
18
—
91
Northern Mariana Islands
0
0
—
13
14
—
0
0
—
0
0
—
1
1
—
0
0
—
0
0
—
14
15 36.6
Puerto Rico
1
1
—
1
1
—
6
6
—
18,372
18,314
—
1
1
—
25
26
—
0
0
—
18,406
18,350 555.7
Republic of Palau
0
—
—
0
—
—
1
—
—
1
—
—
2
—
—
0
—
—
0
—
—
4
U.S. Virgin Islands
0
0
—
0
0
—
333
332
—
189
193
—
0
0
—
44
44
—
1
0
—
570
573 632.7
Subtotal
1
1
—
54
55
—
345
344
—
18,566
18,511
—
15
13
—
82
83
—
21
18
—
19,087
19,028 526.5
3,154 3,031
—
8,981 8,378
—
374,994 334,185
—
174,612 169,089
—
857 619
—
291,196 273,563
—
12,140 11,149
—
Totalg
2
4.4
89 65.7
—
—
866,723 800,784 327.6
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c
Includes persons of unknown race/ethnicity.
d
Includes data from areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 and that have reported these data to CDC since at least June 2007. Estimated numbers resulted
from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
e Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
f
Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
67
68
Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 2009—United States and 6 U.S. dependent
areas
American Indian/
Alaska Native
Estimated
Area of residence
Alabama
No.
No.
2
2
Asian
d
Rate
a
Black/African American
d
Estimated
No.
No.
Rate
Hispanic/Latino
d
Estimated
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
b
d
Estimated
No.
No.
Rate
White
d
Estimated
No.
No.
Multiple races
d
Estimated
Rate
No.
No.
Rate
Total
d
Estimated
No.
No.
Rate
No.
c
d
Estimated
e
No.
Rate
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
10.6
5
5
12.6
2,844
2,773
279.2
119
118
118.5
2
2
173.8
1,389
1,364
50.2
64
62
198.8
4,426
4,327
Alaska
87
84 104.1
6
6
21.7
42
41
204.1
37
37
119.1
3
3
87.5
164
158
41.3
5
5
25.0
344
334
59.1
Arizona
230
227 108.0
24
25
18.8
559
549
289.8
1,585
1,563
107.3
6
6
84.6
3,274
3,228
99.0
62
57
95.7
5,741
5,656
106.4
4
4
13.5
901
852
240.8
94
93
79.4
5
5
237.6
1,163
1,118
60.9
16
13
50.8
2,193
2,093
88.2
2,116 2,162
55.8
12,279
12,263
667.8
21,423
21,741
213.5
139
144
142.0
30,599
30,644
227.2
511
509
97.7
67,371 67,765
224.6
Arkansas
6
California
285
284 172.4
6
35.3
Colorado
111.0
38
38 121.7
39
39
37.1
699
693
443.2
1,018
1,014
138.0
3
3
69.3
2,828
2,791
91.9
28
27
51.5
4,653
4,605
111.7
Connecticut
7
7 104.3
16
16
16.5
2,354
2,313
861.4
2,224
2,201
672.6
0
0
0.0
2,368
2,308
103.9
68
68
251.7
7,037
6,913
234.2
Delaware
3
3 133.0
3
3
15.1
1,231
1,232
835.1
113
114
258.8
0
0
0.0
502
509
99.1
10
11
154.4
1,862
1,872
254.4
District of Columbia
6
6 427.5
23
24 147.4
6,951
6,946 2,589.9
480
488 1,168.3
5
5 1,534.6
1,236
1,242
683.2
85
83 1,391.7
8,787
8,796 1,704.7
9,908
9,718
305.2
133.3
16,130
15,771
163.4
791
753
532.8
53,041 51,821
331.9
19,627 19,932
251.1
Florida
28
27
59.3
Georgia
18
19
91.8
Hawaii
5
5 103.3
Idaho
8
8
52.6
Illinois
23
23 122.2
Indiana
2
2
Iowa
-
0
110
31.0
26,061
25,429 1,142.0
45
47
20.5
13,532
13,745
587.6
921
949
170.9
3
3
75.0
4,782
4,841
102.6
324
326
462.5
212
210
47.9
80
79
280.7
125
123
150.8
144
141
153.8
749
738
261.0
70
69
44.3
1,385
1,365
0
0
0.0
17
18
253.0
44
44
38.9
0
0
0.0
272
268
25.0
3
3
20.2
344
341
27.6
191
199
43.6
8,729
8,791
584.1
2,905
2,985
208.7
9
9
248.9
5,319
5,376
75.5
406
422
483.0
17,582 17,805
167.6
11.5
31
31
42.3
1,485
1,423
316.1
329
322
133.6
2
2
122.7
2,512
2,402
53.9
82
80
182.9
4,443
4,262
80.7
0.0
11
11
28.8
193
193
331.8
91
90
99.7
0
0
0.0
708
699
30.6
17
17
96.8
1,020
1,010
11
40.5
12
59.9
9
9
17.8
349
345
266.8
220
220
120.7
2
2
164.0
891
874
46.1
34
33
112.1
1,517
1,496
64.9
Kentucky
Louisiana
7
7
82.4
12
12
34.7
858
841
318.3
158
159
203.1
1
1
66.9
1,692
1,662
52.5
13
13
49.3
2,741
2,696
75.2
11
9
40.5
22
22
41.6
5,933
5,524
488.9
320
315
253.8
2
2
177.7
2,589
2,465
106.0
36
29
107.7
8,914
8,367
227.3
Maine
Maryland
3
3
47.9
2
2
21.6
48
49
509.9
31
32
242.4
0
0
0.0
515
511
47.2
2
2
21.5
601
599
53.0
9
9
72.9
50
53
22.1
13,306
13,639 1,006.7
703
738
247.7
10
11
440.0
2,629
2,675
96.6
389
401
765.8
17,097 17,529
370.3
Massachusetts
12
13
112.6
135
143
52.9
2,940
3,081
968.2
2,404
2,515
572.9
2
3
130.6
4,250
4,376
97.5
26
28
55.1
9,776 10,165
182.2
Michigan
15
15
32.6
34
34
18.0
4,329
4,130
367.6
316
304
100.6
2
2
88.1
2,618
2,535
38.6
149
142
150.0
7,463
7,162
Minnesota
62
59 133.0
39
38
25.6
989
970
549.4
303
300
198.8
1
1
48.8
1,437
1,394
36.8
24
23
50.7
2,855
2,786
63.9
Mississippi
6
6
53.3
6
6
30.0
2,665
2,602
304.4
86
86
161.1
1
1
147.6
790
766
53.1
47
47
309.9
3,601
3,514
146.6
Missouri
15
15
65.2
19
19
26.8
2,534
2,463
457.0
251
252
178.0
1
1
30.4
2,990
2,923
70.7
43
38
71.3
5,853
5,710
115.1
Montana
20
20
44.4
0
0
0.0
9
9
216.6
10
10
48.6
0
0
0.0
197
195
26.6
2
2
14.9
238
236
28.8
Nebraska
12
12 101.2
14
14
62.0
232
229
382.4
138
137
136.3
1
1
106.5
487
482
38.3
6
6
48.5
890
880
60.0
Nevada
25
24 109.3
76
76
53.0
752
735
463.5
726
722
144.7
11
11
114.7
1,693
1,655
130.5
20
20
50.9
3,303
3,244
151.5
0.0
4
4
19.6
93
94
839.1
65
64
239.7
0
0
0.0
439
431
40.8
5
5
55.5
606
598
53.2
10,197 1,091.9
19,082 19,161
264.3
Kansas
New Hampshire
0
0
110
New Jersey
16
16 141.5
95
100
18.3
10,166
New Mexico
91
88
64.5
7
7
32.8
62
New York
60
62
119.4
783
813
71.8
34,140
North Carolina
90
88 103.1
30
30
20.2
6,430
12
12
4,183
4,208
376.8
8
8
297.3
4,388
4,406
96.4
219
217
342.2
177.9
646
636
89.9
1
1
86.9
584
572
79.5
12
12
68.8
34,830 1,471.9
25,942
26,463 1,031.6
9
10
134.1
15,278
15,499
153.0
6
6
160.8
2,473
2,425
45.5
61
6,256
387.3
611
612
129.2
2,347 2,389 1,505.3
65
67
106.8
1,403
126.1
86.0
1,376
84.1
78,599 80,106
488.2
9,708
9,486
123.0
Table 22. Adults and adolescents living with an AIDS diagnosis, by race/ethnicity and area of residence, year-end 2009—United States and 6 U.S. dependent
areas (cont)
American Indian/
Alaska Native
Estimated
Area of residence
Rate
d
Estimated
No.
No.
Rate
Estimated
No.
No.
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
d
Estimated
Rate
No.
No.
d
White
d
Estimated
Rate
Rate
Estimated
No.
No.
Totalc
Multiple races
d
Rate
Estimated
No.
No.
d
Rate
d
Estimated
e
No.
Rate
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
No.
No.
8
8
30.4
1
1
24.2
13
13
254.0
4
4
38.1
0
0
0.0
60
59
12.0
0
0
0.0
86
85
Ohio
8
7
34.9
31
32
21.6
3,467
3,376
308.5
403
391
169.5
0
0
0.0
3,939
3,824
47.6
99
100
111.6
7,947
7,729
80.4
165
157
70.0
14
14
28.1
527
504
224.9
192
190
91.9
3
3
127.2
1,429
1,360
61.6
58
54
55.1
2,388
2,282
75.7
Oregon
No.
d
Black/African American
North Dakota
Oklahoma
No.
Asiana
No.
15.7
34
32
88.9
50
50
43.7
218
217
410.2
390
392
133.2
8
8
99.3
2,492
2,463
93.6
17
16
27.1
3,209
3,178
99.4
Pennsylvania
9
9
57.9
95
95
37.8
9,246
9,078
863.0
2,683
2,653
573.9
10
10
359.7
5,784
5,719
65.0
697
686
929.2
18,524
18,251
171.2
Rhode Island
6
6 170.0
20
20
88.3
372
368
870.2
336
335
355.2
1
1
204.3
622
609
84.4
7
7
74.3
1,364
1,346
150.5
South Carolina
8
8
59.4
9
10
21.3
5,465
5,284
513.1
242
241
172.7
2
2
136.4
1,737
1,688
67.0
52
50
178.7
7,515
7,284
192.7
South Dakota
27
26
55.0
1
1
18.9
41
43
669.9
4
4
24.8
0
0
0.0
94
94
16.1
0
0
0.0
167
168
25.2
8
8
54.2
14
14
20.8
4,176
4,137
497.4
250
253
146.3
1
1
48.2
3,166
3,137
76.8
61
60
143.5
7,676
7,611
145.8
172.9
Tennessee
Texas
53
52
66.0
259
259
37.8
12,450
12,026
534.4
9,745
9,547
143.2
13
13
97.6
12,392
11,947
121.9
169
148
87.9
35,082
33,993
Utah
17
16
66.3
10
10
23.3
107
107
544.9
230
230
99.5
1
1
6.8
917
906
51.2
10
10
41.8
1,292
1,280
60.2
1
1
49.2
0
0
0.0
28
28
688.3
11
11
153.8
1
1
671.5
199
200
39.1
2
2
40.1
242
243
45.3
6
32.6
108
113
35.2
5,276
5,335
424.9
665
691
167.7
4
4
108.9
3,061
3,097
69.5
105
105
136.7
9,225
9,351
142.9
101 131.3
165
165
43.4
933
930
498.9
693
689
146.2
26
26
110.0
4,114
4,057
95.0
68
66
53.8
6,110
6,042
109.2
Vermont
Virginia
Washington
West Virginia
6
104
3
3
95.1
1
1
10.7
188
191
368.9
15
16
93.5
0
0
0.0
611
619
42.7
4
3
29.4
822
834
54.0
Wisconsin
15
13
34.5
25
25
27.5
911
884
345.8
312
309
149.2
0
0
0.0
1,169
1,132
27.7
26
24
66.2
2,458
2,389
50.6
Wyoming
5
5
51.0
0
0
0.0
6
6
149.0
13
13
41.7
0
0
0.0
87
86
21.7
3
2
50.4
114
112
25.0
1,690 1,656
87.9
4,976 5,086
44.9
207,216 205,923
679.7
94,717 95,340
267.1
461
469
131.4 161,808 160,301
93.9
250.4 478,324 476,186
188.0
—
0
0
Subtotal
7,359 7,314
f
U.S. dependent areas
American Samoa
0
0
—
1
1
—
0
0
—
0
0
—
0
0
—
1
1
—
2
2
4.4
Guam
0
0
—
15
15
—
1
1
—
0
0
—
8
8
—
2
2
—
9
8
—
35
33
24.7
Northern Mariana Islands
0
0
—
3
3
—
0
0
—
0
0
—
1
1
—
0
0
—
0
0
—
4
4
10.5
Puerto Rico
1
1
—
0
0
—
3
3
—
—
0
0
—
17
17
—
0
0
—
11,042
10,866
329.1
Republic of Palau
0
0
—
0
0
—
0
0
—
0
0
—
1
1
—
0
0
—
0
0
—
1
1
5.6
U.S. Virgin Islands
0
0
—
0
0
—
189
189
—
105
106
—
0
0
—
27
27
—
0
0
—
321
321
355.0
Subtotal
1
1
—
19
19
—
193
193
—
11,126 10,951
—
10
10
—
46
45
—
10
9
—
11,405
11,228
309.2
— 489,729 487,414
189.7
11,021 10,845
g
Total
1,691 1,657
— 4,995 5,105
— 207,409 206,116
— 105,843 106,291
—
471
479
— 161,854 160,346
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c
Includes persons of unknown race/ethnicity.
d Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
e
Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
f
Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited.
g Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
—
7,369 7,323
69
Table 23. Diagnoses of HIV infection, 2010, and persons living with a diagnosis of HIV infection, year-end 2009,
by metropolitan statistical area of residence—United States and Puerto Rico
Diagnosis, 2010
Living with HIV infection, year-end 2009
Estimateda
Area of residence
No.
No.
Rate
Estimateda
No.
No.
Rate
Akron, OH
33
35
5.1
740
717
102.5
Albany–Schenectady–Troy, NY
75
99
11.6
2,014
2,103
245.3
Albuquerque, NM
70
76
8.9
1,186
1,165
135.8
Allentown–Bethlehem–Easton, PA–NJ
65
73
8.9
1,421
1,416
173.5
Atlanta–Sandy Springs–Marietta, GA
1,184
1,644
30.0
22,977
23,227
424.2
Augusta–Richmond County, GA–SC
89
128
23.8
2,036
2,043
378.9
Austin–Round Rock, TX
239
262
15.4
4,226
4,166
244.4
Bakersfield, CA
112
138
17.1
1,636
1,620
200.6
Baltimore–Towson, MD
819
—
—
18,346
—
—
Baton Rouge, LA
314
339
43.0
3,955
3,779
480.2
Birmingham–Hoover, AL
219
240
21.2
3,368
3,322
293.7
25
27
4.5
401
401
66.1
438
—
—
10,655
—
—
Boston Division
228
—
—
6,351
—
—
Cambridge Division
125
—
—
2,758
—
—
62
—
—
1,271
—
—
85
92
13.4
1,625
1,596
232.0
Bridgeport–Stamford–Norwalk, CT
107
142
15.8
2,752
2,792
309.8
Buffalo–Niagara Falls, NY
127
169
15.1
2,143
2,264
201.5
89
97
16.5
1,573
1,556
265.0
Charleston–North Charleston, SC
124
135
20.5
2,034
1,991
302.0
Charlotte–Gastonia–Concord, NC–SC
408
459
26.3
5,714
5,615
321.7
Boise City–Nampa, ID
Boston, Mass–NH
b
Essex Division
Bradenton–Sarasota–Venice, FL
Cape Coral–Fort Myers, FL
Chattanooga, TN–GA
55
65
12.4
1,069
1,067
203.4
Chicago, IL–IN–WI
1,212
1,482
15.5
27,942
27,581
287.9
Chicago Division
1,091
1,334
16.7
26,121
25,789
322.4
60
73
10.4
1,073
1,048
148.8
Gary Division
61
76
8.6
748
743
84.7
Cincinnati–Middletown, OH–KY–IN
Lake Division
227
247
11.4
2,997
2,942
135.4
Cleveland–Elyria–Mentor, OH
213
230
11.0
4,359
4,241
202.8
37
40
6.4
728
724
115.6
Columbia, SC
211
230
30.9
3,600
3,536
474.8
Columbus, OH
316
340
18.9
4,330
4,253
236.0
1,335
1,456
22.6
19,151
18,801
291.6
1,090
1,184
27.4
15,266
14,989
346.5
245
271
12.8
3,885
3,812
179.7
94
102
12.2
1,237
1,205
144.3
327
359
14.0
8,418
8,368
327.9
39
43
7.6
504
502
89.2
Colorado Springs, CO
Dallas, TX
Dallas Division
Fort Worth Division
Dayton, OH
Denver–Aurora, CO
Des Moines, IA
70
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Table 23. Diagnoses of HIV infection, 2010, and persons living with a diagnosis of HIV infection, year-end 2009,
by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, 2010
Living with HIV infection, year-end 2009
Estimateda
Area of residence
No.
Detroit, MI
No.
Estimateda
Rate
No.
No.
Rate
509
545
12.4
9,163
8,903
202.2
Detroit Division
351
376
19.5
6,859
6,641
344.8
Warren Division
158
169
6.8
2,304
2,262
91.3
Durham–Chapel Hill, NC
109
119
23.8
1,856
1,826
364.3
El Paso, TX
121
132
17.6
1,527
1,507
200.6
Fresno, CA
97
117
12.8
1,281
1,267
138.4
Grand Rapids–Wyoming, MI
41
44
5.6
820
808
103.9
Greensboro–High Point, NC
128
139
19.5
2,099
2,063
288.6
Greenville, SC
67
73
11.4
1,189
1,164
181.9
Harrisburg–Carlisle, PA
53
57
10.7
1,282
1,275
237.6
164
207
17.3
3,514
3,533
295.4
61
—
—
1,570
—
—
Hartford–West Hartford–East Hartford, CT
Honolulu, HI
Houston–Baytown–Sugar Land, TX
1,430
1,559
26.6
21,170
20,661
352.1
Indianapolis, IN
249
272
15.6
3,997
3,916
224.6
Jackson, MS
167
184
34.0
3,011
2,952
545.8
Jacksonville, FL
356
389
29.3
5,738
5,641
424.7
Kansas City, MO–KS
225
248
12.0
4,423
4,388
212.2
Knoxville, TN
47
51
7.2
1,041
1,036
148.2
Lakeland, FL
113
123
21.1
1,658
1,631
279.6
Lancaster, PA
46
50
9.9
729
726
142.9
352
388
20.4
5,541
5,475
287.7
89
98
14.3
1,666
1,624
236.9
2,341
3,168
24.6
46,266
46,273
359.4
2,045
2,803
28.5
40,047
40,148
407.7
296
366
12.1
6,219
6,125
202.4
171
187
14.9
2,731
2,688
213.6
Madison, WI
37
40
7.1
602
593
104.0
McAllen–Edinburg–Pharr, TX
85
94
12.6
823
811
109.5
396
440
33.7
6,902
6,891
528.1
2,521
2,757
49.7
48,915
48,177
868.5
889
976
55.2
15,895
15,684
887.8
1,297
1,415
56.6
25,330
24,940
997.3
335
366
28.6
7,690
7,553
590.1
Milwaukee–Waukesha–West Allis, WI
165
180
11.6
2,784
2,735
175.4
Minneapolis–St. Paul–Bloomington, MN–WI
312
345
10.6
5,596
5,530
169.1
17
20
4.0
503
498
97.5
Nashville–Davidson–Murfreesboro, TN
301
331
20.9
4,706
4,680
295.8
New Haven–Milford, CT
104
136
16.0
3,204
3,251
383.4
New Orleans–Metairie–Kenner, LA
406
439
36.9
7,635
7,380
620.2
Las Vegas–Paradise, NV
Little Rock–North Little Rock, AR
Los Angeles, CA
Los Angeles Division
Santa Ana Division
Louisville, KY–IN
Memphis, TN–MS–AR
Miami, FL
Fort Lauderdale Division
Miami Division
West Palm Beach Division
Modesto, CA
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
71
Table 23. Diagnoses of HIV infection, 2010, and persons living with a diagnosis of HIV infection, year-end 2009,
by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, 2010
Living with HIV infection, year-end 2009
Estimateda
Estimateda
Area of residence
No.
No.
Rate
No.
No.
New York, NY–NJ–PA
Rate
4,683
6,160
32.3
139,031
140,988
739.3
Edison Division
180
300
12.9
4,787
4,858
208.0
Nassau Division
256
344
12.0
5,694
5,995
208.4
3,730
4,657
39.7
114,630
116,050
989.2
517
860
40.4
13,920
14,086
662.5
12
13
2.4
246
245
45.3
143
157
12.8
2,273
2,211
180.2
81
90
10.6
1,154
1,147
135.0
New York–White Plains—Wayne Division
Newark Division
Ogden–Clearfield, UT
Oklahoma City, OK
Omaha–Council Bluffs, NE–IA
626
686
32.9
9,504
9,398
451.3
Oxnard–Thousand Oaks–Ventura, CA
Orlando, FL
35
43
5.4
796
790
98.4
Palm Bay–Melbourne–Titusville, FL
75
82
15.3
1,174
1,155
215.4
1,199
—
—
25,942
—
—
Philadelphia, PA–NJ–DE–MD
Camden Division
124
207
16.5
2,898
2,949
235.2
Philadelphia Division
966
1,060
26.4
20,600
20,345
507.0
Wilmington Division
109
—
—
2,444
—
—
Phoenix–Mesa–Scottsdale, AZ
454
490
11.2
8,905
8,840
202.6
Pittsburgh, PA
154
167
7.1
2,784
2,755
117.0
30
36
7.0
565
579
112.0
Portland–Vancouver–Beaverton, OR–WA
198
218
9.7
4,113
4,088
182.4
Poughkeepsie–Newburgh–Middletown, NY
70
94
13.8
2,192
2,280
336.7
153
149
14.1
2,727
1,796
170.6
7
8
1.4
125
124
22.4
Raleigh–Cary, NC
192
209
18.5
2,989
2,961
263.0
Richmond, VA
219
263
21.2
4,086
4,114
332.2
Portland–South Portland, ME
Providence–New Bedford–Fall River, RI–MA
Provo–Orem, UT
Riverside–San Bernardino–Ontario, CA
366
447
10.8
7,505
7,338
177.1
Rochester, NY
118
156
15.1
2,923
3,063
295.8
Sacramento–Arden-Arcade–Roseville, CA
191
234
11.0
3,257
3,233
152.0
St. Louis, MO–IL
382
432
15.1
6,239
6,116
214.4
57
62
5.4
1,786
1,777
157.2
San Antonio, TX
Salt Lake City, UT
273
298
14.4
4,442
4,369
210.8
San Diego–Carlsbad–San Marcos, CA
516
631
20.7
11,139
10,962
359.0
San Francisco, CA
873
1,035
24.0
23,274
23,101
535.0
Oakland Division
328
401
15.8
6,520
6,356
251.0
San Francisco Division
545
634
35.5
16,754
16,745
938.0
San Jose–Sunnyvale–Santa Clara, CA
144
180
9.8
2,898
2,878
156.4
San Juan–Caguas–Guaynabo, PR
475
778
29.7
12,552
12,505
477.8
Scranton–Wilkes-Barre, PA
30
34
6.2
578
574
104.5
407
444
13.0
8,056
7,994
234.6
Seattle Division
345
377
14.4
7,125
7,073
270.9
Tacoma Division
62
67
8.4
931
921
115.6
Seattle, WA
72
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Table 23. Diagnoses of HIV infection, 2010, and persons living with a diagnosis of HIV infection, year-end 2009,
by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, 2010
Living with HIV infection, year-end 2009
Estimateda
Area of residence
No.
No.
Rate
Estimateda
No.
No.
Rate
Springfield, MA
73
—
—
1,731
—
—
Stockton, CA
87
107
15.8
1,055
1,042
154.4
Syracuse, NY
49
65
10.0
1,049
1,103
170.7
580
637
23.2
9,927
9,760
355.3
Tampa–St. Petersburg–Clearwater, FL
Toledo, OH
35
38
5.7
909
887
132.0
Tucson, AZ
96
105
10.3
1,900
1,882
184.5
Tulsa, OK
81
87
9.3
1,418
1,381
148.7
335
400
23.9
6,007
6,039
360.6
1,718
—
—
29,532
—
—
168
—
—
3,431
—
—
1,550
—
—
26,101
—
—
49
55
8.9
743
735
119.9
Virginia Beach–Norfolk–Newport News, VA–NC
Washington, DC–VA–MD–WV
Bethesda Division
Washington Division
Wichita, KS
Worcester, MA
61
—
—
1,467
—
—
Youngstown–Warren–Boardman, OH–PA
37
40
7.0
639
620
110.1
35,332
38,079
20.2
716,711
647,021
342.8
Metropolitan areas (population of 50,000–499,999)
4,919
5,720
10.4
89,291
86,466
156.9
Nonmetropolitan areas
2,918
3,299
6.8
54,218
52,195
107.2
43,576
47,692
869,227
793,935
271.4
Subtotal for MSAs (population 500,000)
Totalc
16.3
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Because of the lack of U.S. census
information for all U.S. dependent areas, table includes data for only the 50 states, the District of Columbia, and Puerto Rico.
MSA, metropolitan statistical area.
MSA definitions for this report can be found at http://www.census.gov/population/metro/data/metrodef.html.
a
Includes data from areas in which all parts of the MSA or metropolitan division had implemented confidential name-based HIV infection reporting by
at least January 2007 and had reported these data to CDC since at least June 2007. Estimated numbers resulted from statistical adjustment that
accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b Counts of diagnoses of HIV infection for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 1 metropolitan division
with population of <500,000.
c Includes persons whose county of residence is unknown. Because column totals for estimated numbers were calculated independently of the values
for the subpopulations, the values in each column may not sum to the column total.
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
73
74
Table 24. AIDS diagnoses, 2010 and cumulative, and persons living with an AIDS diagnosis, year-end 2009, by metropolitan statistical area of
residence—United States and Puerto Rico
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2010
Estimatedb
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Area of residence
No.
No.
Rate
Children
Rankc
No.
No.
22
3.1
98
871
1
Albany–Schenectady–Troy, NY
69
97
11.3
35
2,584
Albuquerque, NM
43
51
5.9
82
1,660
Augusta–Richmond County, GA–SC
Estimatedb
No.
16
Atlanta–Sandy Springs–Marietta, GA
Living with AIDS, year-end
2009
Estimatedb
Akron, OH
Allentown–Bethlehem–Easton, PA–NJ
Total
No.
No.
Rate
872
383
370
52.9
26
2,611
1,178
1,184
138.1
3
1,663
714
698
81.4
50
58
7.1
73
1,643
21
1,664
827
821
100.6
553
652
11.9
31
27,133
142
27,275
13,476
13,698
250.2
33
47
8.7
53
2,179
24
2,203
1,036
1,043
193.5
105
126
7.4
64
5,593
25
5,618
2,559
2,503
146.8
55
77
9.5
47
2,012
10
2,023
1,155
1,179
146.0
Baltimore–Towson, MD
514
721
26.8
4
24,215
222
24,438
10,547
10,765
400.1
Baton Rouge, LA
245
265
33.7
1
4,796
20
4,816
2,067
1,925
244.7
Birmingham–Hoover, AL
44
52
4.6
93
2,957
25
2,982
1,234
1,208
106.8
Boise City–Nampa, ID
24
28
4.6
92
349
0
349
157
157
25.8
Boston, Mass–NHd
237
570
12.4
29
16,063
158
16,221
6,842
7,100
154.7
Boston Division
121
296
15.4
—
9,935
97
10,032
4,081
4,227
220.3
Cambridge Division
67
164
10.9
—
3,825
37
3,862
1,741
1,818
120.8
Essex Division
41
101
13.6
—
1,939
23
1,962
866
904
121.8
Bradenton–Sarasota–Venice, FL
50
57
8.3
55
2,306
29
2,335
1,018
995
144.6
Bridgeport–Stamford–Norwalk, CT
77
100
11.1
36
4,184
57
4,241
1,865
1,839
204.1
Buffalo–Niagara Falls, NY
64
91
8.1
59
2,861
21
2,882
1,210
1,215
108.1
Cape Coral–Fort Myers, FL
64
75
12.8
27
2,067
26
2,094
909
897
152.8
Charleston–North Charleston, SC
89
107
16.2
15
2,474
22
2,496
1,086
1,048
159.0
168
199
11.4
34
4,236
22
4,258
2,023
1,980
113.4
41
48
9.2
50
1,183
3
1,186
580
577
110.1
Chicago, IL–IN–WI
856
1,197
12.5
28
35,606
269
35,875
15,559
15,735
164.2
Chicago Division
792
1,114
13.9
—
33,384
256
33,640
14,504
14,695
183.7
Gary Division
33
39
5.5
—
1,266
8
1,274
556
535
75.9
Lake Division
31
44
5.0
—
957
5
962
499
505
57.5
Cincinnati–Middletown, OH–KY–IN
138
178
8.2
57
3,444
20
3,464
1,557
1,529
70.4
Cleveland–Elyria–Mentor, OH
119
153
7.3
66
4,906
49
4,955
2,179
2,117
101.2
Austin–Round Rock, TX
Bakersfield, CA
Charlotte–Gastonia–Concord, NC–SC
Chattanooga, TN–GA
Table 24. AIDS diagnoses, 2010 and cumulative, and persons living with an AIDS diagnosis, year-end 2009, by metropolitan statistical area of
residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2010
Estimatedb
Area of residence
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Colorado Springs, CO
No.
No.
Rate
Children
Total
Living with AIDS, year-end
2009
Estimatedb
Rankc
No.
No.
Estimatedb
No.
No.
No.
Rate
17
20
3.1
97
656
5
661
294
289
46.2
Columbia, SC
164
191
25.6
6
4,018
25
4,043
2,042
1,989
267.1
Columbus, OH
185
236
13.1
26
4,057
20
4,077
1,673
1,628
90.3
Dallas, TX
735
874
13.6
23
23,804
63
23,867
10,421
10,123
157.0
Dallas Division
627
741
17.1
—
18,949
37
18,986
8,357
8,116
187.6
Fort Worth Division
108
133
6.3
—
4,854
26
4,880
2,064
2,006
94.6
45
57
6.8
75
1,477
15
1,492
668
647
77.4
218
258
10.1
42
7,994
22
8,016
3,553
3,515
137.7
26
30
5.4
83
651
4
655
313
311
55.3
Dayton, OH
Denver–Aurora, CO
Des Moines, IA
Detroit, MI
342
375
8.5
54
12,133
76
12,209
4,988
4,759
108.1
Detroit Division
252
277
14.4
—
9,576
59
9,635
3,782
3,589
186.4
Warren Division
90
97
3.9
—
2,558
17
2,575
1,206
1,170
47.2
Durham–Chapel Hill, NC
50
61
12.1
30
1,467
10
1,477
608
592
118.1
El Paso, TX
47
55
7.3
67
1,816
10
1,826
946
928
123.5
Fresno, CA
55
76
8.3
56
1,890
11
1,901
844
872
95.3
Grand Rapids–Wyoming, MI
33
37
4.7
91
978
6
984
478
468
60.1
Greensboro–High Point, NC
58
71
10.0
43
1,587
19
1,606
689
671
93.9
Greenville, SC
53
63
9.8
45
1,512
4
1,516
683
662
103.6
Harrisburg–Carlisle, PA
Hartford–West Hartford–East Hartford, CT
Honolulu, HI
38
44
8.2
58
1,488
9
1,497
735
731
136.2
122
158
13.2
24
5,730
47
5,777
2,364
2,299
192.3
41
49
5.3
85
2,426
14
2,440
953
938
103.3
Houston–Baytown–Sugar Land, TX
913
1,063
18.1
12
30,510
174
30,684
12,115
11,680
199.1
Indianapolis, IN
156
181
10.4
39
4,527
25
4,552
2,118
2,037
116.8
Jackson, MS
134
158
29.2
3
2,968
30
2,998
1,334
1,299
240.2
Jacksonville, FL
231
269
20.3
11
7,359
78
7,437
3,297
3,209
241.6
Kansas City, MO–KS
125
148
7.2
71
5,658
16
5,674
2,560
2,521
121.9
Knoxville, TN
43
51
7.3
70
1,087
5
1,092
533
527
75.4
Lakeland, FL
80
92
15.8
16
2,270
21
2,291
1,012
988
169.4
Lancaster, PA
29
34
6.7
77
865
22
887
401
398
78.5
75
76
Table 24. AIDS diagnoses, 2010 and cumulative, and persons living with an AIDS diagnosis, year-end 2009, by metropolitan statistical area of
residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2010
Estimatedb
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Area of residence
Las Vegas–Paradise, NV
Little Rock–North Little Rock, AR
Los Angeles, CA
Los Angeles Division
Santa Ana Division
No.
No.
Children
Total
Living with AIDS, year-end
2009
Estimatedb
Rate
Rankc
No.
No.
Estimatedb
No.
No.
No.
Rate
213
250
13.1
25
5,705
28
5,733
2,746
2,693
141.5
55
60
8.8
52
1,617
14
1,631
796
762
111.1
1,207
2,007
15.6
17
67,525
302
67,828
28,267
28,181
218.9
1,057
1,794
18.2
—
59,522
258
59,780
24,606
24,503
248.8
150
213
7.0
—
8,003
45
8,048
3,661
3,678
121.5
Louisville, KY–IN
79
93
7.4
65
2,827
28
2,855
1,347
1,317
104.6
Madison, WI
13
15
2.6
101
617
5
622
303
295
51.8
McAllen–Edinburg–Pharr, TX
Memphis, TN–MS–AR
Miami, FL
Fort Lauderdale Division
33
40
5.4
84
816
12
828
455
446
60.2
234
276
21.1
9
6,177
20
6,197
3,018
2,994
229.4
1,436
1,681
30.3
2
64,399
1,008
65,408
26,858
26,240
473.0
551
646
36.5
—
19,655
265
19,920
8,586
8,408
476.0
Miami Division
637
744
29.7
—
33,709
518
34,226
13,609
13,277
530.9
West Palm Beach Division
248
292
22.8
—
11,036
225
11,261
4,663
4,555
355.8
86
102
6.6
78
2,933
18
2,951
1,342
1,304
83.6
145
170
5.2
86
5,167
23
5,190
2,533
2,468
75.5
Milwaukee–Waukesha–West Allis, WI
Minneapolis–St. Paul–Bloomington, MN–WI
Modesto, CA
Nashville–Davidson–Murfreesboro, TN
New Haven–Milford, CT
New Orleans–Metairie–Kenner, LA
13
20
3.8
96
808
6
814
378
388
76.0
141
163
10.3
41
4,572
21
4,593
2,476
2,454
155.1
71
93
11.0
38
5,030
76
5,106
2,199
2,171
256.1
279
311
26.2
5
10,169
71
10,240
4,031
3,816
320.7
2,986
4,318
22.6
8
221,281
3,008
224,289
83,243
84,703
444.2
Edison Division
114
175
7.5
—
7,569
144
7,713
2,731
2,738
117.2
Nassau Division
154
220
7.6
—
9,196
116
9,311
3,635
3,649
126.9
2,388
3,418
29.1
—
182,011
2,397
184,407
69,577
70,999
605.2
330
505
23.8
—
22,505
352
22,858
7,300
7,317
344.1
25.6
New York, NY–NJ–PA
New York–White Plains—Wayne Division
Newark Division
Ogden–Clearfield, UT
11
13
2.5
102
291
4
295
141
139
Oklahoma City, OK
69
75
6.1
80
2,656
5
2,661
1,101
1,052
85.7
Omaha–Council Bluffs, NE–IA
55
65
7.7
62
1,274
5
1,279
627
619
72.9
364
422
20.3
10
10,644
97
10,742
5,042
4,943
237.4
16
23
2.9
100
1,175
3
1,178
510
520
64.8
Orlando, FL
Oxnard–Thousand Oaks–Ventura, CA
Table 24. AIDS diagnoses, 2010 and cumulative, and persons living with an AIDS diagnosis, year-end 2009, by metropolitan statistical area of
residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2010
Estimatedb
Area of residence
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Palm Bay–Melbourne–Titusville, FL
Philadelphia, PA–NJ–DE–MD
Camden Division
Philadelphia Division
Wilmington Division
Phoenix–Mesa–Scottsdale, AZ
Pittsburgh, PA
Portland–South Portland, ME
No.
No.
Rate
Children
Total
Living with AIDS, year-end
2009
Estimatedb
Rankc
No.
No.
Estimatedb
No.
No.
No.
Rate
41
49
9.1
51
1,729
11
1,740
779
762
142.1
681
846
14.2
21
32,920
323
33,244
15,143
14,930
250.1
79
118
9.4
—
3,675
44
3,720
1,521
1,531
122.1
529
621
15.5
—
25,711
257
25,968
12,134
11,909
296.8
73
107
15.3
—
3,534
22
3,556
1,488
1,489
212.2
349
407
9.3
49
9,200
32
9,232
4,223
4,167
95.5
84
98
4.1
94
3,691
20
3,711
1,582
1,562
66.3
11
16
3.0
99
675
1
676
315
315
61.0
Portland–Vancouver–Beaverton, OR–WA
137
159
7.1
72
5,549
10
5,559
2,536
2,513
112.1
Poughkeepsie–Newburgh–Middletown, NY
37
52
7.8
61
3,439
25
3,465
1,392
1,392
205.6
Providence–New Bedford–Fall River, RI–MA
64
105
6.6
79
4,526
44
4,571
2,019
2,033
127.0
Provo–Orem, UT
3
4
0.7
103
137
3
140
74
73
13.1
Raleigh–Cary, NC
115
134
11.9
32
2,715
15
2,730
1,466
1,445
128.4
Richmond, VA
152
216
17.4
13
4,113
36
4,149
1,728
1,742
140.7
Riverside–San Bernardino–Ontario, CA
203
281
6.8
76
10,287
64
10,350
4,886
4,896
118.2
165.8
Rochester, NY
59
83
8.0
60
3,586
15
3,601
1,704
1,717
Sacramento–Arden-Arcade–Roseville, CA
114
159
7.5
63
4,674
29
4,704
1,897
1,934
90.9
St. Louis, MO–IL
231
281
9.8
44
7,108
41
7,149
3,211
3,128
109.7
Salt Lake City, UT
40
46
4.1
95
1,958
10
1,968
974
966
85.5
San Antonio, TX
180
214
10.3
40
6,049
31
6,080
2,681
2,613
126.1
San Diego–Carlsbad–San Marcos, CA
310
432
14.2
22
14,917
72
14,990
6,745
6,785
222.2
San Francisco, CA
520
701
16.2
14
44,883
102
44,985
15,505
15,690
363.4
Oakland Division
198
274
10.8
—
11,404
51
11,455
4,649
4,667
184.3
San Francisco Division
322
428
24.0
—
33,479
50
33,530
10,856
11,023
617.5
San Jose–Sunnyvale–Santa Clara, CA
142
203
11.0
37
4,578
15
4,593
2,056
2,105
114.4
San Juan–Caguas–Guaynabo, PR
274
374
14.3
20
23,934
279
24,213
7,816
7,684
293.6
29
33
6.1
81
670
6
676
325
325
59.2
Scranton–Wilkes-Barre, PA
77
78
Table 24. AIDS diagnoses, 2010 and cumulative, and persons living with an AIDS diagnosis, year-end 2009, by metropolitan statistical area of
residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2010
Estimatedb
HIV Infection and AIDS Data for States and Metropolitan Statistical Areas
Area of residence
Seattle, WA
Seattle Division
Tacoma Division
No.
No.
Rate
Children
Total
Living with AIDS, year-end
2009
Estimatedb
Rankc
No.
No.
Estimatedb
No.
No.
No.
Rate
206
249
7.3
68
10,404
28
10,432
4,637
4,583
134.5
175
210
8.1
—
9,234
19
9,253
4,130
4,084
156.4
31
38
4.8
—
1,170
9
1,179
507
498
62.5
Springfield, MA
44
108
15.4
18
2,515
30
2,546
991
1,024
146.5
Stockton, CA
47
66
9.7
46
1,354
14
1,368
637
649
96.2
Syracuse, NY
32
45
6.9
74
1,522
9
1,531
668
668
103.4
346
409
14.9
19
13,238
120
13,358
5,691
5,547
201.9
Toledo, OH
25
34
5.0
90
990
15
1,005
446
435
64.7
Tucson, AZ
64
74
7.3
69
2,325
10
2,335
980
962
94.3
Tampa–St. Petersburg–Clearwater, FL
Tulsa, OK
42
47
5.0
88
1,774
10
1,784
787
753
81.0
Virginia Beach–Norfolk–Newport News, VA–NC
112
158
9.4
48
5,584
65
5,650
2,451
2,451
146.4
Washington, DC–VA–MD–WV
928
1,377
25.1
7
38,576
329
38,904
17,687
17,986
328.4
84
128
10.7
—
3,713
26
3,740
2,025
2,099
175.0
844
1,248
29.2
—
34,862
303
35,165
15,662
15,887
371.5
26
31
5.0
89
980
2
982
443
434
70.9
Bethesda Division
Washington Division
Wichita, KS
Worcester, MA
36
93
11.6
33
2,171
21
2,192
983
1,019
126.8
Youngstown–Warren–Boardman, OH–PA
21
28
5.1
87
666
0
666
282
272
48.3
20,805
27,429
13.4
—
973,372
8,528
981,899
408,936
407,727
198.7
Metropolitan areas (population of 50,000–499,999)
2,807
3,471
6.2
—
109,446
838
110,284
48,736
48,032
85.8
Nonmetropolitan areas
1,833
2,246
4.5
—
64,962
467
65,429
29,898
29,369
58.9
25,726
33,605
10.8
—
1,152,845
9,880
1,162,724
489,912
487,606
156.8
Subtotal for MSAs (population 500,000)
Totale
Note. Because of the lack of U.S. census information for all U.S. dependent areas, table includes data for only the 50 states, the District of Columbia, and Puerto Rico.
MSA, metropolitan statistical area.
MSA definitions for this report can be found at http://www.census.gov/population/metro/data/metrodef.html.
a
From the beginning of the epidemic through 2010.
b
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
c Based on estimated rate.
d
Counts of AIDS diagnoses for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 1 metropolitan division with population of <500,000.
e
Includes persons whose county of residence is unknown. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column
may not sum to the column total.
Web Addresses for Reports of State and Local HIV Surveillance
Alabama
Alaska
Arizona
Arkansas
California
Chicago
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Houston
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Los Angeles
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Philadelphia
Rhode Island
San Francisco
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
http://www.adph.org/aids/Default.asp?id=984
http://www.epi.hss.state.ak.us/bulletins/catlist.jsp?cattype=HIV+(Human+Immunodeficiency+Virus)
http://azdhs.gov/phs/hiv/reporting/index.htm
http://www.healthy.arkansas.gov/programsServices/healthStatistics/Pages/stdHIVRegistry.aspx
http://www.cdph.ca.gov/data/statistics/Pages/OAHIVAIDSStatistics.aspx
http://www.cityofchicago.org/HealthInformation
http://www.cdphe.state.co.us/dc/HIVandSTD/surveillance.html
http://www.ct.gov/dph/cwp/view.asp?a=3135&q=393048
http://www.dhss.delaware.gov/dhss/dph/epi/disstatshiv.html
http://doh.dc.gov/doh/frames.asp?doc=/doh/lib/doh/services/administration_offices/hiv_aids/pdf/2010_Annual_Report_FINAL.pdf
http://www.doh.state.fl.us/Disease_ctrl/aids/trends/trends.html
http://health.state.ga.us/epi/hivaids/index.asp
http://hawaii.gov/health/healthy-lifestyles/std-aids/data-statistics/index.html
http://www.houstontx.gov/health/HIV-STD/
http://healthandwelfare.idaho.gov/Health/FamilyPlanningSTDHIV/HIVAIDS/tabid/390/Default.aspx
http://www.idph.state.il.us/aids/stats.htm
http://www.in.gov/isdh/23266.htm
http://www.idph.state.ia.us/HivStdHep/HIV-AIDS.aspx?prog=Hiv&pg=HivSurv
http://www.kdheks.gov/hiv/surveillance.html
http://chfs.ky.gov/dph/epi/hivaids/surveillance.htm
http://publichealth.lacounty.gov/phcommon/public/reports/rptspubdisplay.cfm?unit=hiv&ou=ph&prog=hae
http://new.dhh.louisiana.gov/index.cfm/newsroom/category/63
http://www.maine.gov/dhhs/boh/ddc/hiv-std/data/index.shtml
http://ideha.dhmh.md.gov/OIDEOR/CHSE/SitePages/statistics.aspx
http://www.mass.gov/eohhs/researcher/physical-health/diseases-and-conditions/hiv-aids/surveillance/surveillance/
http://www.michigan.gov/mdch/0,4612,7-132-2940_2955_2982_46000_46003---,00.html
http://www.health.state.mn.us/divs/idepc/diseases/hiv/hivstatistics.html
http://www.msdh.state.ms.us/msdhsite/index.cfm/14,0,150,134,html
http://www.dhss.mo.gov/data/hivstdaids/index.php
http://hivdata.hhs.mt.gov/
http://dhhs.ne.gov/publichealth/Pages/dpc_hiv.aspx
http://health.nv.gov/FP_Publications.htm
http://www.dhhs.nh.gov/data/index.htm
http://www.state.nj.us/health/aids/aidsqtr.shtml
http://nmhealth.org/ERD/HealthData/hiv_aids.shtml
http://www.health.state.ny.us/diseases/aids/statistics/index.htm
http://www.nyc.gov/html/doh/html/dires/epi_reports.shtml
http://www.epi.state.nc.us/epi/hiv/stats.html
http://www.ndhealth.gov/hiv/
http://www.odh.ohio.gov/healthStats/disease/hivcov.aspx
http://www.ok.gov/health/Disease,_Prevention,_Preparedness/HIV_STD_Service/HIV_STD_Statistics/index.html
http://public.health.oregon.gov/DiseasesConditions/CommunicableDisease/DiseaseSurveillanceData/HIVData/Pages/index.aspx
http://www.portal.state.pa.us/portal/server.pt?open=514&objID=557343&mode=2
http://www.phila.gov/health/AACO/AACODataResearch.html
http://www.health.ri.gov/programs/hivaidssurveillance/
http://www.sfdph.org/dph/files/reports/default.asp
http://www.dhec.sc.gov/health/disease/stdhiv/surveillance.htm
http://doh.sd.gov/Disease/statistics.aspx
http://health.state.tn.us/statistics/std.htm
http://www.dshs.state.tx.us/hivstd/reports/default.shtm
http://health.utah.gov/cdc/sp.htm
http://healthvermont.gov/prevent/aids/quarter/reports.aspx
http://www.vdh.virginia.gov/epidemiology/DiseasePrevention/DAta/
http://www.doh.wa.gov/cfh/hiv/statistics/reporting/default.htm
http://www.wvhiv.org/DiseaseSurveillance/tabid/1674/Default.aspx
http://dhs.wisconsin.gov/aids-hiv/Stats/index.htm
http://www.health.wyo.gov/PHSD/hivsurveillance/index.html
Note. Electronic reports were not available for the following areas: American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, and
the U.S. Virgin Islands.
Web Addresses for Reports of State or Local HIV Surveillance
79
| File Type | application/pdf |
| File Title | Microsoft Word - Attachment 6_cover.doc |
| Author | smh1 |
| File Modified | 2012-10-29 |
| File Created | 2012-08-31 |